<html class="no-js" lang="en"><head><meta class="foundation-mq-small"/><meta class="foundation-mq-small-only"/><meta class="foundation-mq-medium"/><meta class="foundation-mq-medium-only"/><meta class="foundation-mq-large"/><meta class="foundation-mq-large-only"/><meta class="foundation-mq-xlarge"/><meta class="foundation-mq-xlarge-only"/><meta class="foundation-mq-xxlarge"/><meta class="foundation-data-attribute-namespace"/><script src="https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101"></script><script async="" src="https://www.google-analytics.com/analytics.js" type="text/javascript"></script><script src="https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019070801.js"></script><script async="" src="https://www.gstatic.com/recaptcha/api2/v1562567553145/recaptcha__en.js" type="text/javascript"></script><script src="https://v1.addthis.com/live/red_lojson/300lo.json?si=5d2a2aea2a29e6f9&amp;bkl=0&amp;bl=1&amp;pdt=2310&amp;sid=5d2a2aea2a29e6f9&amp;pub=xa-5265518246c10183&amp;rev=v8.4.11-wp&amp;ln=en&amp;pc=men&amp;cb=0&amp;ab=-&amp;dp=academic.oup.com&amp;fp=cid%2Farticle%2F58%2F8%2F1149%2F355966&amp;fr=&amp;of=0&amp;pd=0&amp;irt=0&amp;vcl=0&amp;md=0&amp;ct=1&amp;tct=0&amp;abt=0&amp;cdn=0&amp;pi=1&amp;rb=0&amp;gen=100&amp;chr=UTF-8&amp;colc=1563044586133&amp;jsl=1&amp;uvs=5d2a2aea0c4e273c000&amp;skipb=1&amp;callback=addthis.cbs.vhp1_58055022175532470" type="text/javascript"></script><script src="https://v1.addthisedge.com/live/boost/xa-5265518246c10183/_ate.track.config_resp" type="text/javascript"></script>
<title>Guillain-Barré Syndrome, Influenza, and Influenza Vaccination: The Epidemiologic Evidence | Clinical Infectious Diseases | Oxford Academic</title>
<script async="" src="https://www.googletagmanager.com/gtm.js?id=GTM-W6DD7HV"></script><script src="https://ajax.googleapis.com/ajax/libs/jquery/2.2.4/jquery.min.js" type="text/javascript"></script>
<script>window.jQuery || document.write('<script src="/UI/app/js/jquery-2.2.4.js">\x3C/script>')</script>
<meta content="width=device-width, initial-scale=1, maximum-scale=1" name="viewport"/>
<meta charset="utf-8"/>
<meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
<meta content="IE=Edge" http-equiv="X-UA-Compatible"/>
<link href="https://academic.oup.com/UI/app/img/apple-touch-icon.png" rel="apple-touch-icon" sizes="180x180"/>
<link href="https://academic.oup.com/UI/app/img/favicon-32x32.png" rel="icon" sizes="32x32" type="image/png"/>
<link href="https://academic.oup.com/UI/app/img/favicon-16x16.png" rel="icon" sizes="16x16" type="image/png"/>
<link href="https://academic.oup.com/UI/app/img/manifest.json" rel="manifest"/>
<link color="#5bbad5" href="https://academic.oup.com/UI/app/img/safari-pinned-tab.svg" rel="mask-icon"/>
<link href="https://academic.oup.com/UI/app/img/favicon.ico" rel="shortcut icon"/>
<meta content="/UI/app/img/browserconfig.xml" name="msapplication-config"/>
<meta content="#002f65" name="theme-color"/>
<link href="//oup.silverchair-cdn.com/UI/app/css/style.min.css" rel="stylesheet" type="text/css"/>
<link href="//oup.silverchair-cdn.com/UI/app/vendor/oupCookiePolicy/css/jquery.fancybox-1.3.4_1.css" rel="stylesheet" type="text/css"/>
<link href="//oup.silverchair-cdn.com/UI/app/vendor/jscrollpane/jscrollpane.css" rel="stylesheet" type="text/css"/>
<link href="//oup.silverchair-cdn.com/UI/app/vendor/jquery.tablesorter/theme.default.css" rel="stylesheet" type="text/css"/>
<link href="https://fonts.googleapis.com/css?family=Merriweather:300,400,400italic,700,700italic|Source+Sans+Pro:400,400italic,700,700italic" rel="stylesheet" type="text/css"/>
<link href="//oup.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/CSS/journals/global.css" rel="stylesheet" type="text/css"/>
<link href="//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/CSS/cid/Site605467745.css" rel="stylesheet" type="text/css"/>
<script>
            (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
                j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
                    'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
            })(window, document, 'script', 'dataLayer', 'GTM-W6DD7HV');
        </script>
<script type="text/javascript">
            var App = App || {};
            App.LoginUserInfo = {
                isInstLoggedIn: [0],
                isIndividualLoggedIn: [0]
            };

            App.CurrentSubdomain = 'cid';
            App.SiteURL = 'academic.oup.com/cid';
        </script>
<link href="https://cdn.jsdelivr.net/chartist.js/latest/chartist.min.css" rel="stylesheet" type="text/css"/>
<script type="application/ld+json">
        {"@context":"http://schema.org","@id":"https://academic.oup.com/cid/article/58/8/1149/355966","@type":"ScholarlyArticle","name":"Guillain-Barré Syndrome, Influenza, and Influenza Vaccination: The Epidemiologic Evidence","about":["influenza","guillain-barre syndrome","influenza vaccines","vaccination","vaccines","infection","swine influenza"],"datePublished":"2014-01-09","isPartOf":{"@id":"https://academic.oup.com/cid/issue/58/8","@type":"PublicationIssue","issueNumber":"8","datePublished":"2014-04-15","isPartOf":{"@id":"https://academic.oup.com/cid","@type":"Periodical","name":"Clinical Infectious Diseases","issn":["1537-6591"]}},"url":"http://dx.doi.org/10.1093/cid/ciu005","keywords":["influenza","guillain-barre syndrome","influenza vaccines","vaccination","vaccines","infection","swine influenza","Guillain-Barré syndrome","influenza","influenza vaccination"],"inLanguage":"en","copyrightHolder":"Infectious Diseases Society of America","copyrightYear":"2019","publisher":"Oxford University Press","sameAs":"https://academic.oup.com/cid/article/58/8/1149/355966","author":[{"name":"Vellozzi, Claudia","affiliation":"Immunization Safety Office ,  National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention ,  Atlanta, Georgia","@type":"Person"},{"name":"Iqbal, Shahed","affiliation":"Immunization Safety Office ,  National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention ,  Atlanta, Georgia","@type":"Person"},{"name":"Broder, Karen","affiliation":"Immunization Safety Office ,  National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention ,  Atlanta, Georgia","@type":"Person"}],"description":"A small increased risk of Guillain-Barré syndrome (GBS) has been observed following influenza vaccination but is 10-fold less than that observed following the 1","pageStart":"1149","pageEnd":"1155","thumbnailURL":"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/Issue/58/8/0/m_cid58_8.cover.gif?Expires=1626097536&Signature=ZQaPvkWCHxcBbiFRoW5NLcgE2wn5Xc~3mY0y~5e77Od2wS144uqfpCooLOA3Vp6MMbEuDZWJy1caBawqqqvlcyZjiJN1JkltS1MsztkCDUw8lMZQq9QEVF0weYF8CPK37TbgiT~5k5TTpDIbf4dOnIC9adSnpf7ILdIxlLnCR0sGFlxtkOi5vE0aSzYCDxJZkaS8re2dOovBWMviRCJ9AFOK3IxuiKtIJojDP77elf8a~0oIvwds~HzS-A2n6A4xEfsB1IEO7AKRNxNxEIS0ZPnE1W6LT98cznLNvLngdc-i9oPUztRn52ZZFzqAaYLVsf7G2wvXBi561AjUg1-Gwg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA","headline":"Guillain-Barré Syndrome, Influenza, and Influenza Vaccination: The Epidemiologic Evidence","image":"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/Issue/58/8/0/m_cid58_8.cover.gif?Expires=1626097536&Signature=ZQaPvkWCHxcBbiFRoW5NLcgE2wn5Xc~3mY0y~5e77Od2wS144uqfpCooLOA3Vp6MMbEuDZWJy1caBawqqqvlcyZjiJN1JkltS1MsztkCDUw8lMZQq9QEVF0weYF8CPK37TbgiT~5k5TTpDIbf4dOnIC9adSnpf7ILdIxlLnCR0sGFlxtkOi5vE0aSzYCDxJZkaS8re2dOovBWMviRCJ9AFOK3IxuiKtIJojDP77elf8a~0oIvwds~HzS-A2n6A4xEfsB1IEO7AKRNxNxEIS0ZPnE1W6LT98cznLNvLngdc-i9oPUztRn52ZZFzqAaYLVsf7G2wvXBi561AjUg1-Gwg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA"}
    </script>
<meta content="article" property="og:type"/>
<meta content="Guillain-Barré Syndrome, Influenza, and Influenza Vaccination: The Epidemiologic Evidence" property="og:title"/>
<meta content="A small increased risk of Guillain-Barré syndrome (GBS) has been observed following influenza vaccination but is 10-fold less than that observed following the 1" property="og:description"/>
<meta content="https://academic.oup.com/cid/article/58/8/1149/355966" property="og:url"/>
<meta content="https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/Issue/58/8/0/m_cid58_8.cover.gif?Expires=1626097536&amp;Signature=ZQaPvkWCHxcBbiFRoW5NLcgE2wn5Xc~3mY0y~5e77Od2wS144uqfpCooLOA3Vp6MMbEuDZWJy1caBawqqqvlcyZjiJN1JkltS1MsztkCDUw8lMZQq9QEVF0weYF8CPK37TbgiT~5k5TTpDIbf4dOnIC9adSnpf7ILdIxlLnCR0sGFlxtkOi5vE0aSzYCDxJZkaS8re2dOovBWMviRCJ9AFOK3IxuiKtIJojDP77elf8a~0oIvwds~HzS-A2n6A4xEfsB1IEO7AKRNxNxEIS0ZPnE1W6LT98cznLNvLngdc-i9oPUztRn52ZZFzqAaYLVsf7G2wvXBi561AjUg1-Gwg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" property="og:image"/>
<meta content="2014-01-09" property="og:updated_time"/>
<meta content="OUP Academic" property="og:site_name"/>
<meta content="Vellozzi, Claudia" name="citation_author"/><meta content="Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia" name="citation_author_institution"/><meta content="Iqbal, Shahed" name="citation_author"/><meta content="Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia" name="citation_author_institution"/><meta content="Broder, Karen" name="citation_author"/><meta content="Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia" name="citation_author_institution"/><meta content="Guillain-Barré Syndrome, Influenza, and Influenza Vaccination: The Epidemiologic Evidence" name="citation_title"/><meta content="1149" name="citation_firstpage"/><meta content="1155" name="citation_lastpage"/><meta content="10.1093/cid/ciu005" name="citation_doi"/><meta content="influenza" name="citation_keyword"/><meta content="guillain-barre syndrome" name="citation_keyword"/><meta content="influenza vaccines" name="citation_keyword"/><meta content="vaccination" name="citation_keyword"/><meta content="Clinical Infectious Diseases" name="citation_journal_title"/><meta content="Clin Infect Dis" name="citation_journal_abbrev"/><meta content="58" name="citation_volume"/><meta content="8" name="citation_issue"/><meta content="2014/04/15" name="citation_publication_date"/><meta content="1058-4838" name="citation_issn"/><meta content="Narnia" name="citation_publisher"/><meta content="citation_title=Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977; Am J Epidemiol;  citation_year=1979;  citation_volume=110;  citation_pages=105-23; " name="citation_reference"/><meta content="citation_title=Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP); citation_author=Centers for Disease Control and Prevention; MMWR Morb Mortal Wkly Rep;  citation_year=2010;  citation_volume=59;  citation_issue=RR-8;  citation_pages=1-61; " name="citation_reference"/><meta content="citation_publisher=University Press of the Pacific, Honolulu, HI; The swine flu affair: decision-making on a slippery disease;  citation_year=1978; " name="citation_reference"/><meta content="citation_title=Guillain-Barre syndrome; Lancet;  citation_year=2005;  citation_volume=366;  citation_pages=1653-66; " name="citation_reference"/><meta content="citation_title=Guillain-Barre syndrome; N Engl J Med;  citation_year=2012;  citation_volume=366;  citation_pages=2294-304; " name="citation_reference"/><meta content="citation_title=Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis; Neuroepidemiology;  citation_year=2011;  citation_volume=36;  citation_pages=123-33; " name="citation_reference"/><meta content="citation_title=Guillain-Barre syndrome incidence in a large United States cohort (2000–2009); Neuroepidemiology;  citation_year=2012;  citation_volume=39;  citation_pages=109-15; " name="citation_reference"/><meta content="citation_title=The epidemiology of Guillain-Barre syndrome worldwide: a systematic literature review; Neuroepidemiology;  citation_year=2009;  citation_volume=32;  citation_pages=150-63; " name="citation_reference"/><meta content="citation_title=Guillain-Barre syndrome after exposure to influenza virus; Lancet Infect Dis;  citation_year=2010;  citation_volume=10;  citation_pages=643-51; " name="citation_reference"/><meta content="citation_title=Campylobacter jejuni and cytomegalovirus (CMV) infections in patients with the Guillain-Barre syndrome; Arch Pediatr;  citation_year=2006;  citation_volume=13;  citation_pages=1561-5; " name="citation_reference"/><meta content="citation_title=Prevalence and characteristics of Guillain-Barre syndromes associated with Campylobacter jejuni and cytomegalovirus in greater Paris; citation_text=S99; Int J Antimicrob Agents;  citation_year=2004;  citation_volume=24; " name="citation_reference"/><meta content="citation_title=Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain-Barre syndrome, England; Emerg Infect Dis;  citation_year=2006;  citation_volume=12;  citation_pages=1880-7; " name="citation_reference"/><meta content="citation_title=The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study; Neurology;  citation_year=1998;  citation_volume=51;  citation_pages=1110-5; " name="citation_reference"/><meta content="citation_title=An epidemiologic and clinical-evaluation of Guillain-Barre-syndrome reported in association with the administration of swine influenza vaccines; Am J Epidemiol;  citation_year=1984;  citation_volume=119;  citation_pages=841-79; " name="citation_reference"/><meta content="Institute of Medicine Immunization safety review: influenza vaccines and neurological complications. The National Academies Press, Washington, D.C. 2003 " name="citation_reference"/><meta content="citation_title=Lack of association of Guillain-Barre syndrome with vaccinations; Clin Infect Dis;  citation_year=2013;  citation_volume=57;  citation_pages=197-204; " name="citation_reference"/><meta content="citation_title=Evaluation of Guillain-Barre syndrome among recipients of influenza vaccine in 2000 and 2001; Am J Prev Med;  citation_year=2010;  citation_volume=39;  citation_pages=296-304; " name="citation_reference"/><meta content="citation_title=Near real-time surveillance for influenza vaccine safety: proof-of-concept in the vaccine safety datalink project; Am J Epidemiol;  citation_year=2010;  citation_volume=171;  citation_pages=177-88; " name="citation_reference"/><meta content="citation_title=Guillain-Barre syndrome—reply; Lancet;  citation_year=2006;  citation_volume=367;  citation_pages=473-4; " name="citation_reference"/><meta content="citation_title=Guillain-Barre syndrome after influenza vaccination in adults—a population-based study; Arch Int Med;  citation_year=2006;  citation_volume=166;  citation_pages=2217-21; " name="citation_reference"/><meta content="citation_title=Guillain-Barre-syndrome in the United States, 1979–1980 and 1980–1981—lack of an association with influenza vaccination; JAMA;  citation_year=1982;  citation_volume=248;  citation_pages=698-700; " name="citation_reference"/><meta content="citation_title=The Guillain-Barre syndrome and the 1993 and 1993–1994 influenza vaccines; N Engl J Med;  citation_year=1998;  citation_volume=339;  citation_pages=1797-802; " name="citation_reference"/><meta content="citation_title=Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom general practice research database; Am J Epidemiol;  citation_year=2009;  citation_volume=169;  citation_pages=382-8; " name="citation_reference"/><meta content="Centers for Disease Control and Prevention Vaccine information statement: influenza vaccine Available at: http://www.cdc.gov/vaccines/hcp/vis/vis-statements/flu.pdf Accessed 29 August 2013 " name="citation_reference"/><meta content="citation_author=Institute of Medicine; citation_publisher=The National Academies Press, Washington, D.C., ; Adverse effects of vaccines: evidence and causality;  citation_year=2012; " name="citation_reference"/><meta content="citation_title=Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program; Pediatrics;  citation_year=2011;  citation_volume=127;  citation_pages=S78-86; " name="citation_reference"/><meta content="Centers for Disease Control and Prevention Emerging Infections Program Available at: http://www.cdc.gov/ncezid/dpei/eip/ Accessed 28 November 2012 " name="citation_reference"/><meta content="citation_title=Preliminary results: surveillance for Guillain-Barre syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine—United States, 2009–2010; citation_author=Centers for Disease Control and Prevention; MMWR Morb Mortal Wkly Rep;  citation_year=2010;  citation_volume=59;  citation_pages=657-61; " name="citation_reference"/><meta content="citation_title=The risk of Guillain-Barre syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009–2010 seasonal influenza vaccines: results from self-controlled analyses; Pharmacoepidemiol Drug Saf;  citation_year=2012;  citation_volume=21;  citation_pages=546-52; " name="citation_reference"/><meta content="citation_title=Guillain-Barre syndrome during the 2009–2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans; Am J Epidemiol;  citation_year=2012;  citation_volume=175;  citation_pages=1110-9; " name="citation_reference"/><meta content="citation_title=Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the vaccine safety datalink project, 2009–2010; Am J Epidemiol;  citation_year=2012;  citation_volume=175;  citation_pages=1100-9; " name="citation_reference"/><meta content="citation_title=Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the post-licensure rapid immunization safety monitoring (PRISM) system, 2009–2010; Am J Epidemiol;  citation_year=2012;  citation_volume=175;  citation_pages=1120-8; " name="citation_reference"/><meta content="citation_title=Association between Guillain-Barre syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis; Lancet;  citation_year=2013;  citation_volume=381;  citation_pages=1461-8; " name="citation_reference"/><meta content="citation_title=Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe; BMJ;  citation_year=2011;  citation_volume=343;  citation_pages=d3908" name="citation_reference"/><meta content="citation_title=Guillain-Barre syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series; Vaccine;  citation_year=2011;  citation_volume=29;  citation_pages=7878-82; " name="citation_reference"/><meta content="citation_title=International collaboration to assess the risk of Guillain Barre syndrome following influenza A (H1N1) 2009 monovalent vaccines; Vaccine;  citation_year=2013;  citation_volume=31;  citation_pages=4448-58; " name="citation_reference"/><meta content="citation_title=Risk of Guillain-Barre syndrome following H1N1 influenza vaccination in Quebec; JAMA;  citation_year=2012;  citation_volume=308;  citation_pages=175-81; " name="citation_reference"/><meta content="Centers for Disease Control and Prevention Influenza vaccination coverage FluVaxView Available at: http://www.cdc.gov/flu/fluvaxview/index.htm Accessed 30 August 2013 " name="citation_reference"/><meta content="Centers for Disease Control and Prevention Fluview Available at: http://gis.cdc.gov/GRASP/Fluview/FluHospRates.html Accessed 29 August 2013 " name="citation_reference"/><meta content="citation_title=Guillain-Barre syndrome and preceding infection with Campylobacter, influenza and Epstein-Barr virus in the general practice research database; citation_text=2:e344. doi:10.1371/journal.pone.0000344; PLoS One;  citation_year=2007; " name="citation_reference"/><meta content="citation_title=Guillain-Barre syndrome and H1N1 influenza vaccine in UK children; Lancet;  citation_year=2011;  citation_volume=378;  citation_pages=1545-6; " name="citation_reference"/><meta content="citation_title=Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines—a multinational case control study in Europe; Pharmacoepidemiol Drug Saf;  citation_year=2011;  citation_volume=20;  citation_pages=S258-9; " name="citation_reference"/><meta content="citation_title=Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic; citation_text=in press; Am J Public Health;  citation_year=2014; " name="citation_reference"/><meta content="citation_title=Guillain-Barre syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-centered analysis in the vaccine safety Datalink, 2009–2011; PLoS One;  citation_year=2013;  citation_volume=8;  citation_pages=e67185" name="citation_reference"/><meta content="citation_title=Risk of Guillain-Barre syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study; Lancet Infect Dis;  citation_year=2013;  citation_volume=13;  citation_pages=769-76; " name="citation_reference"/><meta content="https://academic.oup.com/cid/article-pdf/58/8/1149/1018675/ciu005.pdf" name="citation_pdf_url"/><meta content="A small increased risk of Guillain-Barré syndrome (GBS) has been observed following influenza vaccination but is 10-fold less than that observed following the 1" name="description"/> <link as="script" href="https://adservice.google.com.ua/adsid/integrator.js?domain=academic.oup.com" rel="preload"/><script src="https://adservice.google.com.ua/adsid/integrator.js?domain=academic.oup.com" type="text/javascript"></script><link as="script" href="https://adservice.google.com/adsid/integrator.js?domain=academic.oup.com" rel="preload"/><script src="https://adservice.google.com/adsid/integrator.js?domain=academic.oup.com" type="text/javascript"></script><script async="" src="https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019070801.js"></script><script id="altmetric-embed-js" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-c09531d6f252ca72ffdadae2d9597c14.js"></script><style type="text/css">.at-icon{fill:#fff;border:0}.at-icon-wrapper{display:inline-block;overflow:hidden}a .at-icon-wrapper{cursor:pointer}.at-rounded,.at-rounded-element .at-icon-wrapper{border-radius:12%}.at-circular,.at-circular-element .at-icon-wrapper{border-radius:50%}.addthis_32x32_style .at-icon{width:2pc;height:2pc}.addthis_24x24_style .at-icon{width:24px;height:24px}.addthis_20x20_style .at-icon{width:20px;height:20px}.addthis_16x16_style .at-icon{width:1pc;height:1pc}#at16lb{display:none;position:absolute;top:0;left:0;width:100%;height:100%;z-index:1001;background-color:#000;opacity:.001}#at_complete,#at_error,#at_share,#at_success{position:static!important}.at15dn{display:none}#at15s,#at16p,#at16p form input,#at16p label,#at16p textarea,#at_share .at_item{font-family:arial,helvetica,tahoma,verdana,sans-serif!important;font-size:9pt!important;outline-style:none;outline-width:0;line-height:1em}* html #at15s.mmborder{position:absolute!important}#at15s.mmborder{position:fixed!important;width:250px!important}#at15s{background:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpiZGBgaGAgAjAxEAlGFVJHIUCAAQDcngCUgqGMqwAAAABJRU5ErkJggg==);float:none;line-height:1em;margin:0;overflow:visible;padding:5px;text-align:left;position:absolute}#at15s a,#at15s span{outline:0;direction:ltr;text-transform:none}#at15s .at-label{margin-left:5px}#at15s .at-icon-wrapper{width:1pc;height:1pc;vertical-align:middle}#at15s .at-icon{width:1pc;height:1pc}.at4-icon{display:inline-block;background-repeat:no-repeat;background-position:top left;margin:0;overflow:hidden;cursor:pointer}.addthis_16x16_style .at4-icon,.addthis_default_style .at4-icon,.at4-icon,.at-16x16{width:1pc;height:1pc;line-height:1pc;background-size:1pc!important}.addthis_32x32_style .at4-icon,.at-32x32{width:2pc;height:2pc;line-height:2pc;background-size:2pc!important}.addthis_24x24_style .at4-icon,.at-24x24{width:24px;height:24px;line-height:24px;background-size:24px!important}.addthis_20x20_style .at4-icon,.at-20x20{width:20px;height:20px;line-height:20px;background-size:20px!important}.at4-icon.circular,.circular .at4-icon,.circular.aticon{border-radius:50%}.at4-icon.rounded,.rounded .at4-icon{border-radius:4px}.at4-icon-left{float:left}#at15s .at4-icon{text-indent:20px;padding:0;overflow:visible;white-space:nowrap;background-size:1pc;width:1pc;height:1pc;background-position:top left;display:inline-block;line-height:1pc}.addthis_vertical_style .at4-icon,.at4-follow-container .at4-icon{margin-right:5px}html>body #at15s{width:250px!important}#at15s.atm{background:none!important;padding:0!important;width:10pc!important}#at15s_inner{background:#fff;border:1px solid #fff;margin:0}#at15s_head{position:relative;background:#f2f2f2;padding:4px;cursor:default;border-bottom:1px solid #e5e5e5}.at15s_head_success{background:#cafd99!important;border-bottom:1px solid #a9d582!important}.at15s_head_success a,.at15s_head_success span{color:#000!important;text-decoration:none}#at15s_brand,#at15sptx,#at16_brand{position:absolute}#at15s_brand{top:4px;right:4px}.at15s_brandx{right:20px!important}a#at15sptx{top:4px;right:4px;text-decoration:none;color:#4c4c4c;font-weight:700}#at15sptx:hover{text-decoration:underline}#at16_brand{top:5px;right:30px;cursor:default}#at_hover{padding:4px}#at_hover .at_item,#at_share .at_item{background:#fff!important;float:left!important;color:#4c4c4c!important}#at_share .at_item .at-icon-wrapper{margin-right:5px}#at_hover .at_bold{font-weight:700;color:#000!important}#at_hover .at_item{width:7pc!important;padding:2px 3px!important;margin:1px;text-decoration:none!important}#at_hover .at_item.athov,#at_hover .at_item:focus,#at_hover .at_item:hover{margin:0!important}#at_hover .at_item.athov,#at_hover .at_item:focus,#at_hover .at_item:hover,#at_share .at_item.athov,#at_share .at_item:hover{background:#f2f2f2!important;border:1px solid #e5e5e5;color:#000!important;text-decoration:none}.ipad #at_hover .at_item:focus{background:#fff!important;border:1px solid #fff}.at15t{display:block!important;height:1pc!important;line-height:1pc!important;padding-left:20px!important;background-position:0 0;text-align:left}.addthis_button,.at15t{cursor:pointer}.addthis_toolbox a.at300b,.addthis_toolbox a.at300m{width:auto}.addthis_toolbox a{margin-bottom:5px;line-height:initial}.addthis_toolbox.addthis_vertical_style{width:200px}.addthis_button_facebook_like .fb_iframe_widget{line-height:100%}.addthis_button_facebook_like iframe.fb_iframe_widget_lift{max-width:none}.addthis_toolbox a.addthis_button_counter,.addthis_toolbox a.addthis_button_facebook_like,.addthis_toolbox a.addthis_button_facebook_send,.addthis_toolbox a.addthis_button_facebook_share,.addthis_toolbox a.addthis_button_foursquare,.addthis_toolbox a.addthis_button_linkedin_counter,.addthis_toolbox a.addthis_button_pinterest_pinit,.addthis_toolbox a.addthis_button_tweet{display:inline-block}.addthis_toolbox span.addthis_follow_label{display:none}.addthis_toolbox.addthis_vertical_style span.addthis_follow_label{display:block;white-space:nowrap}.addthis_toolbox.addthis_vertical_style a{display:block}.addthis_toolbox.addthis_vertical_style.addthis_32x32_style a{line-height:2pc;height:2pc}.addthis_toolbox.addthis_vertical_style .at300bs{margin-right:4px;float:left}.addthis_toolbox.addthis_20x20_style span{line-height:20px}.addthis_toolbox.addthis_32x32_style span{line-height:2pc}.addthis_toolbox.addthis_pill_combo_style .addthis_button_compact .at15t_compact,.addthis_toolbox.addthis_pill_combo_style a{float:left}.addthis_toolbox.addthis_pill_combo_style a.addthis_button_tweet{margin-top:-2px}.addthis_toolbox.addthis_pill_combo_style .addthis_button_compact .at15t_compact{margin-right:4px}.addthis_default_style .addthis_separator{margin:0 5px;display:inline}div.atclear{clear:both}.addthis_default_style .addthis_separator,.addthis_default_style .at4-icon,.addthis_default_style .at300b,.addthis_default_style .at300bo,.addthis_default_style .at300bs,.addthis_default_style .at300m{float:left}.at300b img,.at300bo img{border:0}a.at300b .at4-icon,a.at300m .at4-icon{display:block}.addthis_default_style .at300b,.addthis_default_style .at300bo,.addthis_default_style .at300m{padding:0 2px}.at300b,.at300bo,.at300bs,.at300m{cursor:pointer}.addthis_button_facebook_like.at300b:hover,.addthis_button_facebook_like.at300bs:hover,.addthis_button_facebook_send.at300b:hover,.addthis_button_facebook_send.at300bs:hover{opacity:1}.addthis_20x20_style .at15t,.addthis_20x20_style .at300bs{overflow:hidden;display:block;height:20px!important;width:20px!important;line-height:20px!important}.addthis_32x32_style .at15t,.addthis_32x32_style .at300bs{overflow:hidden;display:block;height:2pc!important;width:2pc!important;line-height:2pc!important}.at300bs{overflow:hidden;display:block;background-position:0 0;height:1pc;width:1pc;line-height:1pc!important}.addthis_default_style .at15t_compact,.addthis_default_style .at15t_expanded{margin-right:4px}#at_share .at_item{width:123px!important;padding:4px;margin-right:2px;border:1px solid #fff}#at16p{background:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpiZGBgaGAgAjAxEAlGFVJHIUCAAQDcngCUgqGMqwAAAABJRU5ErkJggg==);z-index:10000001;position:absolute;top:50%;left:50%;width:300px;padding:10px;margin:0 auto;margin-top:-185px;margin-left:-155px;font-family:arial,helvetica,tahoma,verdana,sans-serif;font-size:9pt;color:#5e5e5e}#at_share{margin:0;padding:0}#at16pt{position:relative;background:#f2f2f2;height:13px;padding:5px 10px}#at16pt a,#at16pt h4{font-weight:700}#at16pt h4{display:inline;margin:0;padding:0;font-size:9pt;color:#4c4c4c;cursor:default}#at16pt a{position:absolute;top:5px;right:10px;color:#4c4c4c;text-decoration:none;padding:2px}#at15sptx:focus,#at16pt a:focus{outline:thin dotted}#at15s #at16pf a{top:1px}#_atssh{width:1px!important;height:1px!important;border:0!important}.atm{width:10pc!important;padding:0;margin:0;line-height:9pt;letter-spacing:normal;font-family:arial,helvetica,tahoma,verdana,sans-serif;font-size:9pt;color:#444;background:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpiZGBgaGAgAjAxEAlGFVJHIUCAAQDcngCUgqGMqwAAAABJRU5ErkJggg==);padding:4px}.atm-f{text-align:right;border-top:1px solid #ddd;padding:5px 8px}.atm-i{background:#fff;border:1px solid #d5d6d6;padding:0;margin:0;box-shadow:1px 1px 5px rgba(0,0,0,.15)}.atm-s{margin:0!important;padding:0!important}.atm-s a:focus{border:transparent;outline:0;transition:none}#at_hover.atm-s a,.atm-s a{display:block;text-decoration:none;padding:4px 10px;color:#235dab!important;font-weight:400;font-style:normal;transition:none}#at_hover.atm-s .at_bold{color:#235dab!important}#at_hover.atm-s a:hover,.atm-s a:hover{background:#2095f0;text-decoration:none;color:#fff!important}#at_hover.atm-s .at_bold{font-weight:700}#at_hover.atm-s a:hover .at_bold{color:#fff!important}.atm-s a .at-label{vertical-align:middle;margin-left:5px;direction:ltr}.at_PinItButton{display:block;width:40px;height:20px;padding:0;margin:0;background-image:url(//s7.addthis.com/static/t00/pinit00.png);background-repeat:no-repeat}.at_PinItButton:hover{background-position:0 -20px}.addthis_toolbox .addthis_button_pinterest_pinit{position:relative}.at-share-tbx-element .fb_iframe_widget span{vertical-align:baseline!important}#at16pf{height:auto;text-align:right;padding:4px 8px}.at-privacy-info{position:absolute;left:7px;bottom:7px;cursor:pointer;text-decoration:none;font-family:helvetica,arial,sans-serif;font-size:10px;line-height:9pt;letter-spacing:.2px;color:#666}.at-privacy-info:hover{color:#000}.body .wsb-social-share .wsb-social-share-button-vert{padding-top:0;padding-bottom:0}.body .wsb-social-share.addthis_counter_style .addthis_button_tweet.wsb-social-share-button{padding-top:40px}.body .wsb-social-share.addthis_counter_style .addthis_button_facebook_like.wsb-social-share-button{padding-top:21px}@media print{#at4-follow,#at4-share,#at4-thankyou,#at4-whatsnext,#at4m-mobile,#at15s,.at4,.at4-recommended{display:none!important}}@media screen and (max-width:400px){.at4win{width:100%}}@media screen and (max-height:700px) and (max-width:400px){.at4-thankyou-inner .at4-recommended-container{height:122px;overflow:hidden}.at4-thankyou-inner .at4-recommended .at4-recommended-item:first-child{border-bottom:1px solid #c5c5c5}}</style><style type="text/css">.at-branding-logo{font-family:helvetica,arial,sans-serif;text-decoration:none;font-size:10px;display:inline-block;margin:2px 0;letter-spacing:.2px}.at-branding-logo .at-branding-icon{background-image:url("data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAMAAAC67D+PAAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAAAZQTFRF////+GlNUkcc1QAAAB1JREFUeNpiYIQDBjQmAwMmkwEM0JnY1WIxFyDAABGeAFEudiZsAAAAAElFTkSuQmCC")}.at-branding-logo .at-branding-icon,.at-branding-logo .at-privacy-icon{display:inline-block;height:10px;width:10px;margin-left:4px;margin-right:3px;margin-bottom:-1px;background-repeat:no-repeat}.at-branding-logo .at-privacy-icon{background-image:url("data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAkAAAAKCAMAAABR24SMAAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABhQTFRF8fr9ot/xXcfn2/P5AKva////////AKTWodjhjAAAAAd0Uk5T////////ABpLA0YAAAA6SURBVHjaJMzBDQAwCAJAQaj7b9xifV0kUKJ9ciWxlzWEWI5gMF65KUTv0VKkjVeTerqE/x7+9BVgAEXbAWI8QDcfAAAAAElFTkSuQmCC")}.at-branding-logo span{text-decoration:none}.at-branding-logo .at-branding-addthis,.at-branding-logo .at-branding-powered-by{color:#666}.at-branding-logo .at-branding-addthis:hover{color:#333}.at-cv-with-image .at-branding-addthis,.at-cv-with-image .at-branding-addthis:hover{color:#fff}a.at-branding-logo:visited{color:initial}.at-branding-info{display:inline-block;padding:0 5px;color:#666;border:1px solid #666;border-radius:50%;font-size:10px;line-height:9pt;opacity:.7;transition:all .3s ease;text-decoration:none}.at-branding-info span{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}.at-branding-info:before{content:'i';font-family:Times New Roman}.at-branding-info:hover{color:#0780df;border-color:#0780df}</style><link href="https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html" rel="prefetch"/><style></style><link href="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed-c0776af83c8e94e4e2c2ba1716193f9a.css" id="altmetric-embed-css" rel="stylesheet" type="text/css"/><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style><style type="text/css">.MathJax_Preview .MJXf-math {color: inherit!important}
</style><style type="text/css">.MJX_Assistive_MathML {position: absolute!important; top: 0; left: 0; clip: rect(1px, 1px, 1px, 1px); padding: 1px 0 0 0!important; border: 0!important; height: 1px!important; width: 1px!important; overflow: hidden!important; display: block!important; -webkit-touch-callout: none; -webkit-user-select: none; -khtml-user-select: none; -moz-user-select: none; -ms-user-select: none; user-select: none}
.MJX_Assistive_MathML.MJX_Assistive_MathML_Block {width: 100%!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MJXp-script {font-size: .8em}
.MJXp-right {-webkit-transform-origin: right; -moz-transform-origin: right; -ms-transform-origin: right; -o-transform-origin: right; transform-origin: right}
.MJXp-bold {font-weight: bold}
.MJXp-italic {font-style: italic}
.MJXp-scr {font-family: MathJax_Script,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-frak {font-family: MathJax_Fraktur,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-sf {font-family: MathJax_SansSerif,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-cal {font-family: MathJax_Caligraphic,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-mono {font-family: MathJax_Typewriter,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-largeop {font-size: 150%}
.MJXp-largeop.MJXp-int {vertical-align: -.2em}
.MJXp-math {display: inline-block; line-height: 1.2; text-indent: 0; font-family: 'Times New Roman',Times,STIXGeneral,serif; white-space: nowrap; border-collapse: collapse}
.MJXp-display {display: block; text-align: center; margin: 1em 0}
.MJXp-math span {display: inline-block}
.MJXp-box {display: block!important; text-align: center}
.MJXp-box:after {content: " "}
.MJXp-rule {display: block!important; margin-top: .1em}
.MJXp-char {display: block!important}
.MJXp-mo {margin: 0 .15em}
.MJXp-mfrac {margin: 0 .125em; vertical-align: .25em}
.MJXp-denom {display: inline-table!important; width: 100%}
.MJXp-denom > * {display: table-row!important}
.MJXp-surd {vertical-align: top}
.MJXp-surd > * {display: block!important}
.MJXp-script-box > *  {display: table!important; height: 50%}
.MJXp-script-box > * > * {display: table-cell!important; vertical-align: top}
.MJXp-script-box > *:last-child > * {vertical-align: bottom}
.MJXp-script-box > * > * > * {display: block!important}
.MJXp-mphantom {visibility: hidden}
.MJXp-munderover {display: inline-table!important}
.MJXp-over {display: inline-block!important; text-align: center}
.MJXp-over > * {display: block!important}
.MJXp-munderover > * {display: table-row!important}
.MJXp-mtable {vertical-align: .25em; margin: 0 .125em}
.MJXp-mtable > * {display: inline-table!important; vertical-align: middle}
.MJXp-mtr {display: table-row!important}
.MJXp-mtd {display: table-cell!important; text-align: center; padding: .5em 0 0 .5em}
.MJXp-mtr > .MJXp-mtd:first-child {padding-left: 0}
.MJXp-mtr:first-child > .MJXp-mtd {padding-top: 0}
.MJXp-mlabeledtr {display: table-row!important}
.MJXp-mlabeledtr > .MJXp-mtd:first-child {padding-left: 0}
.MJXp-mlabeledtr:first-child > .MJXp-mtd {padding-top: 0}
.MJXp-merror {background-color: #FFFF88; color: #CC0000; border: 1px solid #CC0000; padding: 1px 3px; font-style: normal; font-size: 90%}
.MJXp-scale0 {-webkit-transform: scaleX(.0); -moz-transform: scaleX(.0); -ms-transform: scaleX(.0); -o-transform: scaleX(.0); transform: scaleX(.0)}
.MJXp-scale1 {-webkit-transform: scaleX(.1); -moz-transform: scaleX(.1); -ms-transform: scaleX(.1); -o-transform: scaleX(.1); transform: scaleX(.1)}
.MJXp-scale2 {-webkit-transform: scaleX(.2); -moz-transform: scaleX(.2); -ms-transform: scaleX(.2); -o-transform: scaleX(.2); transform: scaleX(.2)}
.MJXp-scale3 {-webkit-transform: scaleX(.3); -moz-transform: scaleX(.3); -ms-transform: scaleX(.3); -o-transform: scaleX(.3); transform: scaleX(.3)}
.MJXp-scale4 {-webkit-transform: scaleX(.4); -moz-transform: scaleX(.4); -ms-transform: scaleX(.4); -o-transform: scaleX(.4); transform: scaleX(.4)}
.MJXp-scale5 {-webkit-transform: scaleX(.5); -moz-transform: scaleX(.5); -ms-transform: scaleX(.5); -o-transform: scaleX(.5); transform: scaleX(.5)}
.MJXp-scale6 {-webkit-transform: scaleX(.6); -moz-transform: scaleX(.6); -ms-transform: scaleX(.6); -o-transform: scaleX(.6); transform: scaleX(.6)}
.MJXp-scale7 {-webkit-transform: scaleX(.7); -moz-transform: scaleX(.7); -ms-transform: scaleX(.7); -o-transform: scaleX(.7); transform: scaleX(.7)}
.MJXp-scale8 {-webkit-transform: scaleX(.8); -moz-transform: scaleX(.8); -ms-transform: scaleX(.8); -o-transform: scaleX(.8); transform: scaleX(.8)}
.MJXp-scale9 {-webkit-transform: scaleX(.9); -moz-transform: scaleX(.9); -ms-transform: scaleX(.9); -o-transform: scaleX(.9); transform: scaleX(.9)}
.MathJax_PHTML .noError {vertical-align: ; font-size: 90%; text-align: left; color: black; padding: 1px 3px; border: 1px solid}
</style></head><body class="off-canvas pg_Article pg_article" data-sitename="clinicalinfectiousdiseases" data-sitestyletemplate="Journal" theme-cid=""><div id="MathJax_Message" style="display: none;"></div><div><div id="cookiepolicy_div"><a href="https://academic.oup.com/#cookiepolicy_data" id="cookiepolicy_link"></a><div id="cookiepolicy_parent" style="display:none"><div id="cookiepolicy_data"></div></div></div></div><div class="widget widget-Hypothesis widget-instance-OUP_Article_Hypothesis">
<div id="hypothesis-container">
</div>
</div>
<meta content="https://academic.oup.com/cid/article-xml/58/8/1149/355966" name="citation_xml_url"/>
<link href="https://academic.oup.com/cid/article/58/8/1149/355966" rel="canonical"/>
<script async="async" src="https://www.googletagservices.com/tag/js/gpt.js"></script>
<script>
    var googletag = googletag || {};
    googletag.cmd = googletag.cmd || [];
</script>
<script type="text/javascript">
                        var gptAdSlots = [];
                    googletag.cmd.push(function() {
            
            var mapping_ad1 = googletag.sizeMapping()
            .addSize([1024, 0], [[970, 90], [728, 90]])
            .addSize([768, 0], [728, 90])
            .addSize([0, 0], [320, 50])
            .build();
            gptAdSlots["ad1"] = googletag.defineSlot('/116097782/cid_Behind_Ad1',
                [[970, 90], [728, 90], [320, 50]],
                'adBlockHeader')
            .defineSizeMapping(mapping_ad1)
            .addService(googletag.pubads());
            

            
            var mapping_ad2 = googletag.sizeMapping()
            .addSize([0, 0], [])
            .addSize([768, 0], [[300, 250], [300, 600], [160, 600]])
            .build();
        gptAdSlots["ad2"] = googletag.defineSlot('/116097782/cid_Behind_Ad2',
                [[300, 250], [160, 600], [300, 600]],
                'adBlockMainBodyTop')
            .defineSizeMapping(mapping_ad2)
            .addService(googletag.pubads());
            

            
            var mapping_ad3 = googletag.sizeMapping()
            .addSize([0, 0], [])
            .addSize([768, 0], [[300, 250], [300, 600], [160, 600]])
            .build();
    gptAdSlots["ad3"] = googletag.defineSlot('/116097782/cid_Behind_Ad3',
                [[300, 250], [160, 600], [300, 600]],
                'adBlockMainBodyBottom')
            .defineSizeMapping(mapping_ad3)
            .addService(googletag.pubads());
            

            
                var mapping_ad4 = googletag.sizeMapping()
                .addSize([0, 0], [])
                .addSize([768, 0], [728, 90])
                .build();
    gptAdSlots["ad4"] = googletag.defineSlot('/116097782/cid_Behind_Ad4', [728, 90], 'adBlockFooter')
                .defineSizeMapping(mapping_ad4)
                .addService(googletag.pubads());
            
            googletag.pubads().setTargeting("jnlspage", "article");
    googletag.pubads().setTargeting("jnlsurl", "cid/article/58/8/1149/355966");
    googletag.pubads().enableSingleRequest();
    googletag.pubads().collapseEmptyDivs();
        });
        </script>
<script>
        var oupcookiepolicy_siteid = "journals";        // the website id
        var oupcookiepolicy_messagetype = 'implied';                        // type of alert message e.g, implied / explicit
        var oupcookiepolicy_preferredlanguage = "en";      // preferred language of the website
        var oupcookiepolicy_impliedmessageclass = 'cookiepolicyimplied';    // the css class for implied alert message
        var oupcookiepolicy_documentroot = '/';	  			                // the document root the cookie is set to
    </script>
<noscript>We use cookies to enhance your experience on our website.By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. <a href="https://global.oup.com/cookiepolicy/"> Find out more</a></noscript>
<script type="text/javascript">
        var NTPT_PGEXTRA= 'event_type=full-text&supplier_tag=SC_Journals&siteid=cid&authzrequired=false&doi=10.1093/cid/ciu005';
    </script>
<noscript>
<iframe height="0" src="https://www.googletagmanager.com/ns.html?id=GTM-W6DD7HV" style="display:none;visibility:hidden" width="0"></iframe>
</noscript>
<a class="skipnav" href="https://academic.oup.com/#main">Skip to Main Content</a>
<input id="hdnSiteID" name="hdnSiteID" type="hidden" value="5269"/><input id="hdnAdDelaySeconds" name="hdnAdDelaySeconds" type="hidden" value="5000"/><input id="hdnAdConfigurationTop" name="hdnAdConfigurationTop" type="hidden" value="scrolldelay"/><input id="hdnAdConfigurationRightRail" name="hdnAdConfigurationRightRail" type="hidden" value="sticky"/>
<div class="master-container js-master-container">
<section class="master-header row js-master-header vt-site-page-header">
<div class="widget widget-SitePageHeader widget-instance-SitePageHeader">
<div class="ad-banner js-ad-banner-header">
<div class="widget widget-AdBlock widget-instance-HeaderAd">
<div data-google-query-id="CKed5erKsuMCFRga4AodYoAO0w" id="adBlockHeader" style=" ">
<div id="google_ads_iframe_/116097782/cid_Behind_Ad1_0__container__" style="border: 0pt none;"><iframe data-google-container-id="1" data-load-complete="true" frameborder="0" height="90" id="google_ads_iframe_/116097782/cid_Behind_Ad1_0" marginheight="0" marginwidth="0" name="google_ads_iframe_/116097782/cid_Behind_Ad1_0" scrolling="no" srcdoc="" style="border: 0px; vertical-align: bottom;" title="3rd party ad content" width="728"></iframe></div></div>
</div>
</div>
<div class="oup-header">
<div class="center-inner-row">
<div class="oup-header-logo">
<a href="https://academic.oup.com/"><img alt="Oxford University Press" class="oup-header-image" src="//oup.silverchair-cdn.com/UI/app/svg/umbrella/oxford-academic-logo.svg"/></a>
</div>
<ul class="oup-header-menu account-menu">
<li class="oup-header-menu-item mobile">
<button class="btn btn-as-icon mobile-dropdown-toggle mobile-search-toggle" href="">
<i class="icon-menu_search"><span class="screenreader-text">Search</span></i>
</button>
</li>
<li class="oup-header-menu-item mobile">
<button class="btn btn-as-icon mobile-dropdown-toggle mobile-account-toggle" href="">
<i class="icon-menu_account"><span class="screenreader-text">Account Menu</span></i>
</button>
</li>
<li class="oup-header-menu-item mobile">
<button class="btn btn-as-icon mobile-dropdown-toggle mobile-nav-toggle" href="">
<i class="icon-menu_hamburger"><span class="screenreader-text">Menu</span></i>
</button>
</li>
<li class="oup-header-menu-item desktop">
<a class="dropdown-toggle signin" href="https://academic.oup.com/" id="header-account-info-user-fullname">
                        
Sign In                        <i class="icon-general-arrow-filled-down arrow-icon"></i>
</a>
<div class="dropdown-panel dropdown-panel-signin dropdown-panel-form">
<div class="spinner"></div>
</div>
</li>
<li class="oup-header-menu-item desktop"><a class="register" href="https://academic.oup.com/my-account/register?siteId=5269&amp;returnUrl=%2fcid%2farticle%2f58%2f8%2f1149%2f355966">Register</a></li>
<!-- <li class="oup-header-menu-item desktop">
                        <a href="" class="dropdown-toggle language">Language</a>
                        <div class="dropdown-panel">
                            <div class="dropdown-menu">
                                <ul>
                                    foreach (var lang in Model.LanguageOptions)
                                    {
                                        string selectedClass = (lang.SiteId == Model.SiteId ? " selected" : "");
                                        Html.Raw(String.Format("<li class=\"header-language-item{0}\"><a href=\"//{1}\">{2}</a></li>", selectedClass, lang.SiteUrl, lang.LanguageText))
                                        ;
                                    }
                                </ul>
                            </div>
                        </div>
                    </li> -->
</ul>
</div>
</div>
<div class="dropdown-panel-wrap">
<div class="dropdown-panel mobile-search-dropdown">
<div class="mobile-search-inner-wrap">
<div class="navbar-search">
<div class="mobile-microsite-search" id="MobileMicrositeSearch">
<label class="screenreader-text" for="mobile-navbar-search-filter">Navbar Search Filter</label>
<select class="navbar-search-filter" id="mobile-navbar-search-filter">
<optgroup label="Search within this journal">
<option class="header-search-bar-filters-item" value="Issue">This issue</option><option class="header-search-bar-filters-item" value="">All  Clinical Infectious Diseases</option>
</optgroup>
<optgroup label="Search beyond this journal">
<option class="header-search-bar-filters-item" value="Parent">All  IDSA Journals</option><option class="header-search-bar-filters-item" value="Journals">All  Journals</option> </optgroup>
</select>
<label class="screenreader-text" for="MobileMicrositeSearchTerm">Mobile Microsite Search Term</label>
<input class="mobile-search-input mobile-microsite-search-term" id="MobileMicrositeSearchTerm" maxlength="255" placeholder="Search" type="text"/>
<span class="mobile-microsite-search-icon mobile-search-submit icon-menu_search" id="MobileMicrositeSearchIcon"></span>
</div>
</div>
</div>
</div>
<div class="dropdown-panel mobile-account-dropdown">
<ul class="site-menu site-menu-lvl-0">
<li class="site-menu-item site-menu-lvl-0">
<a class="nav-link mobile-account-signin dummy-link" href="https://academic.oup.com/" id="header-account-info-user-fullname">
                    
Sign In                    <i class="mobile-nav-arrow icon-general_arrow-down"></i>
</a>
<ul class="site-menu site-menu-lvl-1 individual-menu">
<li class="dropdown-signin-form">
<div class="spinner"></div>
</li>
</ul>
</li>
<li class="site-menu-item">
<a class="register nav-link" href="https://academic.oup.com/my-account/register?siteId=5269&amp;returnUrl=%2fcid%2farticle%2f58%2f8%2f1149%2f355966">Register</a>
</li>
</ul>
</div>
<div class="dropdown-panel mobile-nav-dropdown">
<i class="desktop-nav-arrow icon-general-arrow-filled-down arrow-icon"></i><i class="mobile-nav-arrow icon-general_arrow-down"></i>
<ul class="site-menu site-menu-lvl-0">
<li class="site-menu-item site-menu-lvl-0" id="site-menu-item-1282341">
<a class="nav-link" href="https://academic.oup.com/cid/issue">Issues</a>
</li>
<li class="site-menu-item site-menu-lvl-0" id="site-menu-item-1282337">
<a class="nav-link dummy-link" href="https://academic.oup.com/cid/#">More Content</a>
<i class="desktop-nav-arrow icon-general-arrow-filled-down arrow-icon"></i><i class="mobile-nav-arrow icon-general_arrow-down"></i>
<ul class="site-menu site-menu-lvl-1">
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282342">
<a class="nav-link" href="https://academic.oup.com/cid/advance-articles">Advance articles</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282343">
<a class="nav-link" href="https://academic.oup.com/cid/search-results?page=1&amp;f_OUPSeries=Editor%27s+Choice">Editor's Choice</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282344">
<a class="nav-link" href="https://academic.oup.com/cid/pages/supplemental">Supplement Archive</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282345">
<a class="nav-link" href="https://academic.oup.com/cid/issue-covers/">Cover Archive</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282346">
<a class="nav-link" href="https://academic.oup.com/cid/search-results?f_TocHeadingTitle=IDSA+Guideline&amp;sort=Date+%e2%80%93+Newest+First?">IDSA Guidelines</a>
</li>
</ul>
</li>
<li class="site-menu-item site-menu-lvl-0" id="site-menu-item-1282338">
<a class="nav-link dummy-link" href="https://academic.oup.com/cid/#">Publish</a>
<i class="desktop-nav-arrow icon-general-arrow-filled-down arrow-icon"></i><i class="mobile-nav-arrow icon-general_arrow-down"></i>
<ul class="site-menu site-menu-lvl-1">
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282347">
<a class="nav-link" href="https://academic.oup.com/cid/pages/General_Instructions">Author Guidelines</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282348">
<a class="nav-link" href="http://www.editorialmanager.com/cid">Submit</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282349">
<a class="nav-link" href="https://academic.oup.com/cid/pages/General_Instructions">Open Access</a>
</li>
</ul>
</li>
<li class="site-menu-item site-menu-lvl-0" id="site-menu-item-1282350">
<a class="nav-link" href="https://academic.oup.com/cid/subscribe">Purchase</a>
</li>
<li class="site-menu-item site-menu-lvl-0" id="site-menu-item-1282339">
<a class="nav-link dummy-link" href="https://academic.oup.com/cid/#">Advertise</a>
<i class="desktop-nav-arrow icon-general-arrow-filled-down arrow-icon"></i><i class="mobile-nav-arrow icon-general_arrow-down"></i>
<ul class="site-menu site-menu-lvl-1">
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282351">
<a class="nav-link" href="http://www.oupmediainfo.com">Advertising and Corporate Services</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282352">
<a class="nav-link" href="http://www.oupmediainfo.com/#!/advertising">Advertising</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282353">
<a class="nav-link" href="http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/?t730=&amp;search=&amp;t732=469972&amp;t731=&amp;t733=&amp;t735=&amp;t737=&amp;max=25&amp;site_id=20102">Journals Career Network</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282354">
<a class="nav-link" href="http://oupmediainfo.com/#!/mediakit/clinical-infectious-diseases">Mediakit</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282355">
<a class="nav-link" href="http://www.oupmediainfo.com/#!/reprints-eprints">Reprints and ePrints</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282356">
<a class="nav-link" href="http://www.oupmediainfo.com/#!/sponsored-supplements">Sponsored Supplements</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282357">
<a class="nav-link" href="http://www.oupmediainfo.com/#!/branded-books">Branded Books</a>
</li>
</ul>
</li>
<li class="site-menu-item site-menu-lvl-0" id="site-menu-item-1282340">
<a class="nav-link dummy-link" href="https://academic.oup.com/cid/#">About</a>
<i class="desktop-nav-arrow icon-general-arrow-filled-down arrow-icon"></i><i class="mobile-nav-arrow icon-general_arrow-down"></i>
<ul class="site-menu site-menu-lvl-1">
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282358">
<a class="nav-link" href="https://academic.oup.com/cid/pages/About">About Clinical Infectious Diseases</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282359">
<a class="nav-link" href="https://www.idsociety.org/Index.aspx">About the Infectious Diseases Society of America</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282360">
<a class="nav-link" href="http://www.hivma.org/Home.aspx">About the HIV Medicine Association</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282361">
<a class="nav-link" href="https://academic.oup.com/DocumentLibrary/CID/idsa_coi_policies_november_2013.pdf">IDSA COI Policy</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282362">
<a class="nav-link" href="https://academic.oup.com/cid/pages/Editorial_Board">Editorial Board</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282363">
<a class="nav-link" href="https://academic.oup.com/my-account/email-alerts">Alerts</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282364">
<a class="nav-link" href="https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/self_archiving_policy_b">Self-Archiving Policy</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282365">
<a class="nav-link" href="https://academic.oup.com/cid/pages/For_Reviewers">For Reviewers</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282366">
<a class="nav-link" href="https://academic.oup.com/cid/pages/for_press_offices">For Press Offices</a>
</li>
</ul>
</li>
</ul>
</div>
</div>
<div class="journal-header journal-bg">
<div class="center-inner-row">
<a class="journal-logo-container" href="https://academic.oup.com/cid">
<img alt="Clinical Infectious Diseases" class="journal-logo" id="logo-ClinicalInfectiousDiseases" src="//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_title-1534435182.svg"/>
</a>
<div class="society-logo-block">
<div class="society-block-inner-wrap">
<a class="society-logo-container" href="https://www.idsociety.org/Index.aspx" target="">
<img alt="Infectious Diseases Society of America" class="society-logo" id="logo-InfectiousDiseasesSocietyofAmerica" src="//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_h1-428695167.svg"/>
</a>
<a class="society-logo-container" href="http://www.hivma.org/Home.aspx" target="">
<img alt="HIV Medicine Association" class="society-logo" id="logo-HIVMedicineAssociation" src="//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_h2789191112.svg"/>
</a>
</div>
</div>
</div>
</div>
<div class="navbar">
<div class="center-inner-row">
<nav class="navbar-menu">
<i class="desktop-nav-arrow icon-general-arrow-filled-down arrow-icon"></i><i class="mobile-nav-arrow icon-general_arrow-down"></i>
<ul class="site-menu site-menu-lvl-0">
<li class="site-menu-item site-menu-lvl-0" id="site-menu-item-1282341">
<a class="nav-link" href="https://academic.oup.com/cid/issue">Issues</a>
</li>
<li class="site-menu-item site-menu-lvl-0" id="site-menu-item-1282337">
<a class="nav-link dummy-link" href="https://academic.oup.com/cid/#">More Content</a>
<i class="desktop-nav-arrow icon-general-arrow-filled-down arrow-icon"></i><i class="mobile-nav-arrow icon-general_arrow-down"></i>
<ul class="site-menu site-menu-lvl-1">
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282342">
<a class="nav-link" href="https://academic.oup.com/cid/advance-articles">Advance articles</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282343">
<a class="nav-link" href="https://academic.oup.com/cid/search-results?page=1&amp;f_OUPSeries=Editor%27s+Choice">Editor's Choice</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282344">
<a class="nav-link" href="https://academic.oup.com/cid/pages/supplemental">Supplement Archive</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282345">
<a class="nav-link" href="https://academic.oup.com/cid/issue-covers/">Cover Archive</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282346">
<a class="nav-link" href="https://academic.oup.com/cid/search-results?f_TocHeadingTitle=IDSA+Guideline&amp;sort=Date+%e2%80%93+Newest+First?">IDSA Guidelines</a>
</li>
</ul>
</li>
<li class="site-menu-item site-menu-lvl-0" id="site-menu-item-1282338">
<a class="nav-link dummy-link" href="https://academic.oup.com/cid/#">Publish</a>
<i class="desktop-nav-arrow icon-general-arrow-filled-down arrow-icon"></i><i class="mobile-nav-arrow icon-general_arrow-down"></i>
<ul class="site-menu site-menu-lvl-1">
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282347">
<a class="nav-link" href="https://academic.oup.com/cid/pages/General_Instructions">Author Guidelines</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282348">
<a class="nav-link" href="http://www.editorialmanager.com/cid">Submit</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282349">
<a class="nav-link" href="https://academic.oup.com/cid/pages/General_Instructions">Open Access</a>
</li>
</ul>
</li>
<li class="site-menu-item site-menu-lvl-0" id="site-menu-item-1282350">
<a class="nav-link" href="https://academic.oup.com/cid/subscribe">Purchase</a>
</li>
<li class="site-menu-item site-menu-lvl-0" id="site-menu-item-1282339">
<a class="nav-link dummy-link" href="https://academic.oup.com/cid/#">Advertise</a>
<i class="desktop-nav-arrow icon-general-arrow-filled-down arrow-icon"></i><i class="mobile-nav-arrow icon-general_arrow-down"></i>
<ul class="site-menu site-menu-lvl-1">
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282351">
<a class="nav-link" href="http://www.oupmediainfo.com">Advertising and Corporate Services</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282352">
<a class="nav-link" href="http://www.oupmediainfo.com/#!/advertising">Advertising</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282353">
<a class="nav-link" href="http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/?t730=&amp;search=&amp;t732=469972&amp;t731=&amp;t733=&amp;t735=&amp;t737=&amp;max=25&amp;site_id=20102">Journals Career Network</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282354">
<a class="nav-link" href="http://oupmediainfo.com/#!/mediakit/clinical-infectious-diseases">Mediakit</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282355">
<a class="nav-link" href="http://www.oupmediainfo.com/#!/reprints-eprints">Reprints and ePrints</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282356">
<a class="nav-link" href="http://www.oupmediainfo.com/#!/sponsored-supplements">Sponsored Supplements</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282357">
<a class="nav-link" href="http://www.oupmediainfo.com/#!/branded-books">Branded Books</a>
</li>
</ul>
</li>
<li class="site-menu-item site-menu-lvl-0" id="site-menu-item-1282340">
<a class="nav-link dummy-link" href="https://academic.oup.com/cid/#">About</a>
<i class="desktop-nav-arrow icon-general-arrow-filled-down arrow-icon"></i><i class="mobile-nav-arrow icon-general_arrow-down"></i>
<ul class="site-menu site-menu-lvl-1">
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282358">
<a class="nav-link" href="https://academic.oup.com/cid/pages/About">About Clinical Infectious Diseases</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282359">
<a class="nav-link" href="https://www.idsociety.org/Index.aspx">About the Infectious Diseases Society of America</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282360">
<a class="nav-link" href="http://www.hivma.org/Home.aspx">About the HIV Medicine Association</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282361">
<a class="nav-link" href="https://academic.oup.com/DocumentLibrary/CID/idsa_coi_policies_november_2013.pdf">IDSA COI Policy</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282362">
<a class="nav-link" href="https://academic.oup.com/cid/pages/Editorial_Board">Editorial Board</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282363">
<a class="nav-link" href="https://academic.oup.com/my-account/email-alerts">Alerts</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282364">
<a class="nav-link" href="https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/self_archiving_policy_b">Self-Archiving Policy</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282365">
<a class="nav-link" href="https://academic.oup.com/cid/pages/For_Reviewers">For Reviewers</a>
</li>
<li class="site-menu-item site-menu-lvl-1" id="site-menu-item-1282366">
<a class="nav-link" href="https://academic.oup.com/cid/pages/for_press_offices">For Press Offices</a>
</li>
</ul>
</li>
</ul>
</nav>
<div class="navbar-search-container">
<div class="navbar-search-close js_close-navsearch">Close</div>
<div class="navbar-search">
<div class="microsite-search" id="MicrositeSearch">
<label class="screenreader-text" for="navbar-search-filter">search filter</label>
<select class="navbar-search-filter" id="navbar-search-filter">
<optgroup label="Search within this journal">
<option class="header-search-bar-filters-item" value="Issue">This issue</option><option class="header-search-bar-filters-item" selected="selected" value="">All  Clinical Infectious Diseases</option>
</optgroup>
<optgroup label="Search beyond this journal">
<option class="header-search-bar-filters-item" value="Parent">All  IDSA Journals</option><option class="header-search-bar-filters-item" value="Journals">All  Journals</option> </optgroup>
</select>
<label class="screenreader-text" for="MicrositeSearchTerm">search input</label>
<input class="navbar-search-input microsite-search-term" id="MicrositeSearchTerm" maxlength="255" title="search input" type="text"/>
<span class="microsite-search-icon navbar-search-submit icon-menu_search" id="MicrositeSearchIcon"></span>
</div>
</div>
<div class="navbar-search-advanced"><a class="advanced-search js-advanced-search" href="https://academic.oup.com/cid/advanced-search?page=1&amp;fl_SiteID=5269&amp;SearchSourceType=1">Advanced Search</a></div>
</div>
<div class="navbar-search-collapsed"><i class="icon-menu_search js_expand-navsearch"></i></div>
</div>
</div>
<input id="hfEnableOupOnlineProductsFeatures" name="hfEnableOupOnlineProductsFeatures" type="hidden" value="False"/>
<input id="hfSolrJournalID" name="searchScope" type="hidden" value=""/>
<input id="hfParentSiteName" name="parentSiteName" type="hidden" value="IDSA Journals"/>
<input id="hfparentSiteUrl" name="parentSiteUrl" type="hidden" value="academic.oup.com/idsa"/>
<input id="hfsiteID" name="siteID" type="hidden" value="5269"/>
<input id="hfparentSiteID" name="parentSiteID" type="hidden" value="5532"/>
<input id="hfSolrJournalName" type="hidden" value=""/>
<input id="hfSolrMaxAllowSearchChar" type="hidden" value="100"/>
<input id="hfJournalShortName" type="hidden" value=""/>
<input id="hfSearchPlaceholder" type="hidden" value=""/>
<input id="hfGlobalSearchSiteURL" name="hfGlobalSearchSiteURL" type="hidden" value=""/>
<input id="hfjournalSiteScope" name="journalSiteScope" type="hidden" value="Journals"/>
<input id="hfparentSiteScope" name="parentSiteScope" type="hidden" value="Parent"/>
<input id="hfdefaultSearchURL" name="defaultSearchURL" type="hidden" value="search-results?page=1&amp;q="/>
<input id="hfIssueSearch" name="issueSearch" type="hidden" value="&amp;fl_IssueID=13796"/>
<input id="hfIssueSiteScope" name="issueSiteScope" type="hidden" value="Issue"/>
<input id="hfDefaultAdvancedSearchUrl" name="hfDefaultAdvancedSearchUrl" type="hidden" value="advanced-search?page=1&amp;q="/> <input id="hfSiteURL" name="hfSearchSiteURL" type="hidden" value="academic.oup.com/cid"/>
<script type="text/javascript">
        (function () {
            var hfSiteUrl = document.getElementById('hfSiteURL');
            var siteUrl = hfSiteUrl.value;
            var subdomainIndex = siteUrl.indexOf('/');

            hfSiteUrl.value = location.host + (subdomainIndex >= 0 ? siteUrl.substring(subdomainIndex) : '');
        })();
    </script>
<input id="routename" name="RouteName" type="hidden" value="cid"/>
</div>
</section>
<div class="content-main js-main ui-base" id="main">
<section class="master-main row">
<div class="center-inner-row no-overflow">
<div class="page-column-wrap">
<div class="page-column page-column--left js-left-nav-col" id="InfoColumn">
<div class="mobile-content-topbar hide">
<button class="toggle-left-col toggle-left-col__article">Article Navigation</button>
</div>
<div class="info-inner-wrap js-left-nav" style="top: 0px;">
<button class="toggle-left-col__close btn-as-icon icon-general-close">
<span class="screenreader-text">Close mobile search navigation</span>
</button>
<div class="responsive-nav-title">Article Navigation</div>
<div class="info-widget-wrap">
<div class="widget widget-IssueInfo widget-instance-OUP_IssueInfo_Article">
<div class="article-info-wrap clearfix" id="issueInfo-OUP_IssueInfo_Article">
<i class="icon-general-close mobile-nav-btn nav-open"></i>
<div class="article-issue-img">
<a href="https://academic.oup.com/cid/cid/issue/58/8"><img alt="Issue Cover" class="fb-featured-image" id="issueImage" src="https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/Issue/58/8/0/m_cid58_8.cover.gif?Expires=1563138173&amp;Signature=O7OQK8dEqk4tIOYrGXbL1P2z7e-AArjH1O5sT-~GS6UoR1S6k-JQTX3oPD3fhQSpI1nEJtHSYeQEFPhdqilU-DUlw6v4tPLcMxD~nFUS8nq8c4V-cjU0AhV8pfX6o-w2~2Bsb6l5WagX4LA167rLn~Gt2C6WtaocBWu~hN-233Qek8A2aQPVNy4L1gDONBRgiDd2z1mdiI3SJMdsDqv0EeVcIPTgKk2eZwCLvbbvTFXtLWPYkamW~FNfWB-DSUJKaXlMhCMIcB1Q2ACCu65rwkMHs404zoeOFD8W6w2xoibfET3mh5QgeGh5FdWhXRmlkNkKUTtBtnRJqjh6INfTMA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA"/></a>
</div>
<div class="article-issue-info">
<div class="volume-issue__wrap">
<a href="https://academic.oup.com/cid/issue/58/8">
<div class="volume trailing-comma">Volume 58</div>
<div class="issue">Issue 8</div>
</a>
</div>
<div class="ii-pub-date">
15 April 2014        </div>
</div>
</div>
</div>
<div class="content-nav">
<div class="widget widget-ArticleJumpLinks widget-instance-OUP_ArticleJumpLinks_Widget">
<div class="contents-title">Article Contents</div>
<ul class="jumplink-list">
<li class="section-jump-link head-1" link-destination="5094587">
<div class="section-jump-link__link-wrap">
<a class="js-jumplink scrollTo" href="https://academic.oup.com/#5094587">Abstract</a>
</div>
</li>
<li class="section-jump-link head-1" link-destination="5094593">
<div class="section-jump-link__link-wrap">
<a class="js-jumplink scrollTo" href="https://academic.oup.com/#5094593">GUILLAIN-BARRÉ SYNDROME</a>
</div>
</li>
<li class="section-jump-link head-1" link-destination="5094598">
<div class="section-jump-link__link-wrap">
<a class="js-jumplink scrollTo" href="https://academic.oup.com/#5094598">GBS AND INFLUENZA VACCINES</a>
</div>
</li>
<li class="section-jump-link head-1" link-destination="5094609">
<div class="section-jump-link__link-wrap">
<a class="js-jumplink scrollTo" href="https://academic.oup.com/#5094609">GBS AND INFLUENZA</a>
</div>
</li>
<li class="section-jump-link head-1" link-destination="5094622">
<div class="section-jump-link__link-wrap">
<a class="js-jumplink scrollTo" href="https://academic.oup.com/#5094622">GBS, INFLUENZA, AND INFLUENZA VACCINE</a>
</div>
</li>
<li class="section-jump-link head-1" link-destination="5094631">
<div class="section-jump-link__link-wrap">
<a class="js-jumplink scrollTo" href="https://academic.oup.com/#5094631">Notes</a>
</div>
</li>
<li class="section-jump-link head-1" link-destination="5094636">
<div class="section-jump-link__link-wrap">
<a class="js-jumplink scrollTo" href="https://academic.oup.com/#5094636">References</a>
</div>
</li>
</ul>
</div>
<div class="comments-jumplink">
<a class="js-jumplink scrollTo" href="https://academic.oup.com/#usercomments"><i class="icon-menu_comments"></i>Comments (0)</a>
</div></div>
<div class="widget widget-ArticleNavLinks widget-instance-OUP_ArticleNavLinks_Article">
<ul class="inline-list">
<li class="prev arrow">
<a href="https://academic.oup.com/cid/article/58/8/1140/355853">&lt; Previous</a>
</li>
<li class="next arrow">
<a href="https://academic.oup.com/cid/article/58/8/1156/356172">Next &gt;</a>
</li>
</ul>
</div>
</div>
</div>
</div>
<div class="sticky-toolbar js-sticky-toolbar"></div>
<div class="page-column page-column--center" id="ContentColumn">
<div class="article-browse-top article-browse-mobile-nav js-article-browse-mobile-nav">
<div class="article-browse-mobile-nav-inner js-article-browse-mobile-nav-inner">
<button class="toggle-left-col toggle-left-col__article btn-as-link">
                Article Navigation
            </button>
</div>
</div>
<div class="content-inner-wrap">
<div class="widget widget-ArticleTopInfo widget-instance-OUP_ArticleTop_Info_Widget">
<div class="module-widget article-top-widget">
<div class="widget-items">
<h1 class="wi-article-title article-title-main">Guillain-Barré Syndrome, Influenza, and Influenza Vaccination: The Epidemiologic Evidence
<i class="icon-availability_free" title="Free"></i> </h1>
<div class="wi-authors">
<div class="al-authors-list">
<span class="al-author-name-more">
<span class="al-author-info-wrap arrow-up" style="">
<div class="info-card-author" id="authorInfo_OUP_ArticleTop_Info_Widget">
<div class="name-role-wrap">
<div class="info-card-name">Claudia Vellozzi</div>
</div>
<div class="info-card-affilitation">
<div class="aff"><div class="addr-line">Immunization Safety Office</div>, <div class="insititution">National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</div>, <div class="addr-line">Atlanta, Georgia</div></div>
</div>
<div class="info-card-search-label">
            Search for other works by this author on:
        </div>
<div class="info-card-search info-card-search-oxford">
<a href="https://academic.oup.com/cid/search-results?f_Authors=Claudia+Vellozzi">Oxford Academic</a>
</div>
<div class="info-card-search info-card-search-pubmed">
<a href="http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Vellozzi C">PubMed</a>
</div>
<div class="info-card-search info-card-search-google">
<a href='http://scholar.google.com/scholar?q=author:"Vellozzi Claudia"'>Google Scholar</a>
</div>
</div>
</span>
<a class="linked-name" href="https://academic.oup.com/cid/article/58/8/1149/javascript:;">Claudia Vellozzi</a>
</span>
<span class="al-author-name-more">
<span class="al-author-info-wrap arrow-up" style="">
<div class="info-card-author" id="authorInfo_OUP_ArticleTop_Info_Widget">
<div class="name-role-wrap">
<div class="info-card-name">Shahed Iqbal</div>
</div>
<div class="info-card-affilitation">
<div class="aff"><div class="addr-line">Immunization Safety Office</div>, <div class="insititution">National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</div>, <div class="addr-line">Atlanta, Georgia</div></div>
</div>
<div class="info-card-search-label">
            Search for other works by this author on:
        </div>
<div class="info-card-search info-card-search-oxford">
<a href="https://academic.oup.com/cid/search-results?f_Authors=Shahed+Iqbal">Oxford Academic</a>
</div>
<div class="info-card-search info-card-search-pubmed">
<a href="http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Iqbal S">PubMed</a>
</div>
<div class="info-card-search info-card-search-google">
<a href='http://scholar.google.com/scholar?q=author:"Iqbal Shahed"'>Google Scholar</a>
</div>
</div>
</span>
<a class="linked-name" href="https://academic.oup.com/cid/article/58/8/1149/javascript:;">Shahed Iqbal</a>
</span>
<span class="al-author-name-more">
<span class="al-author-info-wrap arrow-up" style="">
<div class="info-card-author" id="authorInfo_OUP_ArticleTop_Info_Widget">
<div class="name-role-wrap">
<div class="info-card-name">Karen Broder</div>
</div>
<div class="info-card-affilitation">
<div class="aff"><div class="addr-line">Immunization Safety Office</div>, <div class="insititution">National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</div>, <div class="addr-line">Atlanta, Georgia</div></div>
</div>
<div class="info-card-search-label">
            Search for other works by this author on:
        </div>
<div class="info-card-search info-card-search-oxford">
<a href="https://academic.oup.com/cid/search-results?f_Authors=Karen+Broder">Oxford Academic</a>
</div>
<div class="info-card-search info-card-search-pubmed">
<a href="http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Broder K">PubMed</a>
</div>
<div class="info-card-search info-card-search-google">
<a href='http://scholar.google.com/scholar?q=author:"Broder Karen"'>Google Scholar</a>
</div>
</div>
</span>
<a class="linked-name" href="https://academic.oup.com/cid/article/58/8/1149/javascript:;">Karen Broder</a>
</span>
</div>
</div>
<div class="pub-history-wrap clearfix">
<div class="pub-history-row clearfix">
<div class="ww-citation-primary"><em>Clinical Infectious Diseases</em>, Volume 58, Issue 8, 15 April 2014, Pages 1149–1155, <a href="https://doi.org/10.1093/cid/ciu005">https://doi.org/10.1093/cid/ciu005</a></div>
</div>
<div class="pub-history-row clearfix">
<div class="ww-citation-date-wrap">
<div class="citation-label">Published:</div>
<div class="citation-date">09 January 2014</div>
</div>
<div class="ww-citation-history-wrap">
<div class="citation-label">
                                    Article history<i class="icon-general-arrow-filled-down arrow-icon"></i>
</div>
</div>
</div>
<div class="ww-history">
<div class="history-entry">
<div class="wi-state">Received:</div>
<div class="wi-date">02 October 2013</div>
</div>
<div class="history-entry">
<div class="wi-state">Accepted:</div>
<div class="wi-date">29 December 2013</div>
</div>
<div class="ww-history-close"><a>Close</a></div>
</div>
</div>
</div>
</div>
<script>
    $(document).ready(function () {
        $('.article-top-widget').on('click', '.ati-toggle-trigger', function () {
            $(this).find('.icon-general-add, .icon-minus').toggleClass('icon-minus icon-general-add');
            $(this).siblings('.ati-toggle-content').toggleClass('hide');
        });

        // In Chrome, an anchor tag with target="_blank" and a "mailto:" href opens a new tab/window as well as the email client
        // I suspect this behavior will be corrected in the future
        // Remove the target="_blank"
        $('ul.wi-affiliationList').find('a[href^="mailto:"]').each(function () {
            $(this).removeAttr('target');
        });
    });
</script>
</div>
<div class="widget widget-ArticleLinks widget-instance-OUP_Article_Links_Widget">
</div>
<div class="article-body">
<div class="toolbar-wrap js-toolbar-wrap">
<div class="toolbar-inner-wrap">
<ul id="Toolbar" role="navigation">
<li class="toolbar-item item-pdf">
<a class="al-link pdf article-pdfLink" data-article-id="355966" href="https://academic.oup.com/cid/article/58/8/cid/article-pdf/58/8/1149/1018675/ciu005.pdf">
<img alt="pdf" src="https://academic.oup.com/UI/app/svg/pdf.svg"/><span class="pdf-link-text">PDF</span>
</a>
</li>
<li class="toolbar-item item-link item-split-view">
<a class="split-view js-split-view st-split-view" href="https://academic.oup.com/cid/article/58/8/1149/javascript:;" target="">
<i class="icon-menu_split"></i>
                                    Split View
                                </a>
</li>
<li class="toolbar-item item-with-dropdown item-views">
<a aria-haspopup="true" class="drop-trigger" data-dropdown="FilterDrop" href="https://academic.oup.com/cid/article/58/8/1149/javascript:;">
<i class="icon-menu_views"></i>
<div class="toolbar-label">
<div class="toolbar-text">Views</div>
<i class="icon-general-arrow-filled-down arrow-icon"></i>
</div>
</a>
<ul aria-label="submenu" class="f-dropdown" data-dropdown-content="" id="ViewsDrop">
<div class="arrow-up" style="display: block;"></div>
<li class="article-content-filter js-article-content-filter" data-content-filter="article-content" style="display: none;">
<a href="https://academic.oup.com/cid/article/58/8/1149/javascript:;"><span>Article contents</span></a>
</li>
<li class="article-content-filter js-article-content-filter" data-content-filter="figures-tables">
<a href="https://academic.oup.com/cid/article/58/8/1149/javascript:;"><span>Figures &amp; tables</span></a>
</li>
</ul>
</li>
<li class="toolbar-item">
<div class="widget widget-ToolboxGetCitation widget-instance-OUP_Get_Citation">
<a data-reveal="" data-reveal-id="getCitation" href="https://academic.oup.com/#"><i class="icon-read-more"></i><span>Cite</span></a>
<div class="reveal-modal" data-reveal="" id="getCitation">
<div class="modal-title">Citation</div>
<p>Claudia Vellozzi, Shahed Iqbal, Karen Broder,  Guillain-Barré Syndrome, Influenza, and Influenza Vaccination: The Epidemiologic Evidence, <em>Clinical Infectious Diseases</em>, Volume 58, Issue 8, 15 April 2014, Pages 1149–1155, <a href="https://doi.org/10.1093/cid/ciu005">https://doi.org/10.1093/cid/ciu005</a></p>
<p class="citation-label">Download citation file:</p>
<ul>
<li><a href="https://academic.oup.com/Citation/Download?resourceId=355966&amp;resourceType=3&amp;citationFormat=0">Ris (Zotero)</a></li>
<li><a href="https://academic.oup.com/Citation/Download?resourceId=355966&amp;resourceType=3&amp;citationFormat=1">EndNote</a></li>
<li><a href="https://academic.oup.com/Citation/Download?resourceId=355966&amp;resourceType=3&amp;citationFormat=2">BibTex</a></li>
<li><a href="https://academic.oup.com/Citation/Download?resourceId=355966&amp;resourceType=3&amp;citationFormat=3">Medlars</a></li>
<li><a href="https://academic.oup.com/Citation/Download?resourceId=355966&amp;resourceType=3&amp;citationFormat=0">ProCite</a></li>
<li><a href="https://academic.oup.com/Citation/Download?resourceId=355966&amp;resourceType=3&amp;citationFormat=3">RefWorks</a></li>
<li><a href="https://academic.oup.com/Citation/Download?resourceId=355966&amp;resourceType=3&amp;citationFormat=0">Reference Manager</a></li>
</ul>
<hr/>
<p>© 2019 Oxford University Press</p>
<a class="close-reveal-modal" href="https://academic.oup.com/cid/article/58/8/1149/javascript:;"><i class="icon-general-close"></i><span class="screenreader-text">Close</span></a>
</div>
</div>
</li>
<li class="toolbar-item item-tools">
<div class="widget widget-ToolboxPermissions widget-instance-">
<div class="module-widget">
<a class="" href="https://s100.copyright.com/AppDispatchServlet?publisherName=OUP&amp;publication=1537-6591&amp;title=Guillain-Barr%C3%A9%20Syndrome%2C%20Influenza%2C%20and%20Influenza%20Vaccination%3A%20The%20Epidemiologic%20Evidence&amp;publicationDate=2014-01-09&amp;volumeNum=58&amp;issueNum=8&amp;author=Vellozzi%2C%20Claudia%3B%20Iqbal%2C%20Shahed&amp;startPage=1149&amp;endPage=1155&amp;contentId=10.1093%2Fcid%2Fciu005&amp;oa=&amp;copyright=Oxford%20University%20Press&amp;orderBeanReset=True" id="PermissionsLink" target="">
<i class="icon-menu_permissions">
<span class="screenreader-text">Permissions Icon</span>
</i>
            Permissions
        </a>
</div>
</div>
</li>
<li class="toolbar-item item-with-dropdown item-share last">
<a aria-haspopup="true" class="drop-trigger" data-dropdown="ShareDrop" href="https://academic.oup.com/cid/article/58/8/1149/javascript:;">
<i class="icon-menu_share"></i>
<div class="toolbar-label">
<div class="toolbar-text">Share</div>
<i class="icon-general-arrow-filled-down arrow-icon"></i>
</div>
</a>
<ul aria-label="submenu" class="addthis_toolbox addthis_default_style addthis_20x20_style f-dropdown" data-dropdown-content="" id="ShareDrop">
<div class="arrow-up"></div>
<li><a class="addthis_button_email at300b" href="https://academic.oup.com/#" target="" title="Email"><span>Email</span></a></li>
<li><a class="addthis_button_twitter at300b" href="https://academic.oup.com/#" title="Twitter"><span>Twitter</span></a></li>
<li><a class="addthis_button_facebook at300b" href="https://academic.oup.com/#" title="Facebook"><span>Facebook</span></a></li>
<li><a class="addthis_button_compact at300m" href="https://academic.oup.com/#"><span>More</span></a></li>
<div class="atclear"></div></ul>
</li>
</ul>
<div class="toolbar-search">
<div class="widget widget-SitePageHeader widget-instance-OUP_ArticleToolbarSearchBox">
<div class="dropdown-panel-wrap">
<div class="dropdown-panel mobile-search-dropdown">
<div class="mobile-search-inner-wrap">
<div class="navbar-search">
<div class="mobile-microsite-search" id="MobileMicrositeSearch">
<label class="screenreader-text" for="mobile-navbar-search-filter">Navbar Search Filter</label>
<select class="navbar-search-filter" id="mobile-navbar-search-filter">
<optgroup label="Search within this journal">
<option class="header-search-bar-filters-item" value="Issue">This issue</option><option class="header-search-bar-filters-item" value="">All  Clinical Infectious Diseases</option>
</optgroup>
<optgroup label="Search beyond this journal">
<option class="header-search-bar-filters-item" value="Parent">All  IDSA Journals</option><option class="header-search-bar-filters-item" value="Journals">All  Journals</option> </optgroup>
</select>
<label class="screenreader-text" for="MobileMicrositeSearchTerm">Mobile Microsite Search Term</label>
<input class="mobile-search-input mobile-microsite-search-term" id="MobileMicrositeSearchTerm" maxlength="255" placeholder="Search" type="text"/>
<span class="mobile-microsite-search-icon mobile-search-submit icon-menu_search" id="MobileMicrositeSearchIcon"></span>
</div>
</div>
</div>
</div>
<div class="dropdown-panel mobile-account-dropdown">
<ul class="site-menu site-menu-lvl-0">
<li class="site-menu-item site-menu-lvl-0">
<a class="nav-link mobile-account-signin dummy-link" href="https://academic.oup.com/" id="header-account-info-user-fullname">
                    
Sign In                    <i class="mobile-nav-arrow icon-general_arrow-down"></i>
</a>
<ul class="site-menu site-menu-lvl-1 individual-menu">
<li class="dropdown-signin-form">
<div class="spinner"></div>
</li>
</ul>
</li>
<li class="site-menu-item">
<a class="register nav-link" href="https://academic.oup.com/my-account/register?siteId=5269&amp;returnUrl=%2fcid%2farticle%2f58%2f8%2f1149%2f355966">Register</a>
</li>
</ul>
</div>
<div class="dropdown-panel mobile-nav-dropdown">
</div>
</div>
<div class="navbar">
<div class="center-inner-row">
<nav class="navbar-menu">
</nav>
<div class="navbar-search-container">
<div class="navbar-search-close js_close-navsearch">Close</div>
<div class="navbar-search">
<div class="microsite-search" id="MicrositeSearch">
<label class="screenreader-text" for="navbar-search-filter">search filter</label>
<select class="navbar-search-filter" id="navbar-search-filter">
<optgroup label="Search within this journal">
<option class="header-search-bar-filters-item" value="Issue">This issue</option><option class="header-search-bar-filters-item" selected="selected" value="">All  Clinical Infectious Diseases</option>
</optgroup>
<optgroup label="Search beyond this journal">
<option class="header-search-bar-filters-item" value="Parent">All  IDSA Journals</option><option class="header-search-bar-filters-item" value="Journals">All  Journals</option> </optgroup>
</select>
<label class="screenreader-text" for="MicrositeSearchTerm">search input</label>
<input class="navbar-search-input microsite-search-term" id="MicrositeSearchTerm" maxlength="255" title="search input" type="text"/>
<span class="microsite-search-icon navbar-search-submit icon-menu_search" id="MicrositeSearchIcon"></span>
</div>
</div>
<div class="navbar-search-advanced"><a class="advanced-search js-advanced-search" href="https://academic.oup.com/cid/advanced-search?page=1&amp;fl_SiteID=5269&amp;SearchSourceType=1">Advanced Search</a></div>
</div>
<div class="navbar-search-collapsed"><i class="icon-menu_search js_expand-navsearch"></i></div>
</div>
</div>
<input id="hfEnableOupOnlineProductsFeatures" name="hfEnableOupOnlineProductsFeatures" type="hidden" value="False"/>
<input id="routename" name="RouteName" type="hidden" value="cid"/>
</div>
</div>
</div>
</div>
<div class="content active" id="ContentTab">
<div class="widget widget-ArticleFulltext widget-instance-OUP_Article_FullText_Widget">
<div class="module-widget">
<div class="widget-items" data-widgetname="ArticleFulltext">
<h2 class="abstract-title" id="5094587" scrollto-destination="5094587">Abstract</h2>
<section class="abstract"><p>Guillain-Barré syndrome (GBS) is the most common cause of acute flaccid paralysis worldwide, and is thought to be immune-mediated. It is preceded by upper respiratory or gastrointestinal infection in about two-thirds of cases and is associated with some viral infections, including influenza. GBS has also been associated with the 1976 swine-influenza vaccine. Thereafter, some studies have shown a small increased risk of GBS following receipt of seasonal and 2009 H1N1 monovalent influenza vaccines. Studies over the years have also shown an increased risk of GBS following influenza infection, and the magnitude of risk is several times greater than that following influenza vaccination. Because GBS is rare, and even rarer following vaccination, it is difficult to estimate precise risk. We try to shed light on the complex relationship of GBS and its association with influenza and influenza vaccines over the past 35 years.</p></section> <div class="article-metadata-panel clearfix"><div class="kwd-group"><a class="kwd-part kwd-main" data-keyword='"Guillain-Barré syndrome"' href="https://academic.oup.com/cid/article/58/8/1149/javascript:;">Guillain-Barré syndrome</a>, <a class="kwd-part kwd-main" data-keyword="influenza" href="https://academic.oup.com/cid/article/58/8/1149/javascript:;">influenza</a>, <a class="kwd-part kwd-main" data-keyword='"influenza vaccination"' href="https://academic.oup.com/cid/article/58/8/1149/javascript:;">influenza vaccination</a></div><div class="related-topic-tags">
<div class="related-topic-tag-label">Topic:</div>
<ul class="related-topic-tag-list">
<li>
<a href="https://academic.oup.com/cid/search-results?f_SemanticFilterTopics=influenza"><span>influenza</span></a>
</li>
<li>
<a href="https://academic.oup.com/cid/search-results?f_SemanticFilterTopics=guillain-barre syndrome"><span>guillain-barre syndrome</span></a>
</li>
<li>
<a href="https://academic.oup.com/cid/search-results?f_SemanticFilterTopics=influenza vaccines"><span>influenza vaccines</span></a>
</li>
<li>
<a href="https://academic.oup.com/cid/search-results?f_SemanticFilterTopics=vaccination"><span>vaccination</span></a>
</li>
<li>
<a href="https://academic.oup.com/cid/search-results?f_SemanticFilterTopics=vaccines"><span>vaccines</span></a>
</li>
<li>
<a href="https://academic.oup.com/cid/search-results?f_SemanticFilterTopics=infection"><span>infection</span></a>
</li>
<li>
<a href="https://academic.oup.com/cid/search-results?f_SemanticFilterTopics=swine influenza"><span>swine influenza</span></a>
</li>
</ul>
</div><div class="article-metadata-tocSections">
<div class="article-metadata-tocSections-title">Issue Section:</div>
<a href="https://academic.oup.com/cid/search-results?f_TocHeadingTitle=Vaccines">Vaccines</a>
</div></div>
<p>Guillain-Barré syndrome (GBS) came to the forefront during the 1976 swine influenza vaccination program when an increased risk was found following vaccination [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C1" reveal-id="CIU005C1">1</a>]. Thirty-five years later we are still grappling with this increased risk; concerns continue that the risk observed in 1976 might surface again following administration of influenza vaccines, which have a change in the strain nearly every year [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C2" reveal-id="CIU005C2">2</a>]. These concerns have led to many studies assessing this risk, especially, because in the United States, annual influenza vaccine is now recommended for everyone aged ≥6 months [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C2" reveal-id="CIU005C2">2</a>]. In this review, we purport that there may be enough evidence in 2013 to be somewhat reassured to move past the fear that influenza vaccines can cause GBS of the same magnitude that was described in <em>The Swine Flu Affair</em> [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C3" reveal-id="CIU005C3">3</a>].</p> <h2 class="section-title" data-legacy-id="s2" id="5094593" scrollto-destination="5094593">GUILLAIN-BARRÉ SYNDROME</h2>
<p>GBS is the most common cause of acute flaccid paralysis worldwide now that poliomyelitis is nearly eradicated. It results from damage to the peripheral nerves and nerve roots, presenting with progressive bilateral symmetric weakness of the lower limbs over a period of 12 hours and reaching a plateau at approximately 28 days. The onset of symptoms in about two-thirds of the cases is preceded by an upper respiratory or gastrointestinal infection. Most patients completely recover, although there is about a 5% case-mortality rate [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C4" reveal-id="CIU005C4">4</a>, <a class="link link-ref link-reveal xref-bibr" data-open="CIU005C5" reveal-id="CIU005C5">5</a>].</p><p>The annual incidence of GBS is 0.4–4.0 cases per 100 000 population among all ages. In children and adolescents, the range is 0.4–1.5 cases per 100 000 and then the incidence increases throughout adulthood to about 4.0 cases per 100 000 after age 75 years [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C6  CIU005C8" reveal-id="CIU005C6  CIU005C8">6–8</a>]. GBS is thought to be immune-mediated, in which antibodies in response to an antigenic stimulus, such as a bacterial or viral infection, cross-react with nerve ending antigens; this is often referred to as molecular mimicry. Infection preceding GBS is quite common, but the specific infectious agent is unknown in 60% of the cases. Several infectious agents have been shown to be associated with GBS, most notably <em>Campylobacter jejuni</em> [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C9  CIU005C13" reveal-id="CIU005C9  CIU005C13">9–13</a>].</p> <h2 class="section-title" data-legacy-id="s3" id="5094598" scrollto-destination="5094598">GBS AND INFLUENZA VACCINES</h2>
<p>GBS became a major vaccine safety concern in 1976 when there was a threat of a swine-origin influenza pandemic and the United States government initiated a national vaccination program. After approximately 45 million people were vaccinated with influenza A/New Jersey/1976 vaccine, an increased number of postvaccination GBS cases were reported. Investigations revealed up to a 8-fold increased risk of GBS following receipt of the 1976 influenza vaccine; the risk was found to be highest 2–3 weeks after vaccination. The attributable risk was estimated at 1 additional case of GBS for every 100 000 doses administered [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C1" reveal-id="CIU005C1">1</a>, <a class="link link-ref link-reveal xref-bibr" data-open="CIU005C14" reveal-id="CIU005C14">14</a>]. As a result of this adverse outcome following vaccination, as well as the fact that the pandemic never materialized, the 1976 influenza vaccination program was halted [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C3" reveal-id="CIU005C3">3</a>]. Nearly 30 years later, in 2004, the Institute of Medicine (IOM) reviewed the evidence regarding the association of GBS with the 1976 swine influenza vaccine and concluded that “the evidence favors acceptance of a causal relationship between 1976 swine influenza vaccines and GBS in adults” [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C15" reveal-id="CIU005C15">15</a>].</p><p>Since 1976, several published studies have assessed risk of GBS following receipt of seasonal inactivated influenza vaccines. Most studies did not demonstrate a significant association between seasonal influenza vaccine and GBS, and most point estimates were not significant (Figure <a class="link link-reveal link-table xref-fig" data-open="CIU005F1" reveal-id="CIU005F1">1</a>) [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C16  CIU005C23" reveal-id="CIU005C16  CIU005C23">16–23</a>]. However, 2 studies reporting positive findings garnered much attention. In 2006, Juurlink et al studied the association of GBS with influenza vaccines administered during 1992–2004 in Canada; using a self-controlled case series design, they found a small but significant increased risk of GBS in the 6 weeks following receipt of influenza vaccine (relative risk [RR] 1.45; 95% confidence interval [CI], 1.05–1.99) [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C20" reveal-id="CIU005C20">20</a>]. The other notable study used US data from the period 1992–1994 (2 influenza seasons) and demonstrated an overall increased RR of 1.7 (95% CI, 1.0–2.8; <em>P</em> = .04), although an increased risk was not demonstrated when using data from each influenza season separately [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C22" reveal-id="CIU005C22">22</a>]. The RR of 1.7 suggests slightly more than 1 additional case of GBS per million persons vaccinated against influenza. Based on evidence from these 2 studies, a risk estimate of 1 additional GBS case per 1 million persons vaccinated has been communicated to the public and found in the Advisory Committee on Immunization Practices recommendations and the Vaccine Information Statements for influenza vaccines [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C2" reveal-id="CIU005C2">2</a>, <a class="link link-ref link-reveal xref-bibr" data-open="CIU005C24" reveal-id="CIU005C24">24</a>]. The IOM reviewed evidence accumulated after 1976 through 2008 and concluded that “the evidence is inadequate to accept or reject a causal relationship between influenza vaccine and GBS.” The IOM further concluded that the evidence was not adequate because of potential confounding due to season and influenza infection and also because each year the influenza strains included in the vaccine typically differ [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C25" reveal-id="CIU005C25">25</a>].</p><p>More recently, GBS risk assessment following influenza vaccination once again came to the forefront. During the 2009 H1N1 influenza pandemic, vaccine safety surveillance was heightened and critical to the unadjuvanted 2009 monovalent inactivated influenza A(H1N1) (2009 pH1N1 vaccine) vaccination program that began in October 2009. GBS was a particularly important component of the pandemic response, because the 1976 swine-origin influenza vaccine was associated with an increased risk of GBS and the 2009 H1N1 influenza virus was also of swine origin, and there was a high degree of public interest regarding the safety of pandemic H1N1 vaccines. In the United States, several federal agencies enhanced, adapted, or created surveillance systems to monitor 2009 pH1N1 vaccine safety including assessing the risk of GBS following vaccination [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C26" reveal-id="CIU005C26">26</a>]. The results of surveillance from most of these systems are captured in Table <a class="link link-reveal link-table xref-fig" data-open="CIU005TB1" reveal-id="CIU005TB1">1</a>. At the Centers for Disease Control and Prevention (CDC), active GBS case-finding surveillance using a population catchment of nearly 45 million people was implemented as part of the Emerging Infections Program (EIP), a long-standing collaboration with the CDC, local health departments, academic institutions, healthcare providers, specialist networks, and clinical laboratories [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C27" reveal-id="CIU005C27">27</a>]. In November 2009, prospective cohort analyses showed a small increased risk of GBS within the 6 weeks following vaccination and an attributable risk of approximately 1 additional case of GBS per million persons vaccinated [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C28" reveal-id="CIU005C28">28</a>]. Final analyses confirmed this small increased risk within 6 weeks of vaccination [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C29" reveal-id="CIU005C29">29</a>, <a class="link link-ref link-reveal xref-bibr" data-open="CIU005C30" reveal-id="CIU005C30">30</a>]. The CDC's Vaccine Safety Datalink, a population-based database linking vaccine data with health outcome data, also found a significant increased risk of GBS [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C31" reveal-id="CIU005C31">31</a>] in the primary self-controlled analysis, and, although the surveillance from the Food and Drug Administration did not demonstrate a statistically significant finding, the RR point estimate was elevated [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C32" reveal-id="CIU005C32">32</a>]. To increase the power to assess an increased risk of this rare disease, a meta-analysis combined data on 23 million persons vaccinated from all the federal systems that participated in 2009 pH1N1 vaccine safety monitoring. Consistent with previous studies assessing the seasonal influenza vaccine data from earlier years [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C20" reveal-id="CIU005C20">20</a>, <a class="link link-ref link-reveal xref-bibr" data-open="CIU005C22" reveal-id="CIU005C22">22</a>], this pooled analysis found an attributable risk of 1–3 additional GBS cases per million persons vaccinated with pH1N1 [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C33" reveal-id="CIU005C33">33</a>] (Table <a class="link link-reveal link-table xref-fig" data-open="CIU005TB1" reveal-id="CIU005TB1">1</a>). Findings from European studies assessing the risk of GBS following the 2009 pH1N1 vaccines somewhat differed from what was observed in the United States. A multicountry case-control study using data from several European countries, where predominately adjuvanted pH1N1 vaccines were used, found no increased risk for GBS within 6 weeks of vaccination after adjusting for influenza-like illness (ILI)/upper respiratory tract infection (URTI) and seasonal influenza vaccination [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C34" reveal-id="CIU005C34">34</a>]. The United Kingdom also primarily used adjuvanted vaccines and found no increased risk using a self-controlled case series design (RR = 1.05; 95% CI, .37–2.24) [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C35" reveal-id="CIU005C35">35</a>]. In addition, a large international study found a significant increased risk of GBS following the 2009 pH1N1 vaccines (relative incidence [RI] = 2.33; 95% CI, 1.5–3.6); however, when stratifying by vaccine type (adjuvanted or unadjuvanted), the RI for the unadjuvanted group was significantly increased (RI = 3.1; 95% CI, 1.7–5.7) and higher than that for the adjuvanted group (RI = 1.7; 95% CI, .9–3.3) [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C36" reveal-id="CIU005C36">36</a>]. Finally, a study from Quebec, Canada, found an attributable risk of 2 additional cases of GBS per million doses administered, similar to the US surveillance findings; however, Quebec primarily used adjuvanted H1N1 vaccines. The authors noted that the excess risk was only found in persons aged &gt;50 years [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C37" reveal-id="CIU005C37">37</a>]. Results of these studies from the United States, Europe, Canada, and internationally gave mixed results but in general suggest an increased risk of GBS after either adjuvanted or unadjuvanted vaccine. </p> <a id="5094604" scrollto-destination="5094604"></a>
<div class="table-modal" content-id="CIU005TB1" style="display: block;"><div class="table-wrap"><div class="table-wrap-title" data-id="CIU005TB1" id="CIU005TB1"><div class="label">Table 1.</div><div class="caption"><p>2009 Monovalent Inactivated Influenza A(H1N1) Vaccine and Guillain-Barré Syndrome, US Vaccine Safety Surveillance, 2009–2010</p></div> </div><div class="table-overflow"><table><thead align="" name="thead"><tr><th>Data Source [Reference] </th><th>Study Design<sup>a</sup> </th><th>Final Analysis RR/OR (95% CI) </th><th>AR<sup>b</sup> </th></tr></thead><tbody><tr><td rowspan="3">Emerging Infections Program (CDC)<br/>Wise et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C30" reveal-id="CIU005C30">30</a>] </td><td rowspan="3">Unvaccinated control<sup>c</sup> </td><td>1.57 (1.02–2.21) (all ages) </td><td rowspan="3">1.2 </td></tr><tr><td>1.67 (.58–3.22) (&lt;25 y) </td></tr><tr><td>1.54 (.90–2.25) (≥25 y) </td></tr><tr><td rowspan="2">Tokars et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C29" reveal-id="CIU005C29">29</a>] </td><td rowspan="2">Self-controlled </td><td>2.1 (1.2–3.5) (all ages) </td><td rowspan="2">1–3 </td></tr><tr><td>3.0 (1.0–9.1) (6 mo–24 y) </td></tr><tr><td rowspan="2">Vaccine Safety Datalink (CDC)<br/>Greene et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C31" reveal-id="CIU005C31">31</a>] </td><td>Self-controlled </td><td>4.4 (1.3–14.2) </td><td rowspan="2">5 </td></tr><tr><td>Case-centered </td><td>2.0 (.5–8.1) </td></tr><tr><td rowspan="2">PRISM (FDA)<br/>Yih et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C32" reveal-id="CIU005C32">32</a>] </td><td>Self-controlled </td><td>2.50 (.42–15.0) </td><td rowspan="2"> </td></tr><tr><td>Case-centered </td><td>1.15 (.07–18.6) </td></tr><tr><td rowspan="2">Meta-analysis<sup>d</sup><br/>Salmon et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C33" reveal-id="CIU005C33">33</a>] </td><td rowspan="2">Self-controlled </td><td>2.35 (1.42–4.01) (all ages) </td><td rowspan="2">1.6 </td></tr><tr><td>2.33 (.65–10.5) (&lt;18 y) </td></tr></tbody></table></div><div class="table-modal" content-id="CIU005TB1"><table><thead align="" name="thead"><tr><th>Data Source [Reference] </th><th>Study Design<sup>a</sup> </th><th>Final Analysis RR/OR (95% CI) </th><th>AR<sup>b</sup> </th></tr></thead><tbody><tr><td rowspan="3">Emerging Infections Program (CDC)<br/>Wise et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C30" reveal-id="CIU005C30">30</a>] </td><td rowspan="3">Unvaccinated control<sup>c</sup> </td><td>1.57 (1.02–2.21) (all ages) </td><td rowspan="3">1.2 </td></tr><tr><td>1.67 (.58–3.22) (&lt;25 y) </td></tr><tr><td>1.54 (.90–2.25) (≥25 y) </td></tr><tr><td rowspan="2">Tokars et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C29" reveal-id="CIU005C29">29</a>] </td><td rowspan="2">Self-controlled </td><td>2.1 (1.2–3.5) (all ages) </td><td rowspan="2">1–3 </td></tr><tr><td>3.0 (1.0–9.1) (6 mo–24 y) </td></tr><tr><td rowspan="2">Vaccine Safety Datalink (CDC)<br/>Greene et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C31" reveal-id="CIU005C31">31</a>] </td><td>Self-controlled </td><td>4.4 (1.3–14.2) </td><td rowspan="2">5 </td></tr><tr><td>Case-centered </td><td>2.0 (.5–8.1) </td></tr><tr><td rowspan="2">PRISM (FDA)<br/>Yih et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C32" reveal-id="CIU005C32">32</a>] </td><td>Self-controlled </td><td>2.50 (.42–15.0) </td><td rowspan="2"> </td></tr><tr><td>Case-centered </td><td>1.15 (.07–18.6) </td></tr><tr><td rowspan="2">Meta-analysis<sup>d</sup><br/>Salmon et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C33" reveal-id="CIU005C33">33</a>] </td><td rowspan="2">Self-controlled </td><td>2.35 (1.42–4.01) (all ages) </td><td rowspan="2">1.6 </td></tr><tr><td>2.33 (.65–10.5) (&lt;18 y) </td></tr></tbody></table></div><div class="table-wrap-foot"><div content-id=""><div class="fn"><p>Abbreviations: AR, attributable risk; CDC, Centers for Disease Control and Prevention; CI, confidence interval; FDA, Food and Drug Administration; OR, odds ratio; PRISM, Postlicensure Rapid Immunization Safety Monitoring; RR, relative risk.</p></div></div><div content-id=""><div class="fn"><p><sup>a</sup> All cases confirmed through medical records review.</p></div></div><div content-id=""><div class="fn"><p><sup>b</sup> Per million doses administered.</p></div></div><div content-id=""><div class="fn"><p><sup>c</sup> Includes person-time for vaccinated cases that occurred &gt;6 weeks following vaccination.</p></div></div><div content-id=""><div class="fn"><p><sup>d</sup> Includes data from the Emerging Infections Program, Vaccine Safety Datalink, PRISM, Department of Veterans Affairs, Centers for Medicare and Medicaid Services, and Department of Defense.</p></div></div></div><div class="graphic-wrap"><a class="fig-view-orig openInAnotherWindow btn js-view-large" href="https://academic.oup.com/view-large/5094604" target="_blank">View Large</a></div></div></div><div class="table-wrap"><div class="table-wrap-title" data-id="CIU005TB1" id="CIU005TB1"><div class="label">Table 1.</div><div class="caption"><p>2009 Monovalent Inactivated Influenza A(H1N1) Vaccine and Guillain-Barré Syndrome, US Vaccine Safety Surveillance, 2009–2010</p></div> </div><div class="table-overflow"><table><thead align="" name="thead"><tr><th>Data Source [Reference] </th><th>Study Design<sup>a</sup> </th><th>Final Analysis RR/OR (95% CI) </th><th>AR<sup>b</sup> </th></tr></thead><tbody><tr><td rowspan="3">Emerging Infections Program (CDC)<br/>Wise et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C30" reveal-id="CIU005C30">30</a>] </td><td rowspan="3">Unvaccinated control<sup>c</sup> </td><td>1.57 (1.02–2.21) (all ages) </td><td rowspan="3">1.2 </td></tr><tr><td>1.67 (.58–3.22) (&lt;25 y) </td></tr><tr><td>1.54 (.90–2.25) (≥25 y) </td></tr><tr><td rowspan="2">Tokars et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C29" reveal-id="CIU005C29">29</a>] </td><td rowspan="2">Self-controlled </td><td>2.1 (1.2–3.5) (all ages) </td><td rowspan="2">1–3 </td></tr><tr><td>3.0 (1.0–9.1) (6 mo–24 y) </td></tr><tr><td rowspan="2">Vaccine Safety Datalink (CDC)<br/>Greene et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C31" reveal-id="CIU005C31">31</a>] </td><td>Self-controlled </td><td>4.4 (1.3–14.2) </td><td rowspan="2">5 </td></tr><tr><td>Case-centered </td><td>2.0 (.5–8.1) </td></tr><tr><td rowspan="2">PRISM (FDA)<br/>Yih et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C32" reveal-id="CIU005C32">32</a>] </td><td>Self-controlled </td><td>2.50 (.42–15.0) </td><td rowspan="2"> </td></tr><tr><td>Case-centered </td><td>1.15 (.07–18.6) </td></tr><tr><td rowspan="2">Meta-analysis<sup>d</sup><br/>Salmon et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C33" reveal-id="CIU005C33">33</a>] </td><td rowspan="2">Self-controlled </td><td>2.35 (1.42–4.01) (all ages) </td><td rowspan="2">1.6 </td></tr><tr><td>2.33 (.65–10.5) (&lt;18 y) </td></tr></tbody></table></div><div class="table-modal" content-id="CIU005TB1"><table><thead align="" name="thead"><tr><th>Data Source [Reference] </th><th>Study Design<sup>a</sup> </th><th>Final Analysis RR/OR (95% CI) </th><th>AR<sup>b</sup> </th></tr></thead><tbody><tr><td rowspan="3">Emerging Infections Program (CDC)<br/>Wise et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C30" reveal-id="CIU005C30">30</a>] </td><td rowspan="3">Unvaccinated control<sup>c</sup> </td><td>1.57 (1.02–2.21) (all ages) </td><td rowspan="3">1.2 </td></tr><tr><td>1.67 (.58–3.22) (&lt;25 y) </td></tr><tr><td>1.54 (.90–2.25) (≥25 y) </td></tr><tr><td rowspan="2">Tokars et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C29" reveal-id="CIU005C29">29</a>] </td><td rowspan="2">Self-controlled </td><td>2.1 (1.2–3.5) (all ages) </td><td rowspan="2">1–3 </td></tr><tr><td>3.0 (1.0–9.1) (6 mo–24 y) </td></tr><tr><td rowspan="2">Vaccine Safety Datalink (CDC)<br/>Greene et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C31" reveal-id="CIU005C31">31</a>] </td><td>Self-controlled </td><td>4.4 (1.3–14.2) </td><td rowspan="2">5 </td></tr><tr><td>Case-centered </td><td>2.0 (.5–8.1) </td></tr><tr><td rowspan="2">PRISM (FDA)<br/>Yih et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C32" reveal-id="CIU005C32">32</a>] </td><td>Self-controlled </td><td>2.50 (.42–15.0) </td><td rowspan="2"> </td></tr><tr><td>Case-centered </td><td>1.15 (.07–18.6) </td></tr><tr><td rowspan="2">Meta-analysis<sup>d</sup><br/>Salmon et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C33" reveal-id="CIU005C33">33</a>] </td><td rowspan="2">Self-controlled </td><td>2.35 (1.42–4.01) (all ages) </td><td rowspan="2">1.6 </td></tr><tr><td>2.33 (.65–10.5) (&lt;18 y) </td></tr></tbody></table></div><div class="table-wrap-foot"><div content-id=""><div class="fn"><p>Abbreviations: AR, attributable risk; CDC, Centers for Disease Control and Prevention; CI, confidence interval; FDA, Food and Drug Administration; OR, odds ratio; PRISM, Postlicensure Rapid Immunization Safety Monitoring; RR, relative risk.</p></div></div><div content-id=""><div class="fn"><p><sup>a</sup> All cases confirmed through medical records review.</p></div></div><div content-id=""><div class="fn"><p><sup>b</sup> Per million doses administered.</p></div></div><div content-id=""><div class="fn"><p><sup>c</sup> Includes person-time for vaccinated cases that occurred &gt;6 weeks following vaccination.</p></div></div><div content-id=""><div class="fn"><p><sup>d</sup> Includes data from the Emerging Infections Program, Vaccine Safety Datalink, PRISM, Department of Veterans Affairs, Centers for Medicare and Medicaid Services, and Department of Defense.</p></div></div></div><div class="graphic-wrap"><a class="fig-view-orig openInAnotherWindow btn js-view-large" href="https://academic.oup.com/view-large/5094604" target="_blank">View Large</a></div></div><p>Although an increased risk of GBS following 2009 pH1N1 vaccines was reported in most of the US studies, it is perplexing that vaccine safety surveillance in the United States during the years since the 2009 pandemic (2010–2011, 2011–2012, and 2012–2013 influenza seasons) did not find a signal for an increased risk of GBS (CDC, personal communication), yet in all 3 years the influenza vaccines included the 2009 pH1N1 strain. In addition, in 2009–2010, 27.0% of the US population aged ≥6 months received the 2009 pH1N1vaccines. The coverage was 43.0%, 42.0%, and 45.0% in the next 3 seasons, respectively [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C38" reveal-id="CIU005C38">38</a>]. Because an increasing number of individuals received influenza vaccines that included the same 2009 pH1N1 strain, it is reasonable to ask why we did not see an increase risk of GBS following vaccination in the subsequent years. What had changed? Among other things, there were 2 major differences: the lack of nationally representative, large population–based and comprehensive surveillance activities for GBS case finding [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C27" reveal-id="CIU005C27">27</a>] and very low influenza illness during subsequent seasons compared with that of 2009–2010 [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C39" reveal-id="CIU005C39">39</a>].</p> <h2 class="section-title" data-legacy-id="s4" id="5094609" scrollto-destination="5094609">GBS AND INFLUENZA</h2>
<p>Even before the term “Guillain-Barré syndrome” was in use in clinical medicine, postinfectious polyneuritis cases had been reported since the 1918–1920 Spanish influenza pandemic [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C9" reveal-id="CIU005C9">9</a>]. Although URTI has been known to precede GBS, specific association between influenza infection and GBS has only started to be reported more recently. Studies from the United Kingdom in 2007 and 2009 demonstrated a strong association with influenza. Tam et al found an odds ratio (OR) of 18.6 (95% CI, 7.5–46.4) for GBS occurring within 60 days of ILI [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C40" reveal-id="CIU005C40">40</a>], and Stowe et al, using a self-controlled case series design, found an RR of 7.35 (95% CI, 4.36–12.38) for GBS occurring within 90 days of an ILI [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C23" reveal-id="CIU005C23">23</a>]. These 2 studies used the same primary care database, but the Stowe et al analysis used 5 more years of data (1990–2005 vs 1991–2001). Stowe et al also used a 90-day risk period following exposure, whereas Tam et al used a 60-day period of increased risk, which may have accounted for the higher magnitude of risk found in Tam et al's analysis; earlier studies found that the risk for GBS was greatest 2–3 weeks following an exposure but that increased risk continued through 6–8 weeks [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C1" reveal-id="CIU005C1">1</a>]. Another study used time-series analyses demonstrating a positive association between GBS hospital admissions and laboratory-confirmed influenza cases [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C12" reveal-id="CIU005C12">12</a>].</p><p>Studies during the 2009 H1N1 pandemic also support an increased risk of GBS following 2009 pH1N1 infection. A brief report by Verity et al described the GBS cases reported by pediatricians during an active surveillance program implemented specifically during the 2009 H1N1 pandemic [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C41" reveal-id="CIU005C41">41</a>]. From September 2009 through August 2010, 57 children were reported with a diagnosis of GBS, and 49 of the 57 children had clinical or laboratory evidence of infection within the 3 months prior to GBS onset; 9 of these were laboratory-confirmed influenza. Only 1 child had received the pH1N1 vaccine within 6 weeks of GBS, which, based on GBS background incidence for children, was expected by chance alone. Furthermore, the peak of the second wave of the H1N1 pandemic occurred just prior to a notable increase in reported GBS cases among children [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C41" reveal-id="CIU005C41">41</a>]. Other studies assessing the risk of GBS following the 2009 pH1N1 vaccines, such as the Greene et al study in the United States and in the European pooled analysis [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C31" reveal-id="CIU005C31">31</a>, <a class="link link-ref link-reveal xref-bibr" data-open="CIU005C34" reveal-id="CIU005C34">34</a>], both described above, suggested that the findings may have been confounded by influenza illness that peaked just as the vaccines became available and widely distributed (Figure <a class="link link-reveal link-table xref-fig" data-open="CIU005F2" reveal-id="CIU005F2">2</a>). In a secondary analysis (case-centered), Greene et al, controlling for seasonality, which indirectly controls for influenza illness, found that the increased risk for GBS observed in the primary analysis decreased and was no longer significant (OR = 2.0; 95% CI, .5–8.1) (Table <a class="link link-reveal link-table xref-fig" data-open="CIU005TB1" reveal-id="CIU005TB1">1</a>) [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C31" reveal-id="CIU005C31">31</a>]. The results from the European pooled data, before adjustment for ILI and URTI, demonstrated a significant OR of 2.8 (95% CI, 1.3–6.0), but after adjustment, the increased risk estimate disappeared (OR = 1.0; 95% CI, .3–2.7) [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C42" reveal-id="CIU005C42">42</a>].<sup class="sup-zero"><a class="figlink" href="https://academic.oup.com/#CIU005F1">1</a></sup></p> <a id="5094615" scrollto-destination="5094615"></a>
<div class="fig fig-section" data-id="CIU005F1" id="CIU005F1"><div class="label fig-label">Figure 1.</div><div class="graphic-wrap"><img alt="Risk estimates (with 95% confidence intervals) of Guillain-Barré syndrome following influenza vaccines in adults, select studies, 1979–2008. *Included separate estimates for 2000 and 2001. **Included separate estimates for 3 influenza seasons: 2005–2006, 2006–2007, and 2007–2008; sequential analyses do not include confidence intervals. Select studies: Greene et al [18], Burwen et al [17], Baxter R et al [16], Juurlink et al [20], Hughes et al [19], Lasky et al [22], Stowe et al [23], and Kaplan et al [21]." class="content-image" path-from-xml="ciu00501.tiff" src="https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/58/8/10.1093/cid/ciu005/2/m_ciu00501.png?Expires=1563119135&amp;Signature=b-uAwVcMI-k1~WM2qzSsf1CZHB1334nXD0JJVAPOjLVMrTsSctsQUer3eSXcv9FvmiPRbtwMsBwpnvLZYbJyJQ3QITceG7SMmdUqlYPN~UGtEGLNwN-icDYGPpwHi-heZiu6d5CgukTSPiRw9nYJHlsbCa1l48wo-pQzRTtBxmGgPDcmJQpO8r1iAN6h-E4YJspxh8fJZ~RM3RIMRhc2shI19zO0ddbwv1ghADH9KEPMQd8s6H~RXNs9LkwbnKgKvV9QGT-4INnvP-f-sLWoaM0HVvJcLCfI8NoBwYcYY92VEKi2ji4RR~Rubvff5n4LPoy8ApONv9MhcZikuN-doA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA"/><div class="fig-orig original-slide"><a class="fig-view-orig js-view-large openInAnotherWindow" href="https://academic.oup.com/view-large/figure/5094615/ciu00501.tiff" path-from-xml="ciu00501.tiff" target="_blank">View large</a><a class="download-slide" href="//oup.silverchair-cdn.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/58/8/10.1093/cid/ciu005/2/ciu00501.png?Expires=1563119135&amp;Signature=pKZzieEF4CjY4jGa5YfSDs2rJxv2IiIVahT126Xyt6ddQ3wRMXNe0qpX~0e-6xOtf0-qyoWOurGgJyhQgaRi-JuA1UHz1vtU4nZv9g7YfUV9T7411uBLYqzI2dfZ5joCOcV-SIuS3WeGIgZJcDO-DUF4Lj7ju22cd0inpITqyWHsxNBVFywi1M3OFG2UOG9WQg2GGdHnPnBmVVdM3leFcdhQq4pyEcjbqQ8M-Kub3hc-WNbYvR~BrcvbI-RPbvLX1KSXvQ-Z6PYrv-9nUlNXnI1lrF8nax7~uRIvlDv3rOm~FJBtHw5Ec2~DbcoPMw5Ybn4X41ecARS1pwAc9rnL7w__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=5094615&amp;ar=355966&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269" path-from-xml="ciu00501.tiff" section="5094615" target="">Download slide</a></div></div><div class="caption fig-caption"><p>Risk estimates (with 95% confidence intervals) of Guillain-Barré syndrome following influenza vaccines in adults, select studies, 1979–2008. *Included separate estimates for 2000 and 2001. **Included separate estimates for 3 influenza seasons: 2005–2006, 2006–2007, and 2007–2008; sequential analyses do not include confidence intervals. Select studies: Greene et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C18" reveal-id="CIU005C18">18</a>], Burwen et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C17" reveal-id="CIU005C17">17</a>], Baxter R et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C16" reveal-id="CIU005C16">16</a>], Juurlink et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C20" reveal-id="CIU005C20">20</a>], Hughes et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C19" reveal-id="CIU005C19">19</a>], Lasky et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C22" reveal-id="CIU005C22">22</a>], Stowe et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C23" reveal-id="CIU005C23">23</a>], and Kaplan et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C21" reveal-id="CIU005C21">21</a>].</p></div></div><div class="fig fig-modal reveal-modal" content-id="CIU005F1" style="display: block;"><div class="label fig-label">Figure 1.</div><div class="graphic-wrap"><img alt="Risk estimates (with 95% confidence intervals) of Guillain-Barré syndrome following influenza vaccines in adults, select studies, 1979–2008. *Included separate estimates for 2000 and 2001. **Included separate estimates for 3 influenza seasons: 2005–2006, 2006–2007, and 2007–2008; sequential analyses do not include confidence intervals. Select studies: Greene et al [18], Burwen et al [17], Baxter R et al [16], Juurlink et al [20], Hughes et al [19], Lasky et al [22], Stowe et al [23], and Kaplan et al [21]." class="content-image" path-from-xml="ciu00501.tiff" src="https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/58/8/10.1093/cid/ciu005/2/m_ciu00501.png?Expires=1563119135&amp;Signature=b-uAwVcMI-k1~WM2qzSsf1CZHB1334nXD0JJVAPOjLVMrTsSctsQUer3eSXcv9FvmiPRbtwMsBwpnvLZYbJyJQ3QITceG7SMmdUqlYPN~UGtEGLNwN-icDYGPpwHi-heZiu6d5CgukTSPiRw9nYJHlsbCa1l48wo-pQzRTtBxmGgPDcmJQpO8r1iAN6h-E4YJspxh8fJZ~RM3RIMRhc2shI19zO0ddbwv1ghADH9KEPMQd8s6H~RXNs9LkwbnKgKvV9QGT-4INnvP-f-sLWoaM0HVvJcLCfI8NoBwYcYY92VEKi2ji4RR~Rubvff5n4LPoy8ApONv9MhcZikuN-doA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA"/><div class="fig-orig original-slide"><a class="fig-view-orig js-view-large openInAnotherWindow" href="https://academic.oup.com/view-large/figure/5094615/ciu00501.tiff" path-from-xml="ciu00501.tiff" target="_blank">View large</a><a class="download-slide" href="//oup.silverchair-cdn.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/58/8/10.1093/cid/ciu005/2/ciu00501.png?Expires=1563119135&amp;Signature=pKZzieEF4CjY4jGa5YfSDs2rJxv2IiIVahT126Xyt6ddQ3wRMXNe0qpX~0e-6xOtf0-qyoWOurGgJyhQgaRi-JuA1UHz1vtU4nZv9g7YfUV9T7411uBLYqzI2dfZ5joCOcV-SIuS3WeGIgZJcDO-DUF4Lj7ju22cd0inpITqyWHsxNBVFywi1M3OFG2UOG9WQg2GGdHnPnBmVVdM3leFcdhQq4pyEcjbqQ8M-Kub3hc-WNbYvR~BrcvbI-RPbvLX1KSXvQ-Z6PYrv-9nUlNXnI1lrF8nax7~uRIvlDv3rOm~FJBtHw5Ec2~DbcoPMw5Ybn4X41ecARS1pwAc9rnL7w__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=5094615&amp;ar=355966&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269" path-from-xml="ciu00501.tiff" section="5094615" target="">Download slide</a></div></div><div class="caption fig-caption"><p>Risk estimates (with 95% confidence intervals) of Guillain-Barré syndrome following influenza vaccines in adults, select studies, 1979–2008. *Included separate estimates for 2000 and 2001. **Included separate estimates for 3 influenza seasons: 2005–2006, 2006–2007, and 2007–2008; sequential analyses do not include confidence intervals. Select studies: Greene et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C18" reveal-id="CIU005C18">18</a>], Burwen et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C17" reveal-id="CIU005C17">17</a>], Baxter R et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C16" reveal-id="CIU005C16">16</a>], Juurlink et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C20" reveal-id="CIU005C20">20</a>], Hughes et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C19" reveal-id="CIU005C19">19</a>], Lasky et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C22" reveal-id="CIU005C22">22</a>], Stowe et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C23" reveal-id="CIU005C23">23</a>], and Kaplan et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C21" reveal-id="CIU005C21">21</a>].</p></div></div> <a id="5094619" scrollto-destination="5094619"></a>
<div class="fig fig-section" data-id="CIU005F2" id="CIU005F2"><div class="label fig-label">Figure 2.</div><div class="graphic-wrap"><img alt="Percentage of influenza-like illnesses (ILIs) and 2009 pH1N1 vaccinations in the Emerging Infections Program (EIP) by week (weeks ending in corresponding dates), United States, October 2009–May 2010. *Weekly percentage of outpatient visits for ILI among ILINet sentinel physicians in the EIP catchment area." class="content-image" path-from-xml="ciu00502.tiff" src="https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/58/8/10.1093/cid/ciu005/2/m_ciu00502.png?Expires=1563119135&amp;Signature=Tx80~lhxs~1KRhuNw75qBqtzcLGSLJg05Smiy3LdgJr0k85CQbx0M7bCuFXPJyjs9NjlUNo2TY2XWmtCwWCgdxTFTuxk0qwBiwU5AiEym8NObndytNKOJT-m5c6Ilb26oD1GJOWIfbRtw7~rc3Fn1b-pOszpcjmuK1-7rzutkWCuEJYFH0Xx~OVxDB0AKmFf1--DR044ZZ74vu1qv6oSpC6yuB1NGZwGfYSWdDccmISuVQWjLQnj91ZQ1LYtUNfk~ifJ1ACVoMTRxYvn0Wswf8fepjXUTAYp1lZgcF9GGK9wxuecjxgDd7WpACEgMrR3aeDKNdhafLQOOICPjUhPCw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA"/><div class="fig-orig original-slide"><a class="fig-view-orig js-view-large openInAnotherWindow" href="https://academic.oup.com/view-large/figure/5094619/ciu00502.tiff" path-from-xml="ciu00502.tiff" target="_blank">View large</a><a class="download-slide" href="//oup.silverchair-cdn.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/58/8/10.1093/cid/ciu005/2/ciu00502.png?Expires=1563119135&amp;Signature=ViNTSzr2AatkcVpg7s32rDvMiSU5Tma0WBPSZMWhvgZkqi9DNbictWQGN4Dq03VzWR1qX4~TGmqKvIbmKEr3gRGLPX9~fGx76~CiLtkEJe38eq1SFemvs9WXVDmz5nfIM8I5QVz7bmym1UBxtJObOlD9ODQ--Jv7fa~BV4SP6FDFtAogMhmZQT36o750qeX6MIVkSG15yMWxgbXjwpFB0aXMXNTliH2JioczQCRTIpgKVZ6atbv5gGRmAhqV-LETD34pBaQmDfTk7NlaHG4HGhTQibOzVMLVcKL4iZ8SJcCsiKCMUsQAFcz9vdSmE8TiZvhO5a5f6dKnG7K9wDo1aw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=5094619&amp;ar=355966&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269" path-from-xml="ciu00502.tiff" section="5094619" target="">Download slide</a></div></div><div class="caption fig-caption"><p>Percentage of influenza-like illnesses (ILIs) and 2009 pH1N1 vaccinations in the Emerging Infections Program (EIP) by week (weeks ending in corresponding dates), United States, October 2009–May 2010. *Weekly percentage of outpatient visits for ILI among ILINet sentinel physicians in the EIP catchment area.</p></div></div><div class="fig fig-modal reveal-modal" content-id="CIU005F2" style="display: block;"><div class="label fig-label">Figure 2.</div><div class="graphic-wrap"><img alt="Percentage of influenza-like illnesses (ILIs) and 2009 pH1N1 vaccinations in the Emerging Infections Program (EIP) by week (weeks ending in corresponding dates), United States, October 2009–May 2010. *Weekly percentage of outpatient visits for ILI among ILINet sentinel physicians in the EIP catchment area." class="content-image" path-from-xml="ciu00502.tiff" src="https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/58/8/10.1093/cid/ciu005/2/m_ciu00502.png?Expires=1563119135&amp;Signature=Tx80~lhxs~1KRhuNw75qBqtzcLGSLJg05Smiy3LdgJr0k85CQbx0M7bCuFXPJyjs9NjlUNo2TY2XWmtCwWCgdxTFTuxk0qwBiwU5AiEym8NObndytNKOJT-m5c6Ilb26oD1GJOWIfbRtw7~rc3Fn1b-pOszpcjmuK1-7rzutkWCuEJYFH0Xx~OVxDB0AKmFf1--DR044ZZ74vu1qv6oSpC6yuB1NGZwGfYSWdDccmISuVQWjLQnj91ZQ1LYtUNfk~ifJ1ACVoMTRxYvn0Wswf8fepjXUTAYp1lZgcF9GGK9wxuecjxgDd7WpACEgMrR3aeDKNdhafLQOOICPjUhPCw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA"/><div class="fig-orig original-slide"><a class="fig-view-orig js-view-large openInAnotherWindow" href="https://academic.oup.com/view-large/figure/5094619/ciu00502.tiff" path-from-xml="ciu00502.tiff" target="_blank">View large</a><a class="download-slide" href="//oup.silverchair-cdn.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/58/8/10.1093/cid/ciu005/2/ciu00502.png?Expires=1563119135&amp;Signature=ViNTSzr2AatkcVpg7s32rDvMiSU5Tma0WBPSZMWhvgZkqi9DNbictWQGN4Dq03VzWR1qX4~TGmqKvIbmKEr3gRGLPX9~fGx76~CiLtkEJe38eq1SFemvs9WXVDmz5nfIM8I5QVz7bmym1UBxtJObOlD9ODQ--Jv7fa~BV4SP6FDFtAogMhmZQT36o750qeX6MIVkSG15yMWxgbXjwpFB0aXMXNTliH2JioczQCRTIpgKVZ6atbv5gGRmAhqV-LETD34pBaQmDfTk7NlaHG4HGhTQibOzVMLVcKL4iZ8SJcCsiKCMUsQAFcz9vdSmE8TiZvhO5a5f6dKnG7K9wDo1aw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=5094619&amp;ar=355966&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269" path-from-xml="ciu00502.tiff" section="5094619" target="">Download slide</a></div></div><div class="caption fig-caption"><p>Percentage of influenza-like illnesses (ILIs) and 2009 pH1N1 vaccinations in the Emerging Infections Program (EIP) by week (weeks ending in corresponding dates), United States, October 2009–May 2010. *Weekly percentage of outpatient visits for ILI among ILINet sentinel physicians in the EIP catchment area.</p></div></div> <h2 class="section-title" data-legacy-id="s5" id="5094622" scrollto-destination="5094622">GBS, INFLUENZA, AND INFLUENZA VACCINE</h2>
<p>The observed increased risk for GBS following influenza vaccination after 1976 has primarily come from studies completed during the 2009 H1N1 pandemic. However, the 2009 H1N1 pandemic and the 2009–2010 influenza vaccine program were unique in that there was little or no nonpandemic influenza virus strain circulating and the peak circulation of the 2009 H1N1 pandemic virus was much earlier (October 2009) than typical influenza seasons (usually January–February). Furthermore, 2009 pH1N1 vaccines became available and widely distributed at the same time the 2009 H1N1 pandemic peaked (Figure <a class="link link-reveal link-table xref-fig" data-open="CIU005F2" reveal-id="CIU005F2">2</a>).</p><p>In an attempt to determine any confounding due to the simultaneous circulation of wild-type 2009 pH1N1 influenza and administration of 2009 pH1N1 vaccines, data from the CDC EIP active GBS case-finding surveillance collected from October 2009 through May 2010 was reanalyzed using a different approach. Rather than assessing the increased risk of GBS during the 6 weeks following the 2009 pH1N1 vaccination [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C30" reveal-id="CIU005C30">30</a>], the cumulative risk of GBS among the vaccinated and unvaccinated population at the end of the surveillance period (which correlated with the end of the pandemic and the end of administration of 2009 pH1N1 vaccines) was assessed using a survival analysis. The cumulative risk of GBS was significantly higher among the unvaccinated population than the vaccinated population (9.2 per million vs 6.6 per million persons; <em>P</em> = .012; Figure <a class="link link-reveal link-table xref-fig" data-open="CIU005F3" reveal-id="CIU005F3">3</a>). There may indeed be an increased risk of GBS during the 6 weeks following vaccination, and evidence supports this assertion, but at the population level the survival analysis shows that the overall risk of GBS among those vaccinated was lower during the 2009 H1N1 pandemic [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C43" reveal-id="CIU005C43">43</a>]. Previously, Tam et al and Stowe et al suggested similar protective effect of influenza vaccinations, by way of preventing influenza infection itself, on GBS risk [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C23" reveal-id="CIU005C23">23</a>, <a class="link link-ref link-reveal xref-bibr" data-open="CIU005C40" reveal-id="CIU005C40">40</a>]. Finally, 2 recent robust analyses, from Greene et al and Kwong et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C44" reveal-id="CIU005C44">44</a>, <a class="link link-ref link-reveal xref-bibr" data-open="CIU005C45" reveal-id="CIU005C45">45</a>], assessed the association of GBS following influenza vaccines as well as following medically attended infections (specifically influenza in the Kwong et al study). In the Greene et al analysis, data on &gt;9 million individuals from 10 US healthcare organizations was used to determine the observed vs expected odds of vaccination (with 2009 pH1N1 or 2010–2011 seasonal influenza vaccine) or infection occurring during the 6 weeks prior to GBS onset. This was a case-centered study design, which controls for time-varying confounders. The odds of vaccination prior to GBS onset adjusted for GBS onset date, age, sex, site, and infection status in the 6 weeks before GBS was 1.5 (95% CI, .6–4.0), whereas the odds of having a medically attended infection also adjusted for the same covariates and vaccination in the 6 weeks before GBS onset was 7.8 (95% CI, 3.6–16.6) [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C44" reveal-id="CIU005C44">44</a>]. The Kwong et al analysis used a self-controlled risk interval design and included vaccination from 1993 to 2011, from a population size of approximately 13 million. In this design, each individual serves as his or her own control, thus minimizing biases between vaccinated and unvaccinated comparisons. The risk of GBS was higher in the risk interval following vaccination exposure, with an attributable risk of 1.03 GBS cases per 1 million vaccinations. However, a much greater risk for GBS was found in the risk interval following medically attended influenza with an attributable risk of 17.2 cases per million influenza healthcare visits [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C45" reveal-id="CIU005C45">45</a>]. Both of these studies used individual-level information, looking at vaccination or medically attended infections during the same influenza seasons, and both provide compelling evidence that the risk of GBS following infections, including influenza, is far greater than the risk following influenza vaccination. </p> <a id="5094626" scrollto-destination="5094626"></a>
<div class="fig fig-section" data-id="CIU005F3" id="CIU005F3"><div class="label fig-label">Figure 3.</div><div class="graphic-wrap"><img alt="Cumulative risk of Guillain-Barré syndrome (GBS) among the 2009 pH1N1 vaccinated and unvaccinated groups by day and all ages, Emerging Infections Program, United States, 15 October 2009–31 May 2010. Solid line is the cumulative rate of GBS per 1 million persons vaccinated with pH1N1; broken line is the cumulative rate of GBS per 1 million persons unvaccinated. Source: Reprinted with permission from Vellozzi et al [43]." class="content-image" path-from-xml="ciu00503.tiff" src="https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/58/8/10.1093/cid/ciu005/2/m_ciu00503.png?Expires=1563119135&amp;Signature=OpEy5L4U2mZQcV77RYMNtfXrw31vYEJHdWp3pHK7yV9H2nFRsa91zfzuADB-K1-joMgnCtnJ32eMWxiMa-EwO~uU4R0WtVkQ7w7vchyAo0s~3n3l~GYpZWsGYtj~0XS-O940Nau-PlseJbKXlCEt2yByy7zuvhrRcUpiffFdD4SuRe3556QozaHeS0N2jzCvuuaXwUg6WrBPmTxbRqOxFJGOdE-u1WKJYXfd0xpT1CU~~hQt3xMoAoKEbpPROCfYs6BRa01mwEUxSjbsV23mjn5lb~EwZULa~XYRIphRstsbhdkcH0I-xzHWD-umZeIuGUuAhLA7N6ZD94bso0jJrw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA"/><div class="fig-orig original-slide"><a class="fig-view-orig js-view-large openInAnotherWindow" href="https://academic.oup.com/view-large/figure/5094626/ciu00503.tiff" path-from-xml="ciu00503.tiff" target="_blank">View large</a><a class="download-slide" href="//oup.silverchair-cdn.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/58/8/10.1093/cid/ciu005/2/ciu00503.png?Expires=1563119135&amp;Signature=Z8a9BcUqolcPfda5C~s0zKUwXwm-R6cO5A2jDoTVRynoX5j6Zr3qCbA1W2m3H--zpnEdhjLQ~6gtRIx5uc-EL~aYiGfZ7mUsG19ogesOtfMn-eOwQiZwo8bolXNmE98P~UZDFw0Zc1QxGgwGuMeHd-5Oh1hvEgoaikW4KZAzFNUNBt5y9vCT~gDgHTTPT45II3x58yVaNH8bfRy6IqRLMO6kKVqfYVUhY6vBrmytgXEuIAHvDPOiZ~DTjk3yIwFgD0DkVwMAV7d2pimrAV5JBS-jNpvwjXEN~cHdj683ExZz49NcEonjl6UFpmkuo9x~7awbMOASZbNOlliIAulPyQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=5094626&amp;ar=355966&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269" path-from-xml="ciu00503.tiff" section="5094626" target="">Download slide</a></div></div><div class="caption fig-caption"><p>Cumulative risk of Guillain-Barré syndrome (GBS) among the 2009 pH1N1 vaccinated and unvaccinated groups by day and all ages, Emerging Infections Program, United States, 15 October 2009–31 May 2010. Solid line is the cumulative rate of GBS per 1 million persons vaccinated with pH1N1; broken line is the cumulative rate of GBS per 1 million persons unvaccinated. Source: Reprinted with permission from Vellozzi et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C43" reveal-id="CIU005C43">43</a>].</p></div></div><div class="fig fig-modal reveal-modal" content-id="CIU005F3" style="display: block;"><div class="label fig-label">Figure 3.</div><div class="graphic-wrap"><img alt="Cumulative risk of Guillain-Barré syndrome (GBS) among the 2009 pH1N1 vaccinated and unvaccinated groups by day and all ages, Emerging Infections Program, United States, 15 October 2009–31 May 2010. Solid line is the cumulative rate of GBS per 1 million persons vaccinated with pH1N1; broken line is the cumulative rate of GBS per 1 million persons unvaccinated. Source: Reprinted with permission from Vellozzi et al [43]." class="content-image" path-from-xml="ciu00503.tiff" src="https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/58/8/10.1093/cid/ciu005/2/m_ciu00503.png?Expires=1563119135&amp;Signature=OpEy5L4U2mZQcV77RYMNtfXrw31vYEJHdWp3pHK7yV9H2nFRsa91zfzuADB-K1-joMgnCtnJ32eMWxiMa-EwO~uU4R0WtVkQ7w7vchyAo0s~3n3l~GYpZWsGYtj~0XS-O940Nau-PlseJbKXlCEt2yByy7zuvhrRcUpiffFdD4SuRe3556QozaHeS0N2jzCvuuaXwUg6WrBPmTxbRqOxFJGOdE-u1WKJYXfd0xpT1CU~~hQt3xMoAoKEbpPROCfYs6BRa01mwEUxSjbsV23mjn5lb~EwZULa~XYRIphRstsbhdkcH0I-xzHWD-umZeIuGUuAhLA7N6ZD94bso0jJrw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA"/><div class="fig-orig original-slide"><a class="fig-view-orig js-view-large openInAnotherWindow" href="https://academic.oup.com/view-large/figure/5094626/ciu00503.tiff" path-from-xml="ciu00503.tiff" target="_blank">View large</a><a class="download-slide" href="//oup.silverchair-cdn.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/58/8/10.1093/cid/ciu005/2/ciu00503.png?Expires=1563119135&amp;Signature=Z8a9BcUqolcPfda5C~s0zKUwXwm-R6cO5A2jDoTVRynoX5j6Zr3qCbA1W2m3H--zpnEdhjLQ~6gtRIx5uc-EL~aYiGfZ7mUsG19ogesOtfMn-eOwQiZwo8bolXNmE98P~UZDFw0Zc1QxGgwGuMeHd-5Oh1hvEgoaikW4KZAzFNUNBt5y9vCT~gDgHTTPT45II3x58yVaNH8bfRy6IqRLMO6kKVqfYVUhY6vBrmytgXEuIAHvDPOiZ~DTjk3yIwFgD0DkVwMAV7d2pimrAV5JBS-jNpvwjXEN~cHdj683ExZz49NcEonjl6UFpmkuo9x~7awbMOASZbNOlliIAulPyQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=5094626&amp;ar=355966&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269" path-from-xml="ciu00503.tiff" section="5094626" target="">Download slide</a></div></div><div class="caption fig-caption"><p>Cumulative risk of Guillain-Barré syndrome (GBS) among the 2009 pH1N1 vaccinated and unvaccinated groups by day and all ages, Emerging Infections Program, United States, 15 October 2009–31 May 2010. Solid line is the cumulative rate of GBS per 1 million persons vaccinated with pH1N1; broken line is the cumulative rate of GBS per 1 million persons unvaccinated. Source: Reprinted with permission from Vellozzi et al [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C43" reveal-id="CIU005C43">43</a>].</p></div></div><p>What have we learned over the last 35 years? First, increased risk of GBS has been found to be associated with both influenza infections and influenza vaccines. Second, many of the studies assessing the risk of GBS following influenza vaccines have not resulted in significant findings; however, most were not powered to do so; it is important to note that whenever a significant positive association has been reported, the increased risks of GBS following vaccination were well below the observed 8-fold risk following the 1976 swine-origin influenza vaccine and on average demonstrated an attributable risk about one-tenth of that for the 1976 swine-origin influenza vaccine. Third, the increased risk of GBS found following the 2009 pH1N1 vaccines, across several different studies, including a large international study, using different populations and study designs provides evidence in support of a causal association of GBS with influenza vaccination, although potential confounding due to influenza weakens the evidence somewhat. Perhaps during the 2009 H1N1 pandemic, the large population sizes under observation (EIP case finding) [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C29" reveal-id="CIU005C29">29</a>, <a class="link link-ref link-reveal xref-bibr" data-open="CIU005C30" reveal-id="CIU005C30">30</a>] or the meta-analyses combining data from several sources (28 million people vaccinated contributed to the US meta-analysis) [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C33" reveal-id="CIU005C33">33</a>] provided sufficient power to detect a small increased risk for a very rare event.</p><p>Although monitoring for GBS following influenza vaccination remains important, we may have enough evidence to better understand the complex relationships between influenza, influenza vaccines, and the risk of GBS. Evidence supporting an increased risk of GBS during the 6 weeks following receipt of seasonal influenza vaccination is important for individual clinical decisions regarding vaccination and may be important for vaccine injury compensation program determinations. However, risk of GBS following vaccination should be weighed against the potential benefits of vaccination against influenza and reduction in influenza-related complications such as pneumonia, hospitalizations, or death. In summary, despite the small observed increased risk of GBS after influenza vaccination, evidence is growing in support of an apparent larger benefit of vaccination in regard to the overall risk of GBS in the context of population health [<a class="link link-ref link-reveal xref-bibr" data-open="CIU005C23" reveal-id="CIU005C23">23</a>, <a class="link link-ref link-reveal xref-bibr" data-open="CIU005C40" reveal-id="CIU005C40">40</a>, <a class="link link-ref link-reveal xref-bibr" data-open="CIU005C43" reveal-id="CIU005C43">43</a>].</p> <h2 class="backacknowledgements-title" id="5094631" scrollto-destination="5094631">Notes</h2>
<p><strong><em>Acknowledgments.</em></strong> The authors thank Oidda I. Museru, RN, MSN, MPH, at the National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC).</p><p><strong><em>Disclaimer.</em></strong> The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the CDC.</p><p><strong><em>Potential conflicts of interest.</em></strong> All authors: No reported conflicts.</p><p>All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.</p> <h2 class="backreferences-title" id="5094636" scrollto-destination="5094636">References</h2>
<div class="ref-list"><div content-id="CIU005C1" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C1"><div class="label">1</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Schonberger</div> <div class="given-names">LB</div></div>,  <div class="name"><div class="surname">Bregman</div> <div class="given-names">DJ</div></div>,  <div class="name"><div class="surname">Sullivan-Bolyai</div> <div class="given-names">JZ</div></div>, et al. </div><div class="article-title">Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977</div>, <div class="source">Am J Epidemiol</div> , <div class="year">1979</div>, vol. <div class="volume">110</div> (pg. <div class="fpage">105</div>-<div class="lpage">23</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Guillain-Barre%20syndrome%20following%20vaccination%20in%20the%20National%20Influenza%20Immunization%20Program%2C%20United%20States%2C%201976%E2%80%931977&amp;author=LB%20Schonberger&amp;author=DJ%20Bregman&amp;author=JZ%20Sullivan-Bolyai&amp;publication_year=1979&amp;journal=Am%20J%20Epidemiol&amp;volume=110&amp;pages=105-23" target="">Google Scholar</a></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/463869" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Guillain-Barre%20syndrome%20following%20vaccination%20in%20the%20National%20Influenza%20Immunization%20Program%2C%20United%20States%2C%201976%E2%80%931977&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C2" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C2"><div class="label">2</div><div class="citation element-citation"><div class="collab">Centers for Disease Control and Prevention</div><div class="article-title">Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)</div>, <div class="source">MMWR Morb Mortal Wkly Rep</div> , <div class="year">2010</div>, vol. <div class="volume">59</div> <div class="issue">RR-8</div>(pg. <div class="fpage">1</div>-<div class="lpage">61</div>)<div class="citation-links"><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/20075837" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Prevention%20and%20control%20of%20influenza%20with%20vaccines%3A%20recommendations%20of%20the%20Advisory%20Committee%20on%20Immunization%20Practices%20(ACIP)&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C3" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C3"><div class="label">3</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Neustadt</div> <div class="given-names">RE</div></div>,  <div class="name"><div class="surname">Fineberg</div> <div class="given-names">HV</div></div>. </div>, <div class="source">The swine flu affair: decision-making on a slippery disease</div> , <div class="year">1978</div><div class="publisher-loc">Honolulu, HI</div><div class="publisher-name">University Press of the Pacific</div><div class="citation-links"><div class="google-preview-ref-link js-google-preview-ref-link" style="display:none"><a href="https://www.google.com/search?q=The%20swine%20flu%20affair%3A%20decision-making%20on%20a%20slippery%20disease&amp;btnG=Search+Books&amp;tbm=bks&amp;tbo=1" target="">Google Preview</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:The%20swine%20flu%20affair%3A%20decision-making%20on%20a%20slippery%20disease&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C4" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C4"><div class="label">4</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Hughes</div> <div class="given-names">RAC</div></div>,  <div class="name"><div class="surname">Cornblath</div> <div class="given-names">DR</div></div>. </div><div class="article-title">Guillain-Barre syndrome</div>, <div class="source">Lancet</div> , <div class="year">2005</div>, vol. <div class="volume">366</div> (pg. <div class="fpage">1653</div>-<div class="lpage">66</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Guillain-Barre%20syndrome&amp;author=RAC%20Hughes&amp;author=DR%20Cornblath&amp;publication_year=2005&amp;journal=Lancet&amp;volume=366&amp;pages=1653-66" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1016/S0140-6736(05)67665-9" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2FS0140-6736(05)67665-9" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1016%2FS0140-6736(05)67665-9"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/16271648" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Guillain-Barre%20syndrome&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C5" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C5"><div class="label">5</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Yuki</div> <div class="given-names">N</div></div>,  <div class="name"><div class="surname">Hartung</div> <div class="given-names">H-P</div></div>. </div><div class="article-title">Guillain-Barre syndrome</div>, <div class="source">N Engl J Med</div> , <div class="year">2012</div>, vol. <div class="volume">366</div> (pg. <div class="fpage">2294</div>-<div class="lpage">304</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Guillain-Barre%20syndrome&amp;author=N%20Yuki&amp;author=H-P%20Hartung&amp;publication_year=2012&amp;journal=N%20Engl%20J%20Med&amp;volume=366&amp;pages=2294-304" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1056/NEJMra1114525" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1056%2FNEJMra1114525" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1056%2FNEJMra1114525"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/22694000" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Guillain-Barre%20syndrome&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C6" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C6"><div class="label">6</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Sejvar</div> <div class="given-names">JJ</div></div>,  <div class="name"><div class="surname">Baughman</div> <div class="given-names">AL</div></div>,  <div class="name"><div class="surname">Wise</div> <div class="given-names">M</div></div>,  <div class="name"><div class="surname">Morgan</div> <div class="given-names">OW</div></div>. </div><div class="article-title">Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis</div>, <div class="source">Neuroepidemiology</div> , <div class="year">2011</div>, vol. <div class="volume">36</div> (pg. <div class="fpage">123</div>-<div class="lpage">33</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Population%20incidence%20of%20Guillain-Barre%20syndrome%3A%20a%20systematic%20review%20and%20meta-analysis&amp;author=JJ%20Sejvar&amp;author=AL%20Baughman&amp;author=M%20Wise&amp;author=OW%20Morgan&amp;publication_year=2011&amp;journal=Neuroepidemiology&amp;volume=36&amp;pages=123-33" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1159/000324710" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1159%2F000324710" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1159%2F000324710"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/21422765" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Population%20incidence%20of%20Guillain-Barre%20syndrome%3A%20a%20systematic%20review%20and%20meta-analysis&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C7" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C7"><div class="label">7</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Shui</div> <div class="given-names">IM</div></div>,  <div class="name"><div class="surname">Rett</div> <div class="given-names">MD</div></div>,  <div class="name"><div class="surname">Weintraub</div> <div class="given-names">E</div></div>, et al. </div><div class="article-title">Guillain-Barre syndrome incidence in a large United States cohort (2000–2009)</div>, <div class="source">Neuroepidemiology</div> , <div class="year">2012</div>, vol. <div class="volume">39</div> (pg. <div class="fpage">109</div>-<div class="lpage">15</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Guillain-Barre%20syndrome%20incidence%20in%20a%20large%20United%20States%20cohort%20(2000%E2%80%932009)&amp;author=IM%20Shui&amp;author=MD%20Rett&amp;author=E%20Weintraub&amp;publication_year=2012&amp;journal=Neuroepidemiology&amp;volume=39&amp;pages=109-15" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1159/000339248" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1159%2F000339248" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1159%2F000339248"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/22846726" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Guillain-Barre%20syndrome%20incidence%20in%20a%20large%20United%20States%20cohort%20(2000%E2%80%932009)&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C8" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C8"><div class="label">8</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">McGrogan</div> <div class="given-names">A</div></div>,  <div class="name"><div class="surname">Madle</div> <div class="given-names">GC</div></div>,  <div class="name"><div class="surname">Seaman</div> <div class="given-names">HE</div></div>,  <div class="name"><div class="surname">de Vries</div> <div class="given-names">CS</div></div>. </div><div class="article-title">The epidemiology of Guillain-Barre syndrome worldwide: a systematic literature review</div>, <div class="source">Neuroepidemiology</div> , <div class="year">2009</div>, vol. <div class="volume">32</div> (pg. <div class="fpage">150</div>-<div class="lpage">63</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=The%20epidemiology%20of%20Guillain-Barre%20syndrome%20worldwide%3A%20a%20systematic%20literature%20review&amp;author=A%20McGrogan&amp;author=GC%20Madle&amp;author=HE%20Seaman&amp;author=CS%20de%20Vries&amp;publication_year=2009&amp;journal=Neuroepidemiology&amp;volume=32&amp;pages=150-63" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1159/000184748" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1159%2F000184748" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1159%2F000184748"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/19088488" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:The%20epidemiology%20of%20Guillain-Barre%20syndrome%20worldwide%3A%20a%20systematic%20literature%20review&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C9" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C9"><div class="label">9</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Lehmann</div> <div class="given-names">HC</div></div>,  <div class="name"><div class="surname">Hartung</div> <div class="given-names">H-P</div></div>,  <div class="name"><div class="surname">Kieseier</div> <div class="given-names">BC</div></div>,  <div class="name"><div class="surname">Hughes</div> <div class="given-names">RAC</div></div>. </div><div class="article-title">Guillain-Barre syndrome after exposure to influenza virus</div>, <div class="source">Lancet Infect Dis</div> , <div class="year">2010</div>, vol. <div class="volume">10</div> (pg. <div class="fpage">643</div>-<div class="lpage">51</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Guillain-Barre%20syndrome%20after%20exposure%20to%20influenza%20virus&amp;author=HC%20Lehmann&amp;author=H-P%20Hartung&amp;author=BC%20Kieseier&amp;author=RAC%20Hughes&amp;publication_year=2010&amp;journal=Lancet%20Infect%20Dis&amp;volume=10&amp;pages=643-51" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1016/S1473-3099(10)70140-7" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2FS1473-3099(10)70140-7" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1016%2FS1473-3099(10)70140-7"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/20797646" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Guillain-Barre%20syndrome%20after%20exposure%20to%20influenza%20virus&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C10" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C10"><div class="label">10</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Orlikowski</div> <div class="given-names">D</div></div>,  <div class="name"><div class="surname">Quijano-Roy</div> <div class="given-names">S</div></div>,  <div class="name"><div class="surname">Sivadon-Tardy</div> <div class="given-names">V</div></div>,  <div class="name"><div class="surname">Raphael</div> <div class="given-names">JC</div></div>,  <div class="name"><div class="surname">Gaillard</div> <div class="given-names">JL</div></div>. </div><div class="article-title"><em>Campylobacter jejuni</em> and cytomegalovirus (CMV) infections in patients with the Guillain-Barre syndrome</div>, <div class="source">Arch Pediatr</div> , <div class="year">2006</div>, vol. <div class="volume">13</div> (pg. <div class="fpage">1561</div>-<div class="lpage">5</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Campylobacter%20jejuni%20and%20cytomegalovirus%20(CMV)%20infections%20in%20patients%20with%20the%20Guillain-Barre%20syndrome&amp;author=D%20Orlikowski&amp;author=S%20Quijano-Roy&amp;author=V%20Sivadon-Tardy&amp;author=JC%20Raphael&amp;author=JL%20Gaillard&amp;publication_year=2006&amp;journal=Arch%20Pediatr&amp;volume=13&amp;pages=1561-5" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1016/j.arcped.2006.09.002" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2Fj.arcped.2006.09.002" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1016%2Fj.arcped.2006.09.002"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/17030119" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Campylobacter%20jejuni%20and%20cytomegalovirus%20(CMV)%20infections%20in%20patients%20with%20the%20Guillain-Barre%20syndrome&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C11" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C11"><div class="label">11</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Sivadon-Tardy</div> <div class="given-names">V</div></div>,  <div class="name"><div class="surname">Orlikowski</div> <div class="given-names">D</div></div>,  <div class="name"><div class="surname">Rozenberg</div> <div class="given-names">F</div></div>, et al. </div><div class="article-title">Prevalence and characteristics of Guillain-Barre syndromes associated with <em>Campylobacter jejuni</em> and cytomegalovirus in greater Paris</div>, <div class="source">Int J Antimicrob Agents</div> , <div class="year">2004</div>, vol. <div class="volume">24</div>  <div class="comment">S99</div><div class="citation-links"><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Prevalence%20and%20characteristics%20of%20Guillain-Barre%20syndromes%20associated%20with%20Campylobacter%20jejuni%20and%20cytomegalovirus%20in%20greater%20Paris&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C12" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C12"><div class="label">12</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Tam</div> <div class="given-names">CC</div></div>,  <div class="name"><div class="surname">O'Brien</div> <div class="given-names">SJ</div></div>,  <div class="name"><div class="surname">Rodrigues</div> <div class="given-names">LC</div></div>. </div><div class="article-title">Influenza, <em>Campylobacter</em> and <em>Mycoplasma</em> infections, and hospital admissions for Guillain-Barre syndrome, England</div>, <div class="source">Emerg Infect Dis</div> , <div class="year">2006</div>, vol. <div class="volume">12</div> (pg. <div class="fpage">1880</div>-<div class="lpage">7</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Influenza%2C%20Campylobacter%20and%20Mycoplasma%20infections%2C%20and%20hospital%20admissions%20for%20Guillain-Barre%20syndrome%2C%20England&amp;author=CC%20Tam&amp;author=SJ%20O'Brien&amp;author=LC%20Rodrigues&amp;publication_year=2006&amp;journal=Emerg%20Infect%20Dis&amp;volume=12&amp;pages=1880-7" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.3201/eid1212.051032" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.3201%2Feid1212.051032" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.3201%2Feid1212.051032"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/17326939" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Influenza%2C%20Campylobacter%20and%20Mycoplasma%20infections%2C%20and%20hospital%20admissions%20for%20Guillain-Barre%20syndrome%2C%20England&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C13" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C13"><div class="label">13</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Jacobs</div> <div class="given-names">BC</div></div>,  <div class="name"><div class="surname">Rothbarth</div> <div class="given-names">PH</div></div>,  <div class="name"><div class="surname">van der Meche</div> <div class="given-names">FG</div></div>, et al. </div><div class="article-title">The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study</div>, <div class="source">Neurology</div> , <div class="year">1998</div>, vol. <div class="volume">51</div> (pg. <div class="fpage">1110</div>-<div class="lpage">5</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=The%20spectrum%20of%20antecedent%20infections%20in%20Guillain-Barre%20syndrome%3A%20a%20case-control%20study&amp;author=BC%20Jacobs&amp;author=PH%20Rothbarth&amp;author=FG%20van%20der%20Meche&amp;publication_year=1998&amp;journal=Neurology&amp;volume=51&amp;pages=1110-5" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1212/WNL.51.4.1110" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1212%2FWNL.51.4.1110" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1212%2FWNL.51.4.1110"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/9781538" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:The%20spectrum%20of%20antecedent%20infections%20in%20Guillain-Barre%20syndrome%3A%20a%20case-control%20study&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C14" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C14"><div class="label">14</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Langmuir</div> <div class="given-names">AD</div></div>,  <div class="name"><div class="surname">Bregman</div> <div class="given-names">DJ</div></div>,  <div class="name"><div class="surname">Kurland</div> <div class="given-names">LT</div></div>,  <div class="name"><div class="surname">Nathanson</div> <div class="given-names">N</div></div>,  <div class="name"><div class="surname">Victor</div> <div class="given-names">M</div></div>. </div><div class="article-title">An epidemiologic and clinical-evaluation of Guillain-Barre-syndrome reported in association with the administration of swine influenza vaccines</div>, <div class="source">Am J Epidemiol</div> , <div class="year">1984</div>, vol. <div class="volume">119</div> (pg. <div class="fpage">841</div>-<div class="lpage">79</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=An%20epidemiologic%20and%20clinical-evaluation%20of%20Guillain-Barre-syndrome%20reported%20in%20association%20with%20the%20administration%20of%20swine%20influenza%20vaccines&amp;author=AD%20Langmuir&amp;author=DJ%20Bregman&amp;author=LT%20Kurland&amp;author=N%20Nathanson&amp;author=M%20Victor&amp;publication_year=1984&amp;journal=Am%20J%20Epidemiol&amp;volume=119&amp;pages=841-79" target="">Google Scholar</a></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/6328974" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:An%20epidemiologic%20and%20clinical-evaluation%20of%20Guillain-Barre-syndrome%20reported%20in%20association%20with%20the%20administration%20of%20swine%20influenza%20vaccines&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C15" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C15"><div class="label">15</div><div class="citation element-citation"><div class="collab">Institute of Medicine</div><div class="article-title">Immunization safety review: influenza vaccines and neurological complications. The National Academies Press, Washington, D.C.</div>, <div class="year">2003</div></div></div></div></div><div content-id="CIU005C16" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C16"><div class="label">16</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Baxter</div> <div class="given-names">R</div></div>,  <div class="name"><div class="surname">Bakshi</div> <div class="given-names">N</div></div>,  <div class="name"><div class="surname">Fireman</div> <div class="given-names">B</div></div>, et al. </div><div class="article-title">Lack of association of Guillain-Barre syndrome with vaccinations</div>, <div class="source">Clin Infect Dis</div> , <div class="year">2013</div>, vol. <div class="volume">57</div> (pg. <div class="fpage">197</div>-<div class="lpage">204</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Lack%20of%20association%20of%20Guillain-Barre%20syndrome%20with%20vaccinations&amp;author=R%20Baxter&amp;author=N%20Bakshi&amp;author=B%20Fireman&amp;publication_year=2013&amp;journal=Clin%20Infect%20Dis&amp;volume=57&amp;pages=197-204" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1093/cid/cit222" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Fcid%2Fcit222" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1093%2Fcid%2Fcit222"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/23580737" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Lack%20of%20association%20of%20Guillain-Barre%20syndrome%20with%20vaccinations&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C17" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C17"><div class="label">17</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Burwen</div> <div class="given-names">DR</div></div>,  <div class="name"><div class="surname">Ball</div> <div class="given-names">R</div></div>,  <div class="name"><div class="surname">Bryan</div> <div class="given-names">WW</div></div>, et al. </div><div class="article-title">Evaluation of Guillain-Barre syndrome among recipients of influenza vaccine in 2000 and 2001</div>, <div class="source">Am J Prev Med</div> , <div class="year">2010</div>, vol. <div class="volume">39</div> (pg. <div class="fpage">296</div>-<div class="lpage">304</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Evaluation%20of%20Guillain-Barre%20syndrome%20among%20recipients%20of%20influenza%20vaccine%20in%202000%20and%202001&amp;author=DR%20Burwen&amp;author=R%20Ball&amp;author=WW%20Bryan&amp;publication_year=2010&amp;journal=Am%20J%20Prev%20Med&amp;volume=39&amp;pages=296-304" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1016/j.amepre.2010.05.022" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2Fj.amepre.2010.05.022" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1016%2Fj.amepre.2010.05.022"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/20837279" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Evaluation%20of%20Guillain-Barre%20syndrome%20among%20recipients%20of%20influenza%20vaccine%20in%202000%20and%202001&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C18" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C18"><div class="label">18</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Greene</div> <div class="given-names">SK</div></div>,  <div class="name"><div class="surname">Kulldorff</div> <div class="given-names">M</div></div>,  <div class="name"><div class="surname">Lewis</div> <div class="given-names">EM</div></div>, et al. </div><div class="article-title">Near real-time surveillance for influenza vaccine safety: proof-of-concept in the vaccine safety datalink project</div>, <div class="source">Am J Epidemiol</div> , <div class="year">2010</div>, vol. <div class="volume">171</div> (pg. <div class="fpage">177</div>-<div class="lpage">88</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Near%20real-time%20surveillance%20for%20influenza%20vaccine%20safety%3A%20proof-of-concept%20in%20the%20vaccine%20safety%20datalink%20project&amp;author=SK%20Greene&amp;author=M%20Kulldorff&amp;author=EM%20Lewis&amp;publication_year=2010&amp;journal=Am%20J%20Epidemiol&amp;volume=171&amp;pages=177-88" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1093/aje/kwp345" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Faje%2Fkwp345" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1093%2Faje%2Fkwp345"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/19965887" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Near%20real-time%20surveillance%20for%20influenza%20vaccine%20safety%3A%20proof-of-concept%20in%20the%20vaccine%20safety%20datalink%20project&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C19" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C19"><div class="label">19</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Hughes</div> <div class="given-names">RAC</div></div>,  <div class="name"><div class="surname">Cornblath</div> <div class="given-names">DR</div></div>. </div><div class="article-title">Guillain-Barre syndrome—reply</div>, <div class="source">Lancet</div> , <div class="year">2006</div>, vol. <div class="volume">367</div> (pg. <div class="fpage">473</div>-<div class="lpage">4</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Guillain-Barre%20syndrome%E2%80%94reply&amp;author=RAC%20Hughes&amp;author=DR%20Cornblath&amp;publication_year=2006&amp;journal=Lancet&amp;volume=367&amp;pages=473-4" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1016/S0140-6736(06)68176-2" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2FS0140-6736(06)68176-2" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1016%2FS0140-6736(06)68176-2"> </span></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Guillain-Barre%20syndrome%E2%80%94reply&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C20" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C20"><div class="label">20</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Juurlink</div> <div class="given-names">DN</div></div>,  <div class="name"><div class="surname">Stukel</div> <div class="given-names">TA</div></div>,  <div class="name"><div class="surname">Kwong</div> <div class="given-names">J</div></div>, et al. </div><div class="article-title">Guillain-Barre syndrome after influenza vaccination in adults—a population-based study</div>, <div class="source">Arch Int Med</div> , <div class="year">2006</div>, vol. <div class="volume">166</div> (pg. <div class="fpage">2217</div>-<div class="lpage">21</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Guillain-Barre%20syndrome%20after%20influenza%20vaccination%20in%20adults%E2%80%94a%20population-based%20study&amp;author=DN%20Juurlink&amp;author=TA%20Stukel&amp;author=J%20Kwong&amp;publication_year=2006&amp;journal=Arch%20Int%20Med&amp;volume=166&amp;pages=2217-21" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1001/archinte.166.20.2217" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1001%2Farchinte.166.20.2217" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1001%2Farchinte.166.20.2217"> </span></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Guillain-Barre%20syndrome%20after%20influenza%20vaccination%20in%20adults%E2%80%94a%20population-based%20study&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C21" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C21"><div class="label">21</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Kaplan</div> <div class="given-names">JE</div></div>,  <div class="name"><div class="surname">Katona</div> <div class="given-names">P</div></div>,  <div class="name"><div class="surname">Hurwitz</div> <div class="given-names">ES</div></div>,  <div class="name"><div class="surname">Schonberger</div> <div class="given-names">LB</div></div>. </div><div class="article-title">Guillain-Barre-syndrome in the United States, 1979–1980 and 1980–1981—lack of an association with influenza vaccination</div>, <div class="source">JAMA</div> , <div class="year">1982</div>, vol. <div class="volume">248</div> (pg. <div class="fpage">698</div>-<div class="lpage">700</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Guillain-Barre-syndrome%20in%20the%20United%20States%2C%201979%E2%80%931980%20and%201980%E2%80%931981%E2%80%94lack%20of%20an%20association%20with%20influenza%20vaccination&amp;author=JE%20Kaplan&amp;author=P%20Katona&amp;author=ES%20Hurwitz&amp;author=LB%20Schonberger&amp;publication_year=1982&amp;journal=JAMA&amp;volume=248&amp;pages=698-700" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1001/jama.1982.03330060038030" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1001%2Fjama.1982.03330060038030" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1001%2Fjama.1982.03330060038030"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/7097920" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Guillain-Barre-syndrome%20in%20the%20United%20States%2C%201979%E2%80%931980%20and%201980%E2%80%931981%E2%80%94lack%20of%20an%20association%20with%20influenza%20vaccination&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C22" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C22"><div class="label">22</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Lasky</div> <div class="given-names">T</div></div>,  <div class="name"><div class="surname">Terracciano</div> <div class="given-names">GJ</div></div>,  <div class="name"><div class="surname">Magder</div> <div class="given-names">L</div></div>, et al. </div><div class="article-title">The Guillain-Barre syndrome and the 1993 and 1993–1994 influenza vaccines</div>, <div class="source">N Engl J Med</div> , <div class="year">1998</div>, vol. <div class="volume">339</div> (pg. <div class="fpage">1797</div>-<div class="lpage">802</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=The%20Guillain-Barre%20syndrome%20and%20the%201993%20and%201993%E2%80%931994%20influenza%20vaccines&amp;author=T%20Lasky&amp;author=GJ%20Terracciano&amp;author=L%20Magder&amp;publication_year=1998&amp;journal=N%20Engl%20J%20Med&amp;volume=339&amp;pages=1797-802" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1056/NEJM199812173392501" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1056%2FNEJM199812173392501" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1056%2FNEJM199812173392501"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/9854114" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:The%20Guillain-Barre%20syndrome%20and%20the%201993%20and%201993%E2%80%931994%20influenza%20vaccines&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C23" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C23"><div class="label">23</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Stowe</div> <div class="given-names">J</div></div>,  <div class="name"><div class="surname">Andrews</div> <div class="given-names">N</div></div>,  <div class="name"><div class="surname">Wise</div> <div class="given-names">L</div></div>,  <div class="name"><div class="surname">Miller</div> <div class="given-names">E</div></div>. </div><div class="article-title">Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom general practice research database</div>, <div class="source">Am J Epidemiol</div> , <div class="year">2009</div>, vol. <div class="volume">169</div> (pg. <div class="fpage">382</div>-<div class="lpage">8</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Investigation%20of%20the%20temporal%20association%20of%20Guillain-Barre%20syndrome%20with%20influenza%20vaccine%20and%20influenzalike%20illness%20using%20the%20United%20Kingdom%20general%20practice%20research%20database&amp;author=J%20Stowe&amp;author=N%20Andrews&amp;author=L%20Wise&amp;author=E%20Miller&amp;publication_year=2009&amp;journal=Am%20J%20Epidemiol&amp;volume=169&amp;pages=382-8" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1093/aje/kwn310" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Faje%2Fkwn310" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1093%2Faje%2Fkwn310"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/19033158" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Investigation%20of%20the%20temporal%20association%20of%20Guillain-Barre%20syndrome%20with%20influenza%20vaccine%20and%20influenzalike%20illness%20using%20the%20United%20Kingdom%20general%20practice%20research%20database&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C24" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C24"><div class="label">24</div><div class="citation element-citation"><div class="collab">Centers for Disease Control and Prevention</div><div class="article-title">Vaccine information statement: influenza vaccine</div> <div class="comment">Available at: <a class="link link-uri" href="http://www.cdc.gov/vaccines/hcp/vis/vis-statements/flu.pdf">http://www.cdc.gov/vaccines/hcp/vis/vis-statements/flu.pdf</a> Accessed 29 August 2013</div></div></div></div></div><div content-id="CIU005C25" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C25"><div class="label">25</div><div class="citation element-citation"><div class="collab">Institute of Medicine</div>, <div class="source">Adverse effects of vaccines: evidence and causality</div> , <div class="year">2012</div><div class="publisher-name">The National Academies Press, Washington, D.C.</div><div class="citation-links"><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Adverse%20effects%20of%20vaccines%3A%20evidence%20and%20causality&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C26" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C26"><div class="label">26</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Salmon</div> <div class="given-names">DA</div></div>,  <div class="name"><div class="surname">Akhtar</div> <div class="given-names">A</div></div>,  <div class="name"><div class="surname">Mergler</div> <div class="given-names">MJ</div></div>, et al. </div><div class="article-title">Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program</div>, <div class="source">Pediatrics</div> , <div class="year">2011</div>, vol. <div class="volume">127</div> (pg. <div class="fpage">S78</div>-<div class="lpage">86</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Immunization-safety%20monitoring%20systems%20for%20the%202009%20H1N1%20monovalent%20influenza%20vaccination%20program&amp;author=DA%20Salmon&amp;author=A%20Akhtar&amp;author=MJ%20Mergler&amp;publication_year=2011&amp;journal=Pediatrics&amp;volume=127&amp;pages=S78-86" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1542/peds.2010-1722L" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1542%2Fpeds.2010-1722L" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1542%2Fpeds.2010-1722L"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/21502251" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Immunization-safety%20monitoring%20systems%20for%20the%202009%20H1N1%20monovalent%20influenza%20vaccination%20program&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C27" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C27"><div class="label">27</div><div class="citation element-citation"><div class="collab">Centers for Disease Control and Prevention</div><div class="article-title">Emerging Infections Program</div> <div class="comment">Available at: <a class="link link-uri" href="http://www.cdc.gov/ncezid/dpei/eip/">http://www.cdc.gov/ncezid/dpei/eip/</a> Accessed 28 November 2012</div></div></div></div></div><div content-id="CIU005C28" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C28"><div class="label">28</div><div class="citation element-citation"><div class="collab">Centers for Disease Control and Prevention</div><div class="article-title">Preliminary results: surveillance for Guillain-Barre syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine—United States, 2009–2010</div>, <div class="source">MMWR Morb Mortal Wkly Rep</div> , <div class="year">2010</div>, vol. <div class="volume">59</div> (pg. <div class="fpage">657</div>-<div class="lpage">61</div>)<div class="citation-links"><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/20520590" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Preliminary%20results%3A%20surveillance%20for%20Guillain-Barre%20syndrome%20after%20receipt%20of%20influenza%20A%20(H1N1)%202009%20monovalent%20vaccine%E2%80%94United%20States%2C%202009%E2%80%932010&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C29" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C29"><div class="label">29</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Tokars</div> <div class="given-names">JI</div></div>,  <div class="name"><div class="surname">Lewis</div> <div class="given-names">P</div></div>,  <div class="name"><div class="surname">DeStefano</div> <div class="given-names">F</div></div>, et al. </div><div class="article-title">The risk of Guillain-Barre syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009–2010 seasonal influenza vaccines: results from self-controlled analyses</div>, <div class="source">Pharmacoepidemiol Drug Saf</div> , <div class="year">2012</div>, vol. <div class="volume">21</div> (pg. <div class="fpage">546</div>-<div class="lpage">52</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=The%20risk%20of%20Guillain-Barre%20syndrome%20associated%20with%20influenza%20A%20(H1N1)%202009%20monovalent%20vaccine%20and%202009%E2%80%932010%20seasonal%20influenza%20vaccines%3A%20results%20from%20self-controlled%20analyses&amp;author=JI%20Tokars&amp;author=P%20Lewis&amp;author=F%20DeStefano&amp;publication_year=2012&amp;journal=Pharmacoepidemiol%20Drug%20Saf&amp;volume=21&amp;pages=546-52" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1002/pds.v21.5" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1002%2Fpds.v21.5" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1002%2Fpds.v21.5"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/22407672" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:The%20risk%20of%20Guillain-Barre%20syndrome%20associated%20with%20influenza%20A%20(H1N1)%202009%20monovalent%20vaccine%20and%202009%E2%80%932010%20seasonal%20influenza%20vaccines%3A%20results%20from%20self-controlled%20analyses&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C30" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C30"><div class="label">30</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Wise</div> <div class="given-names">ME</div></div>,  <div class="name"><div class="surname">Viray</div> <div class="given-names">M</div></div>,  <div class="name"><div class="surname">Sejvar</div> <div class="given-names">JJ</div></div>, et al. </div><div class="article-title">Guillain-Barre syndrome during the 2009–2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans</div>, <div class="source">Am J Epidemiol</div> , <div class="year">2012</div>, vol. <div class="volume">175</div> (pg. <div class="fpage">1110</div>-<div class="lpage">9</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Guillain-Barre%20syndrome%20during%20the%202009%E2%80%932010%20H1N1%20influenza%20vaccination%20campaign%3A%20population-based%20surveillance%20among%2045%20million%20Americans&amp;author=ME%20Wise&amp;author=M%20Viray&amp;author=JJ%20Sejvar&amp;publication_year=2012&amp;journal=Am%20J%20Epidemiol&amp;volume=175&amp;pages=1110-9" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1093/aje/kws196" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Faje%2Fkws196" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1093%2Faje%2Fkws196"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/22582209" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Guillain-Barre%20syndrome%20during%20the%202009%E2%80%932010%20H1N1%20influenza%20vaccination%20campaign%3A%20population-based%20surveillance%20among%2045%20million%20Americans&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C31" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C31"><div class="label">31</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Greene</div> <div class="given-names">SK</div></div>,  <div class="name"><div class="surname">Rett</div> <div class="given-names">M</div></div>,  <div class="name"><div class="surname">Weintraub</div> <div class="given-names">ES</div></div>, et al. </div><div class="article-title">Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the vaccine safety datalink project, 2009–2010</div>, <div class="source">Am J Epidemiol</div> , <div class="year">2012</div>, vol. <div class="volume">175</div> (pg. <div class="fpage">1100</div>-<div class="lpage">9</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Risk%20of%20confirmed%20Guillain-Barre%20syndrome%20following%20receipt%20of%20monovalent%20inactivated%20influenza%20A%20(H1N1)%20and%20seasonal%20influenza%20vaccines%20in%20the%20vaccine%20safety%20datalink%20project%2C%202009%E2%80%932010&amp;author=SK%20Greene&amp;author=M%20Rett&amp;author=ES%20Weintraub&amp;publication_year=2012&amp;journal=Am%20J%20Epidemiol&amp;volume=175&amp;pages=1100-9" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1093/aje/kws195" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Faje%2Fkws195" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1093%2Faje%2Fkws195"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/22582210" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Risk%20of%20confirmed%20Guillain-Barre%20syndrome%20following%20receipt%20of%20monovalent%20inactivated%20influenza%20A%20(H1N1)%20and%20seasonal%20influenza%20vaccines%20in%20the%20vaccine%20safety%20datalink%20project%2C%202009%E2%80%932010&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C32" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C32"><div class="label">32</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Yih</div> <div class="given-names">WK</div></div>,  <div class="name"><div class="surname">Lee</div> <div class="given-names">GM</div></div>,  <div class="name"><div class="surname">Lieu</div> <div class="given-names">TA</div></div>, et al. </div><div class="article-title">Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the post-licensure rapid immunization safety monitoring (PRISM) system, 2009–2010</div>, <div class="source">Am J Epidemiol</div> , <div class="year">2012</div>, vol. <div class="volume">175</div> (pg. <div class="fpage">1120</div>-<div class="lpage">8</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Surveillance%20for%20adverse%20events%20following%20receipt%20of%20pandemic%202009%20H1N1%20vaccine%20in%20the%20post-licensure%20rapid%20immunization%20safety%20monitoring%20(PRISM)%20system%2C%202009%E2%80%932010&amp;author=WK%20Yih&amp;author=GM%20Lee&amp;author=TA%20Lieu&amp;publication_year=2012&amp;journal=Am%20J%20Epidemiol&amp;volume=175&amp;pages=1120-8" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1093/aje/kws197" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Faje%2Fkws197" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1093%2Faje%2Fkws197"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/22582207" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Surveillance%20for%20adverse%20events%20following%20receipt%20of%20pandemic%202009%20H1N1%20vaccine%20in%20the%20post-licensure%20rapid%20immunization%20safety%20monitoring%20(PRISM)%20system%2C%202009%E2%80%932010&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C33" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C33"><div class="label">33</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Salmon</div> <div class="given-names">DA</div></div>,  <div class="name"><div class="surname">Proschan</div> <div class="given-names">M</div></div>,  <div class="name"><div class="surname">Forshee</div> <div class="given-names">R</div></div>, et al. </div><div class="article-title">Association between Guillain-Barre syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis</div>, <div class="source">Lancet</div> , <div class="year">2013</div>, vol. <div class="volume">381</div> (pg. <div class="fpage">1461</div>-<div class="lpage">8</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Association%20between%20Guillain-Barre%20syndrome%20and%20influenza%20A%20(H1N1)%202009%20monovalent%20inactivated%20vaccines%20in%20the%20USA%3A%20a%20meta-analysis&amp;author=DA%20Salmon&amp;author=M%20Proschan&amp;author=R%20Forshee&amp;publication_year=2013&amp;journal=Lancet&amp;volume=381&amp;pages=1461-8" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1016/S0140-6736(12)62189-8" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2FS0140-6736(12)62189-8" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1016%2FS0140-6736(12)62189-8"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/23498095" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Association%20between%20Guillain-Barre%20syndrome%20and%20influenza%20A%20(H1N1)%202009%20monovalent%20inactivated%20vaccines%20in%20the%20USA%3A%20a%20meta-analysis&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C34" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C34"><div class="label">34</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Dieleman</div> <div class="given-names">J</div></div>,  <div class="name"><div class="surname">Romio</div> <div class="given-names">S</div></div>,  <div class="name"><div class="surname">Johansen</div> <div class="given-names">K</div></div>, et al. </div><div class="article-title">Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe</div>, <div class="source">BMJ</div> , <div class="year">2011</div>, vol. <div class="volume">343</div> pg. <div class="fpage">d3908</div> <div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Guillain-Barre%20syndrome%20and%20adjuvanted%20pandemic%20influenza%20A%20(H1N1)%202009%20vaccine%3A%20multinational%20case-control%20study%20in%20Europe&amp;author=J%20Dieleman&amp;author=S%20Romio&amp;author=K%20Johansen&amp;publication_year=2011&amp;journal=BMJ&amp;volume=343&amp;pages=d3908" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1136/bmj.d3908" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1136%2Fbmj.d3908" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1136%2Fbmj.d3908"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/21750072" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Guillain-Barre%20syndrome%20and%20adjuvanted%20pandemic%20influenza%20A%20(H1N1)%202009%20vaccine%3A%20multinational%20case-control%20study%20in%20Europe&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C35" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C35"><div class="label">35</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Andrews</div> <div class="given-names">N</div></div>,  <div class="name"><div class="surname">Stowe</div> <div class="given-names">J</div></div>,  <div class="name"><div class="surname">Salman</div> <div class="given-names">RA-S</div></div>,  <div class="name"><div class="surname">Miller</div> <div class="given-names">E</div></div>. </div><div class="article-title">Guillain-Barre syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series</div>, <div class="source">Vaccine</div> , <div class="year">2011</div>, vol. <div class="volume">29</div> (pg. <div class="fpage">7878</div>-<div class="lpage">82</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Guillain-Barre%20syndrome%20and%20H1N1%20(2009)%20pandemic%20influenza%20vaccination%20using%20an%20AS03%20adjuvanted%20vaccine%20in%20the%20United%20Kingdom%3A%20self-controlled%20case%20series&amp;author=N%20Andrews&amp;author=J%20Stowe&amp;author=RA-S%20Salman&amp;author=E%20Miller&amp;publication_year=2011&amp;journal=Vaccine&amp;volume=29&amp;pages=7878-82" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1016/j.vaccine.2011.08.069" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2Fj.vaccine.2011.08.069" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1016%2Fj.vaccine.2011.08.069"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/21875631" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Guillain-Barre%20syndrome%20and%20H1N1%20(2009)%20pandemic%20influenza%20vaccination%20using%20an%20AS03%20adjuvanted%20vaccine%20in%20the%20United%20Kingdom%3A%20self-controlled%20case%20series&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C36" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C36"><div class="label">36</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Dodd</div> <div class="given-names">CN</div></div>,  <div class="name"><div class="surname">Romio</div> <div class="given-names">SA</div></div>,  <div class="name"><div class="surname">Black</div> <div class="given-names">S</div></div>, et al. </div><div class="article-title">International collaboration to assess the risk of Guillain Barre syndrome following influenza A (H1N1) 2009 monovalent vaccines</div>, <div class="source">Vaccine</div> , <div class="year">2013</div>, vol. <div class="volume">31</div> (pg. <div class="fpage">4448</div>-<div class="lpage">58</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=International%20collaboration%20to%20assess%20the%20risk%20of%20Guillain%20Barre%20syndrome%20following%20influenza%20A%20(H1N1)%202009%20monovalent%20vaccines&amp;author=CN%20Dodd&amp;author=SA%20Romio&amp;author=S%20Black&amp;publication_year=2013&amp;journal=Vaccine&amp;volume=31&amp;pages=4448-58" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1016/j.vaccine.2013.06.032" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2Fj.vaccine.2013.06.032" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1016%2Fj.vaccine.2013.06.032"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/23770307" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:International%20collaboration%20to%20assess%20the%20risk%20of%20Guillain%20Barre%20syndrome%20following%20influenza%20A%20(H1N1)%202009%20monovalent%20vaccines&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C37" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C37"><div class="label">37</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">De Wals</div> <div class="given-names">P</div></div>,  <div class="name"><div class="surname">Deceuninck</div> <div class="given-names">G</div></div>,  <div class="name"><div class="surname">Toth</div> <div class="given-names">E</div></div>, et al. </div><div class="article-title">Risk of Guillain-Barre syndrome following H1N1 influenza vaccination in Quebec</div>, <div class="source">JAMA</div> , <div class="year">2012</div>, vol. <div class="volume">308</div> (pg. <div class="fpage">175</div>-<div class="lpage">81</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Risk%20of%20Guillain-Barre%20syndrome%20following%20H1N1%20influenza%20vaccination%20in%20Quebec&amp;author=P%20De%20Wals&amp;author=G%20Deceuninck&amp;author=E%20Toth&amp;publication_year=2012&amp;journal=JAMA&amp;volume=308&amp;pages=175-81" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1001/jama.2012.7342" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1001%2Fjama.2012.7342" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1001%2Fjama.2012.7342"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/22782419" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Risk%20of%20Guillain-Barre%20syndrome%20following%20H1N1%20influenza%20vaccination%20in%20Quebec&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C38" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C38"><div class="label">38</div><div class="citation element-citation"><div class="collab">Centers for Disease Control and Prevention</div><div class="article-title">Influenza vaccination coverage FluVaxView</div> <div class="comment">Available at: <a class="link link-uri" href="http://www.cdc.gov/flu/fluvaxview/index.htm">http://www.cdc.gov/flu/fluvaxview/index.htm</a> Accessed 30 August 2013</div></div></div></div></div><div content-id="CIU005C39" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C39"><div class="label">39</div><div class="citation element-citation"><div class="collab">Centers for Disease Control and Prevention</div><div class="article-title">Fluview</div> <div class="comment">Available at: <a class="link link-uri" href="http://gis.cdc.gov/GRASP/Fluview/FluHospRates.html">http://gis.cdc.gov/GRASP/Fluview/FluHospRates.html</a> Accessed 29 August 2013</div></div></div></div></div><div content-id="CIU005C40" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C40"><div class="label">40</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Tam</div> <div class="given-names">CC</div></div>,  <div class="name"><div class="surname">O'Brien</div> <div class="given-names">SJ</div></div>,  <div class="name"><div class="surname">Petersen</div> <div class="given-names">I</div></div>,  <div class="name"><div class="surname">Islam</div> <div class="given-names">A</div></div>,  <div class="name"><div class="surname">Hayward</div> <div class="given-names">A</div></div>,  <div class="name"><div class="surname">Rodrigues</div> <div class="given-names">LC</div></div>. </div><div class="article-title">Guillain-Barre syndrome and preceding infection with <em>Campylobacter</em>, influenza and Epstein-Barr virus in the general practice research database</div>, <div class="source">PLoS One</div> , <div class="year">2007</div> <div class="comment">2:e344. doi:10.1371/journal.pone.0000344</div><div class="citation-links"><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Guillain-Barre%20syndrome%20and%20preceding%20infection%20with%20Campylobacter%2C%20influenza%20and%20Epstein-Barr%20virus%20in%20the%20general%20practice%20research%20database&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C41" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C41"><div class="label">41</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Verity</div> <div class="given-names">C</div></div>,  <div class="name"><div class="surname">Stellitano</div> <div class="given-names">L</div></div>,  <div class="name"><div class="surname">Winstone</div> <div class="given-names">AM</div></div>,  <div class="name"><div class="surname">Andrews</div> <div class="given-names">N</div></div>,  <div class="name"><div class="surname">Stowe</div> <div class="given-names">J</div></div>,  <div class="name"><div class="surname">Miller</div> <div class="given-names">E</div></div>. </div><div class="article-title">Guillain-Barre syndrome and H1N1 influenza vaccine in UK children</div>, <div class="source">Lancet</div> , <div class="year">2011</div>, vol. <div class="volume">378</div> (pg. <div class="fpage">1545</div>-<div class="lpage">6</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Guillain-Barre%20syndrome%20and%20H1N1%20influenza%20vaccine%20in%20UK%20children&amp;author=C%20Verity&amp;author=L%20Stellitano&amp;author=AM%20Winstone&amp;author=N%20Andrews&amp;author=J%20Stowe&amp;author=E%20Miller&amp;publication_year=2011&amp;journal=Lancet&amp;volume=378&amp;pages=1545-6" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1016/S0140-6736(11)61665-6" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2FS0140-6736(11)61665-6" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1016%2FS0140-6736(11)61665-6"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/22035553" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Guillain-Barre%20syndrome%20and%20H1N1%20influenza%20vaccine%20in%20UK%20children&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C42" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C42"><div class="label">42</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Dieleman</div> <div class="given-names">JP</div></div>,  <div class="name"><div class="surname">Romio</div> <div class="given-names">SS</div></div>,  <div class="name"><div class="surname">de Vries</div> <div class="given-names">CS</div></div>, et al. </div><div class="article-title">Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines—a multinational case control study in Europe</div>, <div class="source">Pharmacoepidemiol Drug Saf</div> , <div class="year">2011</div>, vol. <div class="volume">20</div> (pg. <div class="fpage">S258</div>-<div class="lpage">9</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Guillain-Barre%20syndrome%20and%20adjuvanted%20pandemic%20influenza%20A%20(H1N1)%202009%20vaccines%E2%80%94a%20multinational%20case%20control%20study%20in%20Europe&amp;author=JP%20Dieleman&amp;author=SS%20Romio&amp;author=CS%20de%20Vries&amp;publication_year=2011&amp;journal=Pharmacoepidemiol%20Drug%20Saf&amp;volume=20&amp;pages=S258-9" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1002/pds.v20.3" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1002%2Fpds.v20.3" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1002%2Fpds.v20.3"> </span></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Guillain-Barre%20syndrome%20and%20adjuvanted%20pandemic%20influenza%20A%20(H1N1)%202009%20vaccines%E2%80%94a%20multinational%20case%20control%20study%20in%20Europe&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C43" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C43"><div class="label">43</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Vellozzi</div> <div class="given-names">C</div></div>,  <div class="name"><div class="surname">Iqbal</div> <div class="given-names">S</div></div>,  <div class="name"><div class="surname">Stewart</div> <div class="given-names">B</div></div>,  <div class="name"><div class="surname">Tokars</div> <div class="given-names">JI</div></div>,  <div class="name"><div class="surname">DeStefano</div> <div class="given-names">F</div></div>. </div><div class="article-title">Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic</div>, <div class="source">Am J Public Health</div> , <div class="year">2014</div> <div class="comment">in press</div><div class="citation-links"><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Cumulative%20risk%20of%20Guillain-Barr%C3%A9%20syndrome%20among%20vaccinated%20and%20unvaccinated%20populations%20during%20the%202009%20H1N1%20influenza%20pandemic&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C44" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C44"><div class="label">44</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Greene</div> <div class="given-names">SK</div></div>,  <div class="name"><div class="surname">Rett</div> <div class="given-names">MD</div></div>,  <div class="name"><div class="surname">Vellozzi</div> <div class="given-names">C</div></div>, et al. </div><div class="article-title">Guillain-Barre syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-centered analysis in the vaccine safety Datalink, 2009–2011</div>, <div class="source">PLoS One</div> , <div class="year">2013</div>, vol. <div class="volume">8</div> pg. <div class="fpage">e67185</div> <div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Guillain-Barre%20syndrome%2C%20influenza%20vaccination%2C%20and%20antecedent%20respiratory%20and%20gastrointestinal%20infections%3A%20a%20case-centered%20analysis%20in%20the%20vaccine%20safety%20Datalink%2C%202009%E2%80%932011&amp;author=SK%20Greene&amp;author=MD%20Rett&amp;author=C%20Vellozzi&amp;publication_year=2013&amp;journal=PLoS%20One&amp;volume=8&amp;pages=e67185" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1371/journal.pone.0067185" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1371%2Fjournal.pone.0067185" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1371%2Fjournal.pone.0067185"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/23840621" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Guillain-Barre%20syndrome%2C%20influenza%20vaccination%2C%20and%20antecedent%20respiratory%20and%20gastrointestinal%20infections%3A%20a%20case-centered%20analysis%20in%20the%20vaccine%20safety%20Datalink%2C%202009%E2%80%932011&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div><div content-id="CIU005C45" xmlns:helper="urn:XsltStringHelper"><div class="ref false"><div class="ref-content" role="CIU005C45"><div class="label">45</div><div class="citation element-citation"><div class="person-group"><div class="name"><div class="surname">Kwong</div> <div class="given-names">JC</div></div>,  <div class="name"><div class="surname">Vasa</div> <div class="given-names">PP</div></div>,  <div class="name"><div class="surname">Campitelli</div> <div class="given-names">MA</div></div>, et al. </div><div class="article-title">Risk of Guillain-Barre syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study</div>, <div class="source">Lancet Infect Dis</div> , <div class="year">2013</div>, vol. <div class="volume">13</div> (pg. <div class="fpage">769</div>-<div class="lpage">76</div>)<div class="citation-links"><div class="google-scholar-ref-link"><a href="https://scholar.google.com/scholar_lookup?title=Risk%20of%20Guillain-Barre%20syndrome%20after%20seasonal%20influenza%20vaccination%20and%20influenza%20health-care%20encounters%3A%20a%20self-controlled%20study&amp;author=JC%20Kwong&amp;author=PP%20Vasa&amp;author=MA%20Campitelli&amp;publication_year=2013&amp;journal=Lancet%20Infect%20Dis&amp;volume=13&amp;pages=769-76" target="">Google Scholar</a></div><div class="crossref-doi"><a href="http://dx.doi.org/10.1016/S1473-3099(13)70104-X" target="">Crossref</a></div><div class="adsDoiReference hide"><a href="http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2FS1473-3099(13)70104-X" target="">Search ADS</a></div><div class="xslopenurl" style="display:none"><span class="inst-open-url-holders" data-targetid="10.1016%2FS1473-3099(13)70104-X"> </span></div><div class="pub-id"><a class="link link-pub-id" href="http://www.ncbi.nlm.nih.gov/pubmed/23810252" target="">PubMed</a></div><div class="worldcat-reference-ref-link js-worldcat-preview-ref-link" style="display:none"><a href="https://www.worldcat.org/search?q=ti:Risk%20of%20Guillain-Barre%20syndrome%20after%20seasonal%20influenza%20vaccination%20and%20influenza%20health-care%20encounters%3A%20a%20self-controlled%20study&amp;qt=advanced&amp;dblist=638" target="">WorldCat</a></div> </div></div></div></div></div></div>
<div class="copyright copyright-statement">Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.</div>
<span data-userhasaccess="True" id="UserHasAccess"></span>
</div>
</div>
</div>
<div class="widget widget-RelatedTags widget-instance-OUP_Article_RelatedTags_Widget">
</div>
<div class="widget widget-SolrResourceMetadata widget-instance-OUP_Article_ResourceMetadata_Widget">
</div>
<div class="widget widget-EditorInformation widget-instance-OUP_Article_EditorInformation_Widget">
</div>
<div class="widget widget-ArticleOpenScienceBadges widget-instance-OUP_Article_OpenScienceBadge_Widget">
</div>
<div id="ContentTabFilteredView"></div>
<div class="downloadImagesppt js-download-images-ppt st-download-images-ppt">
<a class="js-download-all-images-link" href="//oup.silverchair-cdn.com/DownloadFile/DownloadImage.aspx?image=&amp;PPTtype=SlideSet&amp;ar=355966&amp;xsltPath=~/UI/app/XSLT&amp;siteId=5269" id="lnkDownloadAllImages">Download all figures</a>
</div>
<div class="widget widget-ArticleDataRepositories widget-instance-Article_DryadLink">
</div>
<div class="comments">
<div class="widget widget-UserCommentBody widget-instance-UserCommentBody_Article">
<div class="comment-body__wrap">
<div class="comment-body__title" id="usercomments">
<h2>Comments</h2>
</div>
<div class="comment-body__number">
            0 Comments
        </div>
<div class="submitCommentPlaceHolder"><div class="widget widget-UserComment widget-instance-OUP_UserComment_Article">
<button class="btn comment-body__button" data-reveal="" id="comment-modal-opener">Add comment</button>
<div class="comment-form__modal medium reveal-modal" data-reveal="" id="divCommentModal">
<button class="comment-form__close btn-as-icon icon-general-close">
<span class="screenreader-text">Close comment form modal</span>
</button>
<div class="preloader-wrap hide">
<div class="preloader">
<div class="spinner"></div>
</div>
</div>
<div class="comment-form__wrap" data-reveal="" id="TermsAndConditionsContainer"></div>
<div class="comment-form__row--last terms-conditions" id="termsAgreeRow">
<input class="comment-form__input comment-form__checkbox" id="termsAndConditionsCheckbox" required="required" title="Terms and Conditions" type="checkbox"/>
<label class="comment-form__required-statement required" for="termsAndConditionsCheckbox">I agree to the terms and conditions.</label>
<label class="lblTermsAndConditions errors comment-form__error-label" for="termsAndConditionsCheckbox">
                    You must accept the terms and conditions.
                </label>
</div>
<div class="termsButtonRow comment-form__row" id="termsButtonRow">
<button class="btnUserAgreeTerms btn btn-grey" id="btnUserAgreeTerms">Add comment</button>
<button class="btnModalCancel btn btn-grey" href="#">Cancel</button>
</div>
<div class="comment-form__wrap" id="divUserCommentForm">
<div class="comment-form__title">Submit a comment</div>
<div class="comment-form__row">
<label class="comment-form__input-label required" for="Author">Name</label>
<input class="comment-form__input comment-form__textbox required" dataauthorvalue="" id="Author" maxlength="2000" name="Author" required="required" type="text" value=""/>
</div>
<div class="comment-form__row">
<label class="comment-form__input-label required" for="AffInstitution">Affiliations</label>
<input class="comment-form__input comment-form__textbox required" id="AffInstitution" maxlength="200" name="AffInstitution" required="required" type="text" value=""/>
</div>
<div class="comment-form__row">
<label class="comment-form__input-label required" for="Title">Comment title</label>
<input class="comment-form__input comment-form__textbox required" id="Title" maxlength="250" name="Title" required="required" type="text" value=""/>
</div>
<div class="comment-form__row">
<label class="comment-form__input-label required" for="Comment">Comment</label>
<textarea class="comment-form__input comment-form__textarea required" cols="20" id="Comment" maxlength="@Model.Config.CommentBodyCharLimit" name="Comment" required="required" rows="2"></textarea>
</div>
<div class="captchaAlert comment-form__error-label">
                    You have entered an invalid code
                </div>
<div class="submitRow comment-form__row">
<button class="btnUserCommentSubmit btn btn-grey" id="btnUserCommentSubmit">Submit</button>
<button class="btnModalCancel btn btn-grey" href="#">Cancel</button>
</div>
</div>
<div class="content-form__response comment-form__row">
<div class="content-form__response--success">
<div class="alertmsg content-form__response-text" id="displayAlert">
                        Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.
                    </div>
<button class="btnCommentModalExit content-form__response-button btn btn-grey">Close</button>
</div>
<div class="errors content-form__response--error" id="divError"></div>
</div>
</div>
<script type="text/javascript">

                            /*******************************************************************************
                             * JS here is only being used to assign variables from values in the model
                             * logic should be implemented in external JS files, like client.script.js
                             *******************************************************************************/

                            var SCM = SCM || {};
                            SCM.UserCommentView = SCM.UserCommentView || {};

                            SCM.UserCommentView.articleId = '355966';
                            SCM.UserCommentView.isUserLoggedIn = 'False';
                            SCM.UserCommentView.divId = 'WidgetNoAccessModalSmallOUP_UserComment_Article';
                            SCM.UserCommentView.bShowDisclosure = 'false';
                            SCM.UserCommentView.isNotModerated = 'false';
                            SCM.UserCommentView.showAffiliations = 'true';
                            SCM.UserCommentView.InstanceName = 'OUP_UserComment_Article';
                        </script>
</div></div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="page-column page-column--right" id="Sidebar" style="height: auto;">
<div class="widget widget-AdBlock widget-instance-ArticlePageTopSidebar">
<div data-google-query-id="CKid5erKsuMCFRga4AodYoAO0w" id="adBlockMainBodyTop" style=" ">
<div id="google_ads_iframe_/116097782/cid_Behind_Ad2_0__container__" style="border: 0pt none;"><iframe data-google-container-id="2" data-load-complete="true" frameborder="0" height="250" id="google_ads_iframe_/116097782/cid_Behind_Ad2_0" marginheight="0" marginwidth="0" name="google_ads_iframe_/116097782/cid_Behind_Ad2_0" scrolling="no" srcdoc="" style="border: 0px; vertical-align: bottom;" title="3rd party ad content" width="300"></iframe></div></div>
</div>
<div class="widget widget-dynamic" data-count="1">
<div class="widget-dynamic-inner-wrap">
<div class="widget widget-dynamic" data-count="11">
<div class="widget-dynamic-inner-wrap">
<div class="widget widget-ArticleLevelMetrics widget-instance-Article_RightRailB0Article_RightRail_ArticleLevelMetrics">
<div class="artmet-condensed-wrap clearfix">
<div class="artmet-condensed-stats clearfix">
<div class="artmet-item artmet-views">
<span class="artmet-number">8,745</span>
<span class="artmet-text">Views</span>
</div>
<div class="artmet-item artmet-citations">
<span class="artmet-number">
<a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=WOS:000334113700023&amp;DestLinkType=CitingArticles&amp;DestApp=ALL_WOS&amp;UsrCustomerID=61f30d8ae69c46f86624c5f98a3bc13a" target="">43</a>
</span>
<span class="artmet-text">Citations</span>
</div>
<div class="artmet-item artmet-altmetric">
<div class="widget widget-AltmetricLink widget-instance-ArticleLevelMetrics_AltmetricLinkSummary">
<div class="altmetric-embed" data-badge-type="donut" data-doi="10.1093/cid/ciu005" data-hide-no-mentions="false" data-uuid="95aab638-d8b4-ba7e-6cd5-f8810b90a1da" id="altmetricEmbedId" runat="server"><a href="https://www.altmetric.com/details.php?domain=academic.oup.com&amp;citation_id=2105903" style="display:inline-block;" target="_self">
<img alt="Article has an altmetric score of 39" height="64px" src="https://badges.altmetric.com/?size=128&amp;score=39&amp;types=mbtttfdg" style="border:0; margin:0; max-width: none;" width="64px"/>
</a></div>
<script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script>
</div>
</div>
</div>
<div class="artmet-modal-trigger-wrap clearfix">
<a class="artmet-modal-trigger" data-article-id="355966"><i class="icon-metrics"></i><span>View Metrics</span></a>
</div>
</div>
<div class="artmet-modal" id="MetricsModal">
<div class="artmet-modal-contents">
<a class="artmet-close-modal">×</a>
</div>
</div>
</div>
<div class="widget widget-Alerts widget-instance-Article_RightRailB0Article_RightRail_Alerts">
<div class="alertsWidget">
<h3>Email alerts</h3>
<div class="userAlert alertType-5">
<a aria-label="New issue alert" data-alerttype="5" data-userloggedin="False" role="link">New issue alert</a>
</div>
<div class="userAlert alertType-3">
<a aria-label="Advance article alerts" data-alerttype="3" data-userloggedin="False" role="link">Advance article alerts</a>
</div>
<div class="userAlert alertType-1">
<a aria-label="Article activity alert" data-alerttype="1" data-userloggedin="False" role="link">Article activity alert</a>
</div>
<div class="userAlert alertType-MarketingLink">
<a aria-label="Receive exclusive offers and updates from Oxford Academic" data-additionalurl="/my-account/communication-preferences" data-userloggedin="False" role="link">Receive exclusive offers and updates from Oxford Academic</a>
</div>
<div class="userAlertSignUpModal reveal-modal small" data-reveal="">
<div class="userAlertSignUp"></div>
<label class="screenreader-text" for="alert-signup-modal-close">Close</label>
<a class="close-reveal-modal" href="https://academic.oup.com/cid/article/58/8/1149/javascript:;" id="alert-signup-modal-close" role="button">
<i class="icon-general-close"></i>
</a>
</div>
</div>
</div>
<div class="widget widget-ArticleLinks widget-instance-Article_RightRailB0Article_RightRail_ArticleLinks">
</div>
<div class="widget widget-RelatedContent widget-instance-Article_RightRailB0Article_RightRail_RelatedContent">
<h3 class="article-widget-head">More on this topic</h3>
<div class="widget-related-content">
<div class="article-title"><a href="https://academic.oup.com/cid/article/65/10/1644/3980144">The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014–2015 Influenza Vaccine</a></div>
<div class="article-title"><a href="https://academic.oup.com/cid/article/61/2/171/329279">Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccination in Community-Dwelling Veterans</a></div>
<div class="article-title"><a href="https://academic.oup.com/cid/article/59/11/1519/1746422">Impact of Influenza B Lineage-Level Mismatch Between Trivalent Seasonal Influenza Vaccines and Circulating Viruses, 1999–2012</a></div>
<div class="article-title"><a href="https://academic.oup.com/cid/article/57/2/197/313432">Lack of Association of Guillain-Barré Syndrome With Vaccinations</a></div>
</div>
</div>
<div class="widget widget-RelatedArticleIn widget-instance-Article_RightRailB0Article_RightRail_RelatedArticleIn">
<h3 class="relatedArticleIn-title">Related articles in</h3>
<div class="relatedArticleIn-content">
<ul>
<li>
<a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=WOS:000334113700023&amp;DestLinkType=RelatedRecords&amp;DestApp=ALL_WOS&amp;UsrCustomerID=61f30d8ae69c46f86624c5f98a3bc13a">Web of Science</a>
</li>
<li>
<a href="https://scholar.google.com/scholar?q=related:https%3a%2f%2facademic.oup.com%2fcid%2farticle%2f58%2f8%2f1149%2f355966">Google Scholar</a>
</li>
</ul>
</div>
</div>
<div class="widget widget-RelatedPubMed widget-instance-Article_RightRailB0Article_RightRail_RelatedPubMed">
<h3 class="article-widget-head">Related articles in PubMed</h3>
<div class="widget-related-pubmed">
<div class="inner-content-wrap">
<div class="inner-content">
<div class="article-title"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/31200407" id="article_ArticleTitle" target="">[New in clinical laboratory diagnostics dermatophyte fungi in children with atopic dermatitis.]</a></div>
</div>
</div>
<div class="inner-content-wrap">
<div class="inner-content">
<div class="article-title"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/31200340" id="article_ArticleTitle" target="">Novel trisaccharide based phospholipids as immunomodulators.</a></div>
</div>
</div>
<div class="inner-content-wrap">
<div class="inner-content">
<div class="article-title"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/31200071" id="article_ArticleTitle" target="">Promiscuous T cell epitopes boosts specific IgM immune response against a P0 peptide antigen from sea lice in different teleost species.</a></div>
</div>
</div>
<div class="inner-content-wrap">
<div class="inner-content">
<div class="article-title"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/31199832" id="article_ArticleTitle" target="">Human response to live plague vaccine EV, Almaty region, Kazakhstan, 2014-2015.</a></div>
</div>
</div>
</div>
<!-- <div class="article-widget-foot">
    <div class="view-more">
            <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=((vaccines)+OR+(vaccination)+OR+(influenza+AND+virus+AND+vaccine)+OR+(guillain-barre+AND+syndrome))" id="Config_ViewMoreLink" class="view-more-link" target="_blank">View More</a>
    </div>
</div> -->
</div>
<div class="widget widget-ArticleCitedBy widget-instance-Article_RightRailB0Article_RightRail_ArticleCitedBy">
<div class="rail-widget_wrap vt-articles-cited-by">
<h3 class="article-cited-title">Citing articles via</h3>
<div class="widget-links_wrap">
<div class="article-cited-link-wrap web-of-science">
<a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=WOS:000334113700023&amp;DestLinkType=CitingArticles&amp;DestApp=ALL_WOS&amp;UsrCustomerID=61f30d8ae69c46f86624c5f98a3bc13a" target="">Web of Science (43)</a>
</div>
<div class="article-cited-link-wrap google-scholar-url">
<a href="http://scholar.google.com/scholar?q=link:https%3A%2F%2Facademic.oup.com%2Fcid%2Farticle%2F58%2F8%2F1149%2F355966" target="">Google Scholar</a>
</div>
<div class="article-cited-link-wrap crossref-citedby">
<a href="https://academic.oup.com/cid/CrossRef-CitedBy/355966">CrossRef</a>
</div>
</div>
</div>
</div>
<div class="widget widget-ArticleListNewAndPopular widget-instance-Article_RightRailB0Article_RightRail_ArticleNewPopularCombined">
<ul class="articleListNewAndPopularCombinedView">
<li>
<a class="articleListNewAndPopular-mode active" data-mode="MostRecent" href="https://academic.oup.com/cid/article/58/8/1149/javascript:;">Latest</a>
</li>
<li>
<a class="articleListNewAndPopular-mode" data-mode="MostRead" href="https://academic.oup.com/cid/article/58/8/1149/javascript:;">Most Read</a>
</li>
<li>
<a class="articleListNewAndPopular-mode" data-mode="MostCited" href="https://academic.oup.com/cid/article/58/8/1149/javascript:;">Most Cited</a>
</li>
</ul>
<section class="articleListNewPopContent articleListNewAndPopular-ContentView-MostRecent hasContent">
<div class="fb" id="newPopularList-Article_RightRailB0Article_RightRail_ArticleNewPopularCombined">
<div class="widget-layout widget-layout--vert">
<div class="widget-columns widget-col-1">
<div class="col">
<div class="widget-dynamic-entry">
<a href="https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciz639/5531905?searchresult=1">
<div class="widget-dynamic-journal-title">
                                   Pre-existing anti-neuraminidase antibodies are associated with shortened duration of influenza A (H1N1)pdm virus shedding and illness in naturally infected adults
                               </div>
<div class="widget-dynamic-journal-image-synopsis">
<div class="widget-dynamic-journal-synopsis">
</div>
</div>
</a>
</div>
<div class="widget-dynamic-entry">
<a href="https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciz642/5531897?searchresult=1">
<div class="widget-dynamic-journal-title">
                                   National safety survey of animal-use commercial probiotics and its spillover effects from farm to human: an emerging threat to public health
                               </div>
<div class="widget-dynamic-journal-image-synopsis">
<div class="widget-dynamic-journal-synopsis">
</div>
</div>
</a>
</div>
<div class="widget-dynamic-entry">
<a href="https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciz646/5531896?searchresult=1">
<div class="widget-dynamic-journal-title">
                                   Graded Dalbavancin Challenge in a Patient with Severe Vancomycin Hypersensitivity Reaction
                               </div>
<div class="widget-dynamic-journal-image-synopsis">
<div class="widget-dynamic-journal-synopsis">
</div>
</div>
</a>
</div>
<div class="widget-dynamic-entry">
<a href="https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciz648/5531895?searchresult=1">
<div class="widget-dynamic-journal-title">
                                   Blackwater fever in Ugandan children with severe anemia is associated with poor post-discharge outcomes. A prospective cohort study
                               </div>
<div class="widget-dynamic-journal-image-synopsis">
<div class="widget-dynamic-journal-synopsis">
</div>
</div>
</a>
</div>
<div class="widget-dynamic-entry">
<a href="https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciz649/5531894?searchresult=1">
<div class="widget-dynamic-journal-title">
                                   Community-Acquired Bacterial Meningitis In Adults With Cerebrospinal Fluid Leakage
                               </div>
<div class="widget-dynamic-journal-image-synopsis">
<div class="widget-dynamic-journal-synopsis">
</div>
</div>
</a>
</div>
</div>
</div>
</div></div>
</section>
<section class="articleListNewPopContent articleListNewAndPopular-ContentView-MostRead hide">
</section>
<section class="articleListNewPopContent articleListNewAndPopular-ContentView-MostCited hide">
</section>
</div>
<div class="widget widget-JobTarget widget-instance-Article_RightRailB0Article_RightRail_JobTarget">
<div class="wrapper">
<div class="header">
<a href="http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/">Looking for your next opportunity?</a>
</div>
<div class="jobs-list" id="jobs">
<div class="job">
<div class="job-position"><a href="https://Medicine-and-health-careernetwork.oxfordjournals.org/job/position-in-islamic-studies/49499590/20102/">Position in Islamic Studies</a></div>
<div class="job-location">
                        Cambridge, Massachusetts
                    </div>
</div>
<div class="job">
<div class="job-position"><a href="https://Medicine-and-health-careernetwork.oxfordjournals.org/job/chief-of-the-division-of-allergy-immunology-and-infectious-disease/48205777/20102/">CHIEF OF THE DIVISION OF ALLERGY,  IMMUNOLOGY AND INFECTIOUS DISEASE</a></div>
<div class="job-location">
                        New Brunswick, New Jersey
                    </div>
</div>
<div class="job">
<div class="job-position"><a href="https://Medicine-and-health-careernetwork.oxfordjournals.org/job/chief-of-the-division-of-allergy-immunology-and-infectious-disease/48205762/20102/">CHIEF OF THE DIVISION OF ALLERGY,  IMMUNOLOGY AND INFECTIOUS DISEASE</a></div>
<div class="job-location">
                        New Brunswick, New Jersey
                    </div>
</div>
<div class="job">
<div class="job-position"><a href="https://Medicine-and-health-careernetwork.oxfordjournals.org/job/specialist-respiratory-physician/49318002/20102/">Specialist - Respiratory Physician</a></div>
<div class="job-location">
                        Hamilton, Other / Non US
                    </div>
</div>
</div>
<div class="all-jobs"><a href="http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/">View all jobs</a></div>
<div class="sponsor-and-jobnetwork-links">
<div class="job-sponsor"><a href="http://global.oup.com/"><img alt="OXFORD University Press" src="https://academic.oup.com/data/Multimedia/oup-logo.svg"/></a></div>
<div class="job-network"><a href="http://globaljobs-careernetwork.oxfordjournals.org/home/index.cfm?site_id=20101"><img alt="Journals Career Network" src="https://academic.oup.com/data/Multimedia/journals-careers-network.svg"/></a></div>
</div>
</div>
</div>
</div>
</div>
</div>
</div> <div class="widget widget-AdBlock widget-instance-ArticlePageTopMainBodyBottom">
<div data-google-query-id="CKmd5erKsuMCFRga4AodYoAO0w" id="adBlockMainBodyBottom" style=" ">
<div id="google_ads_iframe_/116097782/cid_Behind_Ad3_0__container__" style="border: 0pt none;"><iframe data-google-container-id="3" data-load-complete="true" frameborder="0" height="250" id="google_ads_iframe_/116097782/cid_Behind_Ad3_0" marginheight="0" marginwidth="0" name="google_ads_iframe_/116097782/cid_Behind_Ad3_0" scrolling="no" srcdoc="" style="border: 0px; vertical-align: bottom;" title="3rd party ad content" width="300"></iframe></div></div>
</div>
</div>
</div>
<input id="hfArticleTitle" name="hfArticleTitle" type="hidden" value=""/>
<input id="hfArticleLeftNavStickyOffset" name="hfArticleLeftNavStickyOffset" type="hidden" value="29"/>
</div>
</section>
</div>
<div class="mobile-mask">
</div>
<section class="footer_wrap vt-site-footer">
<script src="https://s7.addthis.com/js/300/addthis_widget.js#pubid=xa-5265518246c10183&amp;domready=1" type="text/javascript"></script>
<script src="https://www.google.com/recaptcha/api.js?onload=onloadCallback&amp;render=explicit" type="text/javascript"></script>
<script src="https://cdn.jsdelivr.net/chartist.js/latest/chartist.min.js" type="text/javascript"></script>
<script src="//oup.silverchair-cdn.com/UI/app/jsdist/article-page.min.js" type="text/javascript"></script>
<script type="text/javascript">
        googletag.cmd.push(function () {
            
            googletag.pubads().setTargeting("jnlsdoi", "10.1093/cid/ciu005");
            googletag.enableServices();
        });
    </script>
<div class="widget widget-SitePageFooter widget-instance-SitePageFooter">
<div class="ad-banner ad-banner-footer">
<div class="widget widget-AdBlock widget-instance-FooterAd">
<div data-google-query-id="CKqd5erKsuMCFRga4AodYoAO0w" id="adBlockFooter" style=" ">
<div id="google_ads_iframe_/116097782/cid_Behind_Ad4_0__container__" style="border: 0pt none;"><iframe data-google-container-id="4" data-load-complete="true" frameborder="0" height="90" id="google_ads_iframe_/116097782/cid_Behind_Ad4_0" marginheight="0" marginwidth="0" name="google_ads_iframe_/116097782/cid_Behind_Ad4_0" scrolling="no" srcdoc="" style="border: 0px; vertical-align: bottom;" title="3rd party ad content" width="728"></iframe></div>
</div>
</div>
</div>
<div class="journal-footer journal-bg">
<div class="center-inner-row">
<div class="journal-footer-menu">
<ul>
<li class="link-1">
<a href="https://academic.oup.com/cid/pages/About">About Clinical Infectious Diseases</a>
</li>
<li class="link-2">
<a href="https://academic.oup.com/cid/pages/Editorial_Board">Editorial Board</a>
</li>
<li class="link-3">
<a href="https://academic.oup.com/cid/pages/General_Instructions">Author Guidelines</a>
</li>
<li class="link-4">
<a href="https://www.facebook.com/#!/IDSociety/">Facebook</a>
</li>
<li class="link-5">
<a href="https://twitter.com/IDSAInfo">Twitter</a>
</li>
</ul><ul> <li class="link-1">
<a href="https://academic.oup.com/cid/subscribe">Purchase</a>
</li>
<li class="link-2">
<a href="http://www.oxfordjournals.org/en/library-recommendation-form.html">Recommend to your Library</a>
</li>
<li class="link-3">
<a href="http://www.oupmediainfo.com/">Advertising and Corporate Services</a>
</li>
<li class="link-4">
<a href="http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/?t730=&amp;search=&amp;t732=469972&amp;t731=&amp;t733=&amp;t735=&amp;t737=&amp;max=25&amp;site_id=20102">Journals Career Network</a>
</li>
</ul>
</div>
<div class="journal-footer-affiliations">
<a href="https://academic.oup.com/cid" target="">
<img alt="Clinical Infectious Diseases" class="journal-footer-affiliations-logo" id="footer-logo-ClinicalInfectiousDiseases" src="//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_f1-1534435182.svg"/>
</a>
</div>
<div class="journal-footer-colophon">
<ul>
<li>Online ISSN 1537-6591</li>
<li>Print ISSN 1058-4838</li>
<li>Copyright © 2019 Infectious Diseases Society of America</li>
</ul>
</div>
</div>
</div>
</div>
<div class="oup-footer">
<div class="center-inner-row">
<div class="widget widget-SelfServeContent widget-instance-OupUmbrellaFooterSelfServe">
<div class="oup-footer-row journal-links">
<div class="global-footer selfservelinks">
<ul>
<li>
<a href="https://academic.oup.com/journals/pages/about_us">About Us</a>
</li>
<li>
<a href="https://academic.oup.com/journals/pages/contact_us">Contact Us</a>
</li>
<li>
<a href="http://global.oup.com/jobs">Careers</a>
</li>
<li>
<a href="https://academic.oup.com/journals/pages/help">Help</a>
</li>
<li>
<a href="https://academic.oup.com/journals/pages/access_purchase">Access &amp; Purchase</a></li>
<li>
<a href="https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions">Rights &amp; Permissions</a>
</li>
<li>
<a href="https://academic.oup.com/journals/pages/open_access">Open Access</a>
</li>
</ul>
</div>
<div class="global-footer selfservelinks">
<h4 class="title footerheader" id="global-footer-customer services">Connect</h4>
<ul>
<li>
<a href="https://academic.oup.com/my-account/communication-preferences">Join Our Mailing List</a>
</li>
<li>
<a href="http://blog.oup.com/">OUPblog</a>
</li>
<li>
<a href="http://twitter.com/oupacademic">Twitter</a>
</li>
<li>
<a href="https://www.facebook.com/OUPAcademic">Facebook</a>
</li>
<li>
<a href="http://www.youtube.com/playlist?list=PL3MAPgqN8JWioLLTkU4mlFM4-SNt-f1Xs">YouTube</a>
</li>
<li>
<a href="http://oupacademic.tumblr.com/">Tumblr</a>
</li>
</ul>
</div>
<div class="global-footer selfservelinks">
<h4>Resources</h4>
<ul>
<li><a href="https://academic.oup.com/journals/pages/authors">Authors</a></li>
<li><a href="https://academic.oup.com/journals/pages/librarians">Librarians</a></li>
<li><a href="https://academic.oup.com/journals/pages/societies">Societies</a></li>
<li><a href="https://academic.oup.com/journals/pages/sponsorship_and_advertising">Sponsors &amp; Advertisers</a></li>
<li><a href="https://academic.oup.com/journals/pages/press">Press &amp; Media</a></li>
<li><a href="https://academic.oup.com/journals/pages/agents">Agents</a></li>
</ul>
</div>
<div class="global-footer selfservelinks">
<h4>Explore</h4>
<ul>
<li><a href="http://global.oup.com/academic">Shop OUP Academic</a></li>
<li><a href="http://www.oxforddictionaries.com/">Oxford Dictionaries</a></li>
<li><a href="http://oxfordindex.oup.com/">Oxford Index</a></li>
<li><a href="https://www.epigeum.com/">Epigeum</a></li>
<li><a href="http://global.oup.com/">OUP Worldwide</a></li>
<li><a href="http://www.ox.ac.uk/">University of Oxford</a></li>
</ul>
</div>
<div class="OUP-mission">
<p>Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide</p>
<img alt="Oxford University Press" class="journal-footer-logo" height="42" src="//oup.silverchair-cdn.com/UI/app/svg/umbrella/oup-logo.svg" width="150"/>
</div>
</div>
<div class="oup-footer-row">
<div class="oup-footer-row-links">
<ul>
<li>Copyright © 2019 Oxford University Press</li>
<li><a href="https://global.oup.com/cookiepolicy/">Cookie Policy</a></li>
<li><a href="https://global.oup.com/privacy">Privacy Policy</a></li>
<li><a href="https://academic.oup.com/journals/pages/about_us/legal/notices">Legal Notice</a></li>
<li><a href="https://academic.oup.com/journals/pages/sitemap">Site Map</a></li>
<li><a href="https://academic.oup.com/journals/pages/about_us/legal/accessibility">Accessibility</a></li>
<li><a href="https://get.adobe.com/reader/">Get Adobe Reader</a></li>
</ul>
</div>
</div>
<style type="text/css">
    /* Issue right column fix for tablet/mobile */
    @media (max-width: 1200px) {
    .pg_issue .widget-instance-OUP_Issue {
    width: 100%;
    }
    }
</style>
</div>
</div>
</div>
<div class="ss-ui-only">
</div>
</section>
</div><div id="_atssh" style="visibility: hidden; height: 1px; width: 1px; position: absolute; top: -9999px; z-index: 100000;"><iframe id="_atssh335" src="https://s7.addthis.com/static/sh.e4e8af4de595fdb10ec1459d.html#rand=0.5465923775722832&amp;iit=1563044586118&amp;tmr=load%3D1563044586039%26core%3D1563044586107%26main%3D1563044586111%26ifr%3D1563044586123&amp;cb=0&amp;cdn=0&amp;md=0&amp;kw=&amp;ab=-&amp;dh=academic.oup.com&amp;dr=&amp;du=https%3A%2F%2Facademic.oup.com%2Fcid%2Farticle%2F58%2F8%2F1149%2F355966&amp;href=https%3A%2F%2Facademic.oup.com%2Fcid%2Farticle%2F58%2F8%2F1149%2F355966&amp;dt=Guillain-Barr%C3%A9%20Syndrome%2C%20Influenza%2C%20and%20Influenza%20Vaccination%3A%20The%20Epidemiologic%20Evidence&amp;dbg=0&amp;cap=tc%3D0%26ab%3D0&amp;inst=1&amp;jsl=1&amp;prod=undefined&amp;lng=en&amp;ogt=site_name%2Cupdated_time%2Cimage%2Curl%2Cdescription%2Ctitle%2Ctype%3Darticle&amp;pc=men&amp;pub=xa-5265518246c10183&amp;ssl=1&amp;sid=5d2a2aea2a29e6f9&amp;srf=0.01&amp;ver=300&amp;xck=0&amp;xtr=0&amp;og=type%3Darticle%26title%3DGuillain-Barr%25C3%25A9%2520Syndrome%252C%2520Influenza%252C%2520and%2520Influenza%2520Vaccination%253A%2520The%2520Epidemiologic%2520Evidence%26description%3DA%2520small%2520increased%2520risk%2520of%2520Guillain-Barr%25C3%25A9%2520syndrome%2520(GBS)%2520has%2520been%2520observed%2520following%2520influenza%2520vaccination%2520but%2520is%252010-fold%2520less%2520than%2520that%2520observed%2520following%2520the%25201%26url%3Dhttps%253A%252F%252Facademic.oup.com%252Fcid%252Farticle%252F58%252F8%252F1149%252F355966%26image%3Dhttps%253A%252F%252Foup.silverchair-cdn.com%252Foup%252Fbackfile%252FContent_public%252FJournal%252Fcid%252FIssue%252F58%252F8%252F0%252Fm_cid58_8.cover.gif%253FExpires%253D1626097536%2526Signature%253DZQaPvkWCHxcBbiFRoW5NLcgE2wn5Xc~3mY0y~5e77Od2wS144uqfpCooLOA3Vp6MMbEuDZWJy1caBawqqqvlcyZjiJN1JkltS1MsztkCDUw8lMZQq9QEVF0weYF8CPK37TbgiT~5k5TTpDIbf4dOnIC9adSnpf7ILdIxlLnCR0sGFlxtkOi5vE0aSzYCDxJZkaS8re2dOovBWMviRCJ9AFOK3IxuiKtIJojDP77elf8a~0oIvwds~HzS-A2n6A4xEfsB1IEO7AKRNxNxEIS0ZPnE1W6LT98cznLNvLngdc-i9oPUztRn52ZZFzqAaYLVsf7G2wvXBi561AjUg1-Gwg__%2526Key-Pair-Id%253DAPKAIE5G5CRDK6RD3PGA%26updated_time%3D2014-01-09%26site_name%3DOUP%2520Academic&amp;csi=undefined&amp;rev=v8.4.11-wp&amp;ct=1&amp;xld=1&amp;xd=1" style="height: 1px; width: 1px; position: absolute; top: 0px; z-index: 100000; border: 0px; left: 0px;" title="AddThis utility frame"></iframe></div><style id="service-icons-0"></style>
<div class="reveal-modal" data-reveal="" id="revealModal">
<div id="revealContent"></div>
<a class="close-reveal-modal" href="https://academic.oup.com/cid/article/58/8/1149/javascript:;"><i class="icon-general-close"></i><span class="screenreader-text">Close</span></a>
</div>
<div class="reveal-modal small" data-reveal="" id="NeedSubscription">
<div class="subscription-needed">
<h5>This Feature Is Available To Subscribers Only</h5>
<p><a href="https://academic.oup.com/sign-in">Sign In</a> or <a href="https://academic.oup.com/my-account/register?siteId=5269&amp;returnUrl=%2fcid%2farticle%2f58%2f8%2f1149%2f355966">Create an Account</a></p>
</div>
<a class="close-reveal-modal" href="https://academic.oup.com/cid/article/58/8/1149/355966/javascript:;"><i class="icon-general-close"></i><span class="screenreader-text">Close</span></a>
</div>
<div class="reveal-modal tiny" data-reveal="" id="noAccessReveal">
<p>This PDF is available to Subscribers Only</p>
<a class="hide-for-article-page" data-reveal="" id="articleLinkToPurchase"><span>View Article Abstract &amp; Purchase Options</span></a>
<div class="issue-purchase-modal">
<p>For full access to this pdf, sign in to an existing account, or purchase an annual subscription.</p>
</div>
<a class="close-reveal-modal" href="https://academic.oup.com/cid/article/58/8/1149/355966/javascript:;"><i class="icon-general-close"></i><span class="screenreader-text">Close</span></a>
</div>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML" type="text/javascript"></script>
<script src="//oup.silverchair-cdn.com/UI/app/jsdist/footer.min.js" type="text/javascript"></script>
<script src="//ouptag.scholarlyiq.com/ntpagetag.js"></script>
<noscript>
<img alt="Scholarly IQ" border="0" height="1" hspace="0" src="//ouptag.scholarlyiq.com/ntpagetag.gif?js=0" vspace="0" width="1"/>
</noscript>
<div class="reveal-modal" data-reveal="math-jax-load" id="math-jax-modal" style="display: none;"></div><div id="oupcookiepolicy_fancybox-tmp"></div><div id="oupcookiepolicy_fancybox-loading"><div></div></div><div id="oupcookiepolicy_fancybox-overlay"></div><div class="oupcookiepolicy_fancybox-ie" id="oupcookiepolicy_fancybox-wrap" style=""><div id="oupcookiepolicy_fancybox-outer"><div class="oupcookiepolicy_fancybox-bg" id="oupcookiepolicy_fancybox-bg-n"></div><div class="oupcookiepolicy_fancybox-bg" id="oupcookiepolicy_fancybox-bg-ne"></div><div class="oupcookiepolicy_fancybox-bg" id="oupcookiepolicy_fancybox-bg-e"></div><div class="oupcookiepolicy_fancybox-bg" id="oupcookiepolicy_fancybox-bg-se"></div><div class="oupcookiepolicy_fancybox-bg" id="oupcookiepolicy_fancybox-bg-s"></div><div class="oupcookiepolicy_fancybox-bg" id="oupcookiepolicy_fancybox-bg-sw"></div><div class="oupcookiepolicy_fancybox-bg" id="oupcookiepolicy_fancybox-bg-w"></div><div class="oupcookiepolicy_fancybox-bg" id="oupcookiepolicy_fancybox-bg-nw"></div><div id="oupcookiepolicy_fancybox-content"></div><a id=""></a><div id="oupcookiepolicy_fancybox-title"></div><a href="https://academic.oup.com/cid/article/58/8/1149/javascript:;" id="oupcookiepolicy_fancybox-left"><span class="fancy-ico" id="oupcookiepolicy_fancybox-left-ico"></span></a><a href="https://academic.oup.com/cid/article/58/8/1149/javascript:;" id="oupcookiepolicy_fancybox-right"><span class="fancy-ico" id="oupcookiepolicy_fancybox-right-ico"></span></a></div></div><script src="https://api.altmetric.com/v1/doi/10.1093/cid/ciu005?callback=_altmetric.embed_callback&amp;domain=academic.oup.com&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=21-13" type="text/javascript"></script><iframe id="GoogleSetNPA" name="GoogleSetNPA" style="display:none;position:fixed;left:-999px;top:-999px;width:0px;height:0px;"></iframe><iframe id="google_osd_static_frame_4770410435246" name="google_osd_static_frame" style="display: none; width: 0px; height: 0px;"></iframe></body></html>